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ABSTRACT
The mechanisms controlling the growth and development of Benign Prostate 
Hyperplasia (BPH), the most common non-malignant disorder found in men over the 
age of 70, are poorly understood. There is a shortage of relevant “in vitro” models 
suitable for studying this disease. The aim of this project was to develop a 
representative “in vitro” model system for the study of BPH.
Epithelial and fibroblast cell lines (Pre2.8 and S2.13 respectively) were derived from 
the same biopsy of BPH and immortalised using the temperature sensitive SV40 
large-T antigen construct. At 33°C the cells grow progressively under the influence of 
the SV40 large T-antigen, but at 39°C the conformation of the protein changes and the 
protein is no longer functional, so the cells stop dividing and are able to differentiate. 
When monolayer cultures were switched from 33°C to 37°C or 39°C, changes in 
morphology, cell size distribution and a reduction in cell proliferation were observed. 
Both cell lines expressed the 5oc-reductase type I enzyme, but did not express 
androgen receptor (AR) and did not secrete PSA and PAP, hence they are likely to be 
undifferentiated cells. Pre2.8 epithelial cells have a basal cell phenotype at 33°C and 
undergo limited differentiation at 37°C and 39°C. DNA profiling was used to confirm 
the origin of the cells. The cell lines were shown to be Mycoplasma-free. Both cell 
lines showed amplification of DNA on chromosome 20q, a region known to be 
associated with cell immortalisation.
In order to develop a representative model of BPH, Pre2.8 and S2.13 cells were mixed 
in 3-dimensional matrigel cultures and optimised in order to obtain the most suitable 
culture conditions to produce prostate-specific characteristics. The three-dimensional 
culture system consisted of epithelial cells surrounded by a layer of stromal cells and 
in some cases with the formation of acinus like structures. The 3-D model showed 
some prostate-specific characteristics, for instance the epithelial cells expressed the 
androgen receptor. The epithelial cells differentiated towards a luminal phenotype, 
expressing K8 and 18.
In conclusion, a matched pair of epithelial and stromal BPH cell lines has been 
established which show some typical characteristics of prostate cells and have been
grown in a three-dimensional culture. The model may be useful for studying the cell 
interactions that control the growth of benign prostate Hyperplasia.
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CHAPTER 1 
INTRODUCTION
1
1.1 THE PROSTATE
The prostate gland is part of the male reproductive system, producing secretions that 
contribute to the ejaculate. The prostate acts a bit like a junction box. It allows the tubes 
that transport sperm from each testicle and the tubes that drain from the seminal vesicles 
to meet and then empty their contents into the urethra. Some men develop problems 
urinating due to an enlarged prostate. The urethra has to pass through the prostate before 
reaching the penis. It is only in recent years that research into understanding the 
diseases, cancer and benign prostate hyperplasia (BPH) of the prostate has developed. 
This is partly due to the lack of in vitro models of these diseases, particularly BPH. The 
value of such models lies in their ability to increase understanding of the biology and 
development of these conditions. Relying on a continuous supply of human prostate 
tissue for research can be limiting, due to the difficulty in obtaining human tissue and 
also the limited lifespan of primary cells. If the optimum prostate model was developed 
it could have the potential to investigate therapeutic agents for the prevention or 
treatment of these diseases. This thesis concentrates on developing an in vitro model for 
BPH, in the hope to overcome the limitations (e.g. lack of cell differentiation) of current 
in vitro models.
1.1.1 Development And Hormone Control
The gland begins to develop at about the twelfth week of gestation. At birth the prostate 
weighs approximately 4g and at puberty enlarges to approximately 20g. It continues to 
grow throughout adult life by 1 to 2% per year, eventually causing the symptoms of 
benign prostatic hyperplasia (BPH) in approximately 25% of men (McConnell, 1998). 
Between weeks 10 and 12 of gestation, epithelial buds begin to grow out from the 
urogenital sinus to form the prostatic acini and ducts. These epithelial buds grow and 
branch into the surrounding mesenchyme until approximately week 16 of gestation 
(Kellokumpu-Lehtinen and Pelliniemi, 1988).
The development of the human urogenital tract during embryogenesis is initially similar 
in both sexes. The urogenital tract comprises the Wolffian (mesonephric) duct and the 
Mullerian (paramesonephric) duct and includes the urogenital sinus and testis.
Sexual differentiation and development rely on the availability of androgens, 
specifically testosterone and dihydrotestosterone (Coffey and Isaacs, 1981). 
Testosterone is converted to a more active form dihydrotestosterone (DHT) by the
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intracellular enzyme 5a-reductase (5a-R). 5a-R has two main isoforms, types 1 and 2, 
both of which are expressed in the human prostate (Andersson and Russell, 1990) 
(Jenkins et al., 1992a; Thigpen et al., 1993). When testosterone from testicular or 
adrenal sources reaches the prostate it can bind directly to the androgen receptor or be 
converted to DHT. DHT can then bind to the same androgen receptor, but with greater 
affinity than testosterone.
Testosterone is synthesised in the Leydig cells of the foetal testis (Wilson and Siiteri, 
1973) and mediates the development of the Wolffian duct into the epididymis, seminal 
vesicles and the vas deferens (George and Wilson, 1986; Warwick R and Williams PL 
eds, 2002). DHT is required for the development of the prostate and external male 
genitalia. Loss of function mutations in 5a-R2 results in pseudohermaphroditism, with 
incomplete development of the urogenital sinus and external genitalia. Such mutations 
also inhibit prostate growth, but do not affect the development of the Wolffian duct 
(Andersson et al., 1991; Goldstein and Wilson, 1975; Imperato-McGinley et al., 1974).
1.1.2 Anatomy
The prostate is a small gland that lies immediately below the bladder (see figure 1.1). Its 
shape has been described as an inverted pyramid. The prostatic urethra runs from the 
bladder neck proximally to the membranous urethra distally. An angulation of 
approximately 35 degrees occurs midway along the prostatic urethra. This is called the 
verumontanum, and is an embryological remnant located where the ejaculatory ducts 
enter just below the urethral crest. The internal sphincter, which prevents retrograde 
ejaculation, surrounds the proximal urethra at the bladder neck. Ejaculatory contents are 
synthesised and stored in the seminal vesicles, which are connected to the urethra by the 
ejaculatory duct and are situated behind the bladder.
Currently, the most widely accepted anatomical model of the prostate is that proposed 
by (McNeal, 1968). He divided the prostate gland into 4 zones, the transition zone, the 
central zone, the peripheral zone and the anterior fibromuscular stroma (see figure 1.2). 
The transition zone is the smallest portion (5 to 10%) of the glandular tissue and 
surrounds the urethra above the verumontanum. The central zone makes up 
approximately 25% of the glandular prostate. It is a cone shaped region between the 
base of the prostate and the verumontanum, surrounding the ejaculatory ducts, making 
up much of the base of the prostate. The peripheral zone is the largest part (65 to 70%)
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o f  the glandular prostate and extends tow ards the an terior in a horseshoe shape. The 
anterior fibrom uscular strom a m akes up one third o f  the prostate volum e.
Figure 1.1: Anatomy Of Prostate
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Central tendon
Urinary
bladder
Prostate gland 
Denonvilliers' fascia
Symphysis pubis
Area where testis 
should be locatedCorpus spongiosum
Sagittal View O f The Male Pelvis. The growth o f the prostate is controlled by testosterone, the 
male sex hormone. Most testosterone is made by the testis, travelles into the bloodstream and 
finds its way to the prostate. The testis (not shown in diagram) are situated anterior to the 
rectum, with one to the right and left, just behind the penis.
Dorsal vein 
of penis
Puboprostate
ligament
Intermediate anterior 
urethral ligament
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Figure 1.2: Zonal Anatomy Of The Prostate
Zonal anatomy of the prostate in Antero-Posterior (AP) and sagittal planes (SP) showing central 
zone (CZ), peripheral zone (PZ) and transition zone (TZ).
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1.1.3 Morphology And Histology
The human prostate consists of a complex array of secretory ducts and acini surrounded 
by stroma (see figure 1.3). The epithelium consists of two layers, the luminal and basal 
layers. Luminal cells are tall and columnar, and overlay flattened, elongated basal cells 
that rest on a basement membrane. The supporting stroma includes smooth muscle cells, 
fibroblasts, myofibroblasts, blood vessels, nerve terminals and lymphatics (Aumuller, 
1983). The stromal cells are embedded in a loose collagenous extracellular matrix, 
providing mechanical support.
(McNeal, 1968) described zonal differences between the acini. The central zone 
contains large irregular shaped acini folding into luminal ridges. The luminal epithelial 
cells contain large, pale nuclei positioned in an irregular fashion within a granulated 
cytoplasm. The stroma of the central zone contains long tightly packed smooth muscle 
cells aligning the contours of the acini. The peripheral zone acini are small and round 
with no obvious projections. The basal cells contain a small, dark nucleus in a clear 
cytoplasm. The stroma contains loose, randomly arranged smooth muscle cells. The 
acini of the transition zone are similar to those in the peripheral zone.
The transition zone is the site of development of BPH, while the majority of cancers 
develop in the peripheral zone. Although the peripheral and transition zones are similar 
histologically, BPH does not develop in the peripheral zone.
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Figure 1.3: M orphology O f BPH Tissue
Low power magnification showing H&E staining of a Benign Prostatic Hyperplasia nodule. A 
indicates the acinus, M indicates the fibromuscular connective tissue/stroma.
1.1.4 Cell Types
Epithelial Cells
Prostate epithelium  contains 3 distinct cell populations; the secretory lum inal, the 
proliferative basal and the neuroendocrine (NE) cells. These cell populations can be 
distinguished by their proliferative capacity, horm onal sensitivity and cytokeratin 
expression (table 1.1).
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Table 1.1: Characteristics Of Prostate Epithelial Cells
Markers Basal cells Luminal
cells
Neuroendocrine cells
Cytokeratin K5/K14 K8/K18 Mixed basal and luminal 
(complex - K5/K8)
Proliferation Ki-67
Secretion PSA, PAP Chromogranin A
Hormone
Receptor
AR Serotonin, calcitonin
Other Bcl-2, CD44, 
p63
CD57 CD56
The proliferation-associated antigens Ki-67 (Gerdes et al., 1984; Hudson et al., 2001a), 
PCNA and MIB-1 (Cattoretti et al., 1992) have been used to measure the proliferative 
capacity of epithelial cells. These markers, together with DNA cell cycle distribution 
indicate that the basal cells are the main proliferative compartment (BonkhofF et al., 
1994; Dermer, 1978; Merchant et a l, 1983). Co-expression of proliferation markers 
with the neuroendocrine marker chromogranin A has not been observed (Bonkhoff et 
al., 1991). Less than 20% of Ki-67 positive cells are in the luminal layer and most of 
these are in an intermediate position between the basal and luminal layers, while the 
remaining 80% are in the basal layer (Hudson et al., 2001a).
The luminal cells express prostate specific antigen (PSA), prostatic acid phosphatase 
(PSAP), prostate specific membrane antigen (PSMA) (Lilja and Abrahamsson, 1988), 
and androgen receptor (Masai et al., 1990). The basal cells are believed to be androgen 
independent, although there is evidence that the basal cells express nuclear receptors for 
estrogens and progesterone (Ruizeveld de Winter et al., 1991) (Wemert et al., 1988). 
NE cells express the secretory granules of the peptide chromogranin A (Xue et al., 
1998) and serotonin, a neurotransmitter and hormone, (Capella et al., 1981; di 
Sant’Agnese et al., 1985; Fetissof et al., 1983). Some NE cells contain calcitonin 
(Abrahamsson et al., 1986; di SantAgnese and Mesy Jensen, 1984; di Sant'Agnese et 
al., 1989; Fetissof et al., 1986).
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Cytokeratins are a family of 20 polypeptides that form the intermediate filaments of 
epithelial cells. These cell markers have been fundamental in establishing the 
differentiation pattern of epithelial cells. In the prostate the luminal cells express 
keratins (K) 8 and 18, while the basal cells express K5 and K14. An intermediate basal 
cell population expresses K5 with low levels of K8 (Peehl et al., 1994; Purkis et al., 
1990; Xue et al., 1998). Basal cells may also express K17 (Hudson et al., 2001b; 
Troyanovsky et al., 1989). Keratin 19 can be expressed by luminal and basal cells 
(Hudson et al., 2001b; Peehl et al., 1996).
The bcl-2 proto-oncogene is expressed by the basal cells of the prostate (Hockenbery et 
al., 1991; McDonnell et al., 1992). The basal cells express the surface membrane marker 
CD44, distinguishing them from the luminal cells, which express CD57 (Terpe et al., 
1994; Liu et al., 1997). The p63 gene is expressed in normal prostate basal cells only. It 
is thought that this gene is involved in prostate development (Signoretti et al., 2000).
Stromal Cells
The prostate stroma contains smooth muscle cells, fibroblasts, and an intermediate type 
called myofibroblasts (Zhang et al., 1997). Smooth muscle cells make up the largest 
part of prostate stroma (Shapiro et al., 1992).
Like epithelial cells, stroma can be differentially characterised using staining for 
intermediate filaments, including desmin, vimentin and myosin (see table 1.2). Desmin 
forms an interconnecting network across muscle cells. Smooth muscle a-actin (SMA) is 
the major constituent of the microfilaments involved in smooth muscle contraction 
(Darnell, 1986). Vimentin is expressed in all stromal cells and can be used to 
differentiate epithelial cells from stromal cells.
Further characterisation is achieved using SMA (Skalli et al., 1986), myosin and 
desmin, which are expressed in smooth muscle cells but not in fibroblasts (Peehl and 
Sellers, 1997; Zhang et al., 1997). SMA stains twice as many smooth muscle cells as 
desmin, indicating that desmin underestimates the number of smooth muscle cells 
(Peehl and Sellers, 1997; Shapiro et al., 1992). SMA is also expressed in 
myofibroblasts. This means that desmin negative smooth muscle cells are actually 
myofibroblasts.
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The cell adhesion molecule CD44 is expressed in some stromal cells (Fry et al., 2000a) 
and androgen receptor (AR) is expressed in approximately 50% of stromal cells 
(Janssen et a l, 1994).
Table 1.2: Characteristics Of Prostate Stromal Cells
Markers Smooth muscle Myofibroblast Fibroblast
Stromal cell markers 
(intermediate filaments)
Vimentin, SMA, 
SM-Myosin
Vimentin, SMA Vimentin
Hormone AR, ER AR, ER AR, ER
Others CD44 CD44 CD44
1.1.5 Biochemistry
Luminal epithelial cells secrete prostate specific antigen (PSA) (Sinha et al., 1987) and 
prostate acid phosphatase (PSAP) (Lin et al., 1992) PSA and PSAP production are 
under the control of androgens via the androgen receptor.
PSA is a 34 kilodalton, 240-amino acid glycoprotein and is a member of the human 
kallikrein (hGK-1) family (Henttu and Vihko, 1989; Riegman et al., 1989). PSA is a 
serine protease (Watt et al., 1986) that acts like the digestive enzymes chymotrypsin and 
trypsin. PSA is secreted into the seminal fluid where it plays a role in semen 
liquification.
PSAP is a 100 kilo-Dalton dimer (Ostrowski and Kuciel, 1994) and is the major 
phosphotyrosyl (p-tyr) protein phosphatase in prostate epithelial cells (Lin et al., 1992; 
Ostrowski and Kuciel, 1994). It is thought that PSAP is also involved in liquefaction of 
semen and maintenance of sperm motility.
Other secretory products of the prostate include the trace elements selenium, zinc and 
cadmium. The prostate has a higher concentration of zinc than any other human tissue. 
Zinc and selenium are important in reproduction in males and females (Zhang et al., 
1997; Bedwal and Bahuguna, 1994). Zinc deficiency leads to depletion of testosterone 
and inhibition of spermatogenesis. It is thought that zinc extends the life span of the 
ejaculated spermatozoa.
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Selenium is found in sperm mitochondria (Hansen and Deguchi, 1996) and its 
deficiency may be associated with male infertility. It is suggested that selenium may be 
important in prostate cancer prevention (Wynder et al., 1994).
Citrate is produced, accumulated and secreted by the mitochondria of the prostate 
epithelial cells. A much higher level of citrate is found in the prostate compared to other 
tissues in the body, probably because there is limited citrate oxidation via the Krebs 
cycle in the prostate (Costello and Franklin, 1997). It is thought that the high levels of 
zinc in prostate mitochondria inhibit citrate oxidation and hence it is an inefficient 
energy metabolite (Costello and Franklin, 1981). A continuous supply of aspartate and 
glucose is required for citrate production. Aspartate is converted to oxaloacetate (OAA), 
which is converted to acetyl-CoA (AcCoA) (CoA meaning coenzyme acetylation) while 
producing citrate. The end products of glucose metabolism are lactate and citrate, due to 
the conversion of glucose to pyruvate and AcCoA. It is thought that testosterone and 
prolactin regulate this cycle (Costello and Franklin, 1994; Costello et al., 1996; Franklin 
and Costello, 1990).
1.2 BENIGN PROSTATIC HYPERPLASIA (BPH)
Benign prostatic hyperplasia (BPH) develops in the majority of men as they age. BPH 
occurs in the transition zone (McNeal, 1978). Symptoms seldom develop before the age 
of 30, but the incidence increases rapidly after the age of 50. Most older men have 
microscopic BPH (Bartsch et al., 1979), 50% will go on to develop macroscopic BPH 
(enlarged prostate) and 50% of these will develop clinical symptoms (Birkhoff et al., 
1976; Lytton et al., 1968). BPH seldom reduces life expectancy, but it has a major 
impact on quality of life.
There are only two definitive risk factors known, advancing age and the presence of 
androgens. The average weight of an adult human prostate with normal histology is 20g 
± 6. This will slowly increase to approximately 33g ±16 with the development of BPH 
in the ageing man. Only 4% of prostates with BPH will increase to lOOg by the seventh 
decade (Berry et al., 1984). BPH does not develop in men who have been castrated 
before puberty (Boyle, 1990). It is thought that the change in the ratio between 
testosterone and estrogen may drive the growth of BPH.
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Although the causes of BPH are not clear it is thought that inherited and environmental 
factors are involved in BPH. The incidence is lower in Asia than in Europe, but is 
increasing in Japan, perhaps due to the adoption of a diet containing more animal fat 
(Chyou et al., 1993a). Family history is also associated with BPH (Sanda et al., 1994). 
Diet may influence pathogenesis, but there is little supporting evidence. A high fat diet 
increases the levels of the hormone prolactin, which may increase the risk of BPH 
because of its effect on the proliferation of prostatic epithelium. An intake of greater 
than 25oz (equivalent to 708g or 0.741itres or 6 units) of alcohol per month may reduce 
the incidence of BPH (Chyou et al., 1993b).
1.2.1 Etiology Of BPH
There are three main hypotheses to explain the pathogenesis of BPH. These hypotheses 
are based on (1) hormones (2) stromal-epithelial interaction and (3) stem cells.
The hormonal theory
The hormonal theory is based on the fact that a testicular function is required for BPH 
development (Isaacs and Coffey, 1989b), as BPH does not occur in men castrated prior 
to puberty. Androgen withdrawal in non-castrated adults leads to a reversible decrease 
in prostate size (Bosch et al., 1989), also indicating a role for androgen in the 
development and maintenance of BPH.
One theory suggests that the main factor responsible for the development of BPH is an 
age associated increase in DHT levels (Salm et al., 2000). This theory was based on data 
suggesting that DHT levels are higher in BPH tissue than in normal tissue. However, 
this was proven to be incorrect because some of the tissue specimens were obtained 
from cadavers and hormone levels change during the period taken to collect the 
samples. Comparison of previous results with results obtained from BPH and normal 
tissue, collected immediately showed that there was no difference between DHT levels 
in BPH tissue and normal tissue (Isaacs et al., 1983).
Another theory suggests that synergism between oestrogen and androgen may play a 
role in BPH pathogenesis. BPH was induced in dogs by treatment with oestrogen 
androstane-3,17-diol (a DHT derivative) but not with oestrogen alone (Walsh and 
Wilson, 1976; Bartsch et al., 1987). BPH induced with oestradiol and oestrogen 
androstane-3,17-diol is more severe than with androgen alone (Walsh and Wilson,
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1976). It was also shown that BPH tissue contains less oestrogen receptors than normal 
tissue (Isaacs et al., 1983). Alterations in the ratio of androgen to oestrogen may be 
associated with abnormal prostate growth (Griffiths et al., 1991).
Stromal-Epithelial Interaction Theory
The stromal-epithelial interaction theory was initially suggested by Rischemer in 1925. 
He suggested that BPH was a stromal nodule that induced migration of epithelial cells 
resulting in the formation of new acini. In 1978 McNeal suggested that the primary 
lesion of BPH was a glandular budding and branching mechanism that gave rise to new 
acini in the transition zone. He suggested that this mechanism was a reawakening of the 
embryonic potential of prostatic stroma to induce epithelial growth during adulthood 
(McNeal, 1978).
Mouse embryonic mesenchyme can induce bladder epithelial cells to form prostate-like 
glandular structures (Cunha et al., 1983) in the presence of a functioning testis. The 
mechanism of "reawakening" is unknown, but could involve growth factors (Lawson, 
1997) (Griffiths et al., 1998) or the basement membrane (Mawhinney et al., 1974).
Stem Cell Theory
Stem cells are cells that have the ability to self renew and proliferate. Transit amplifying 
(TA) cells originate from stem cells and proliferate for a limited number of cell 
divisions. TA cells divide to form luminal non-proliferative cells. Clonal expansion of 
TA cells eventually results in the prostate growing to its maximal normal size. The stem 
cell theory suggests an imbalance between the growth of new cells and the maturation 
and death of older cells (Isaacs and Coffey, 1989a).
In the normal prostate, proliferation and cell death are in equilibrium. Some alteration in 
this equilibrium may cause BPH. Two possibilities have been suggested: either an 
abnormal increase in stem cell numbers or an abnormal increase in the number of TA 
cells would produce an enlarged prostate.
1.2.2 Clinical Presentation
Symptoms
Patients with BPH can present with lower urinary tract symptoms (LUTS). LUTS are 
veiy common and can be influenced by many factors (including malignancy, infection,
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inflammation, neurological, mechanical and drugs), and so it is important to confirm the 
underlying cause (Blaivas, 1996).
LUTS symptoms are due to obstruction and/or irritation. Obstructive symptoms include 
hesitancy, poor stream and incomplete emptying, while irritative symptoms include 
nocturia, frequency and urgency. The symptoms are influenced by the increase in the 
size of the prostate and dysfunction of the bladder muscle (Blaivas, 1996; Madsen and 
Bruskewitz, 1995a).
Diagnosis
A detailed medical history including patient quality of life (QOL) must be taken. The 
quality of life can be examined by completing a symptom score sheet. The most 
common is the International Prostate Symptom Score (IPSS). Each score determines 
whether a patient has mild (0-7), moderate (8-19) or severe (20-35) symptoms (Barry et 
al., 1992).
Physical examination
A digital rectal examination (DRE) can be carried out to examine the prostate and help 
distinguish between BPH, prostatitis and prostate cancer. A neurologic examination 
would help rule out neurological disorders as a cause of LUTS (McConnell et al., 
1994a; Ziada et al., 1999).
Urine Analysis
In order to rule out urinary tract infection and hematuria, urine analysis using a dipstick 
test or by examination of spun sediment can be done (Madsen and Bruskewitz, 1995b).
PSA levels
PSA analysis has advantages and disadvantages. It is not specific in distinguishing 
between BPH and prostate cancer, but it is the most sensitive and simple test available. 
When PSA and DRE results are combined it becomes a more reliable (Tchetgen and 
Oesterling, 1995). Serum PSA levels greater than 4.0 mg/ml may be indicative of BPH 
or cancer (McConnell JD, 1994).
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Urine Flow Rate
This test is a measure of the maximum flow rate (Qmax) and the rate of flow. This test 
requires a fluid volume of at least 150ml in order to be accurate. A flow rate of less than 
15ml per second is significant for bladder outlet obstruction (BOO) (McConnell et al., 
1994a; Garraway et al., 1993; Chancellor et al., 1991).
Residual Volume
Residual volume is the volume of fluid left in the bladder after void is complete. Greater 
than 150ml is a significant residual volume (McConnell et al., 1994b).
Urodynamics /Pressure flow rate
Urodynamics can be carried out if there is no definitive diagnosis. This is a 
measurement of the pressure in the bladder during voiding. It is carried out by passing a 
pressure transducer into the rectum and one into the bladder to record the change in 
pressure as the bladder fills and as the bladder voids into the flow meter. Patients who 
have pressure flow obstruction due to BPH generally respond better to surgery than 
those who have no obstruction (Griffiths, 1996; McConnell et al., 1994b).
1.2.3 Treatment
Surgery is no longer the only option for the treatment of BPH. Initially LUTS must be 
confirmed as the cause of BPH. Once a diagnosis of BPH is confirmed a decision must 
be made between the patient and the urologist as to what treatment would be preferred. 
The choice of treatment is watchful waiting, medical therapies or surgery. In order to 
make this decision IPSS, quality of life, flow-rate and residual volume must be taken 
into consideration (Ziada et al., 1999; Lepor H, 2002; Altwein JE, 2002).
Watchful Waiting
If the patient has mild symptoms and there are no apparent complications then watchful 
waiting is often the preferred option. The doctor and patient decide not to treat the 
symptoms immediately. Instead they wait and see if symptoms improve or deteroriate 
over time. Follow-ups are carried out after 6-12 months. Improved symptoms are seen 
in approximately 25% of cases, 50% stay the same and 25% deteriorate (Lepor, 2002).
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Medical Treatment
Medical treatment is carried out for mild or moderate symptoms. There are two classes 
of drug, alpha-blockers and 5-a reductase inhibitors (Lepor, 2002).
The effect of a-Blockers is to relax smooth muscle in the bladder neck and in the 
prostate. Smooth muscle contraction in the prostate is mediated by the alpha-1 
adrenoceptor (al-AR) (Hieble et al., 1985; Lepor et al., 1988). a-Blockers target the 
symptoms and their effectiveness seems to be independent of prostate size and 
obstruction. The first a  1-blocker was Phenoxybenzamine, which had many side effects. 
Currently the drugs in use are Praxosin, Indoramin, Infuzosin, Doxazosin and 
Terazosin, all of which have fewer side effects. More recently an cxia blocker has been 
produced, which has even fewer side effects due to a  1-blockade in the brain and 
cardiovascular system.
The efficacy of al-blockers is dose dependent. It is claimed that there is a 20-50% 
improvement of IPSS and therefore an improved QOL. Flow-rate is improved by 20- 
30% (2-3ml/sec). A quick response (48 hrs) is observed after treatment and 
effectiveness can be maintained for 3-4 years, after which the symptoms become 
resistant to the drug.
The most common side effects are tiredness, dizziness and headaches. Less common 
side effects are asthenia, palpitations and gastrointestinal disturbances (nausea, 
vomiting, constipation and diarrhoea). There is also a risk of postural hypertension 
(lowering of blood pressure).
The conversion of testosterone to dihydrotestosterone (DHT) is blocked by 5a-R 
inhibitors and result in reduced prostate size. 5a-R inhibitors aim to treat the disease, 
unlike a-blockers which treat the symptoms. There are two 5a-R isozymes (type I and 
II) (Jenkins et al., 1992b). The most frequently prescribed drug is Finasteride, which 
selectively inhibits 5a-R type II (Vermeulen et al., 1989).
Finasteride is thought to be most effective if the prostate is greater than 40ml in size. It 
is claimed to reduce prostate size by 20-30%. It improves IPSS by 15% and flow rates 
by 1.3-1.6 mL/sec and therefore QOL is improved. 5a-R inhibitors take 6 months to
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achieve maximum effect, which can be maintained for 6 years, after which the disease 
becomes resistant to the drug. The incidence of subsequent acute urinary retention is 
reduced (Polat et al., 1997).
Side effects include ejaculatory disorders and impotence. PSA levels tend to be reduced 
by half over a 12-month period (Guess et al., 1993). This should be taken into 
consideration in order not to miss the possible onset of prostate cancer.
Studies comparing terazosin, finasteride and placebo showed that although finasteride 
caused the prostate to shrink, its effectiveness at increasing urinary flow was little better 
than placebo and less than terazosin. 5a-R inhibitors do not seem to be as effective at 
relieving symptoms as a-blockers. The drugs of choice are a-Blockers unless there is 
substantial prostatic enlargement. In this case treatment with finasteride may be 
beneficial.
Phytotherapeutic agents are chemicals derived from plant extracts that have been used 
for the treatment of BPH. These herbal remedies have not been sufficiently evaluated in 
clinical trials and the mode of action of these agents is not fully understood (Gerber, 
2002; Dreikom, 2002; Lowe, 2001).
Surgical treatment
Removal of BPH tissue using open surgery is carried out by an incision through either 
the abdominal wall or the perineum. It is based on the presence of a cleavage plane 
between the BPH tissue and the unaffected prostate tissue. BPH tissue should be easily 
removed using an index finger along the cleavage plane. Open surgery is very 
successful giving a 98% symptom improvement (Ziada et al., 1999). The main 
disadvantages of this procedure are bleeding and the hospitalisation period (5-10 days) 
required for the patient to recover from open surgery. Open surgery is usually reserved 
for cases with particularly large prostates or if large bladder stones are present (Tubaro 
et al., 2001; Servadio, 1992).
Transurethral Resection of the Prostate (TURP) has largely replaced open surgery, 
especially if the tissue is estimated to weigh 50g or less. A resectoscope is used to 
remove the BPH tissue (Holtgrewe, 1998). It has many advantages over open surgery. 
Hospitalisation time is reduced to 1 or 2 days (Chang et al., 1998). Bleeding is
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minimised. Symptom score improvements of 80-100% and mortality risk improvement 
of 2% can be achieved (Ziada et al., 1999). Associated bladder conditions such as stones 
can easily be observed and dealt with using this technique.
New approaches are being developed in an attempt to replace TURP in order to reduce 
side effects. Transurethral vaporization (TVP), laser therapy, transurethral microwave 
therapy (TUMT), transurethral needle ablation (TUNA) and high-intensity focused 
ultrasound (HIFU) are other techniques that can be used to treat BPH, but none of these 
have replaced TURP (Ziada et al., 1999).
1.3 IN-VITRO MODELS
1.3.1 Primary Culture Systems
Primary cultures proliferate initially for up to 50 population doublings, depending on 
the type of cell population, and usually then undergo crisis, stop dividing and die 
(Hayflick, 1965). This process is called replicative senescence. In culture, cancer cells 
can escape senescence due to genetic changes in key genes, a process called 
spontaneous transformation. Normal cells can escape senescence if they are 
immortalised with a transforming virus, or if transfected with a plasmid containing a 
transforming viral gene. There are two main ways of establishing primary cultures: 
explant culture and enzymatic dissociation.
Explant culture is carried out by cutting tissue into approximately 1 mm3 fragments and 
then placing the explants in tissue culture flasks in a suitable culture medium. Stromal 
and epithelial cells can grow out of the explants.
Human prostatic epithelial cells and fibroblasts from the prostates of 15 cadaveric 
kidney donors (aged under 40 years) and 2 fetuses (35 weeks gestation) were 
established using explant cultures (Cussenot et al., 1994a). Primary prostate stromal cell 
cultures have also been obtained using explant cultures established from BPH and 
prostate cancer tissue (Kooistra et al., 1995a; Planz et al., 1999).
Enzymatic dissociation is achieved by collagenase digestion, of the intercellular 
collagen matrix (Freshney, 1987). The standard enzymatic procedure involves chopping 
the tissue into small fragments, dissociating in medium containing collagenase and
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trypsin and incubating with constant stirring at 37°C for a few hours or overnight. The 
resulting suspension can then be successively sieved through a wire mesh with 
decreasing pore size in order to obtain single cells (Sensibar et al., 1999a; Peehl and 
Stamey, 1986a; Peehl et al., 1988a; Brothman et al., 1992a; Peehl and Sellers, 1997; Fry 
et al., 2000b; Hudson et al., 2000a; Hayflick, 1965; Zhang et a l, 1997). Variations to 
this method include the concentration and type of proteolytic enzymes, number of 
enzymatic treatments, incubation times and whether the final cell extract is sieved.
In a study of rat prostate, cells were isolated using trypsin and then collagenase for 
epithelial cell isolation. A higher concentration of trypsin without collagenase digestion 
was used for stromal cell isolation (Taketa et al., 1990a). The stromal cells digested 
with trypsin could only attach to tissue culture dishes pretreated with 10% FCS or 
fibronectin. Although these findings were made with rat prostates, the information 
obtained was then applied to human prostate cultures. Primary human prostate stromal 
cultures (PNX and BH101) were produced from normal and BPH tissue using 
mechanical dissociation followed by collagenase and hyaluronidase treatment (Tatoud 
et al., 1995). Prostatic stromal cells were isolated by collagenase digestion of BPH 
tissue with constant stirring at 37°C for 2-4 hours, then rinsing tissue pieces in PBS and 
repeating collagenase treatment for 16-18 hours (Kassen et al., 1996a).
In some cases a mixture of the two methods has been used. After mechanical 
dissociation fragments were digested with a collagenase solution and then small 
fragments were seeded onto tissue culture plates and cell outgrowths appeared 
(Robinson et al., 1998a; Janssen et al., 2000).
It is easier to establish stromal cells than epithelial cells in culture. Stromal cells tend to 
outgrow epithelial cells when grown in a basic medium such as RPMI-1640 
supplemented with 10-20% FCS (Kooistra et al., 1995a; Tatoud et al., 1995). Stromal 
cells were isolated from explant cultures (Planz et al., 1999) in equal volumes of DU 145 
cell conditioned medium and RPMI-1640 supplemented with 10% FBS, insulin, 
transferrin and selenium (ITS). Primary stromal cell cultures were isolated in DMEM: 
F12 medium and 20% FCS (Fry et al., 2000b). A pure population of stromal cells is 
usually achieved by the second or third passage.
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A human prostatic smooth muscle cell (SMC) primary culture system was developed 
(Zhang et al., 1997). The culture medium was modified to preferentially stimulate 
smooth muscle growth over myofibroblasts or fibroblasts. It was found that SMC 
growth was stimulated by growth factors such as insulin, dexamethasone, prostate 
cancer conditioned medium and horse serum (it is thought that FBS tends to stimulate 
fibroblasts while horse serum stimulates SMC growth). The hormones found to 
stimulate SMC growth were DHT and hydrocortisone. Estradiol influenced SMC 
differentiation, but not growth. These growth factors and hormones were used to 
supplement MCDB-131 medium for the maintenance of SMCs in culture. It was 
proposed that TGFp is a key regulator of growth and differentiation in prostate stromal 
cells (Peehl and Sellers, 1997).
Pure cultures of prostate epithelial cells can be readily established in serum-free culture 
medium, as the absence of serum inhibits the growth of the stromal cells (Peehl and 
Stamey, 1986b; Peehl et al., 1988b; Brothman et al., 1992b). In a study of the growth 
promoting effect of BPE on rat prostate epithelial cells, McKeehan identified some of 
the growth factors and hormones needed to support prostate epithelial cell growth in the 
absence of serum. A serum-free growth medium was developed called WAJC404, 
supplemented with 130pM cholera toxin, 833nM insulin, 1.6mM EGF, 43nM prolactin, 
lpM dexamethasone and 25pg/ml bovine pituitary extract (BPE) (McKeehan et al., 
1984).
In the study of rat prostate, Taketa et al, found that dexamethasone inhibited the 
proliferation of epithelial cells at concentrations above 30nM. Maximum stromal cell 
growth was seen on addition of 2mg/ml of BSA (in addition to cholera toxin and BPE). 
Higher concentrations of BSA had an inhibitory effect on growth of stromal cells. 
Epithelial cell cultures were maintained in a modified WAJC404 medium (without 
dexamethasone or ovine prolactin). Stromal cells were maintained in MEM medium 
supplemented with 2mg/ml BSA, cholera toxin and BPE (Taketa et al., 1990b).
In order to improve epithelial cell growth a low calcium culture medium was developed 
which was supplemented with specific growth factors. Epithelial cells were maintained 
in low serum and low calcium DMEM medium, while fibroblasts were cultured in 
RPMI-1640 medium supplemented with serum. Two layers developed in the epithelial 
cultures. The cells survived four to five passages before becoming senescent. The
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phenotype of the two layers could be distinguished by their cytokeratin patterns. The 
upper layer displayed a luminal cell pattern. Fibroblasts took longer than epithelial cells 
to become established in culture, but once established they grew faster and achieved up 
to 10 passages. Cultured cells from the transition, peripheral and central zone showed 
the same growth pattern and had the same phenotype (Cussenot et al., 1994b).
In an investigation of prostate stem cells, a lineage analysis was carried out on basal and 
secretory luminal cells by monitoring spontaneous differentiation in primary prostate 
cultures. Primary epithelial cultures were maintained in WAJC404 medium (McKeehan 
et al., 1984). The results were similar to those of Cussenot et al. (1994) where the initial 
monolayer expressed luminal and basal cytokeratins and was AR and PSA positive. 
Multilayer cultures have also been established (Robinson et al., 1998b). The upper layer 
consisting of highly differentiated cells contained secretory vacuoles with increased 
luminal cytokeratin expression.
A comparison of serum-free media for the growth of epithelial primary cultures was 
made (Fry et al., 2000c). PrEGM, a commercially available serum-free medium, was the 
only medium that permitted the long-term cultivation of epithelial cells. The epithelial 
cells could be passaged with 0.25% trypsin in 0.5mM/L versene by harvesting adherent 
cells (allowing cells to lift off the bottom of the dish). Normally epithelial cells are 
grown in a serum free medium but in order for these cells to re-attach to the base of the 
tissue culture flask, 5% FCS was added to medium for 48 hours.
Primary prostate epithelial cell cultures were grown clonally to identify prostate stem 
cells. Single cells were obtained by further digestion with trypsin/versene in saline 
buffer and growth of cells on a mouse 3T3 fibroblast feeder layer on collagen. Two 
types of colonies were distinguishable. Three-dimensional cultures were also developed 
using cells from individual colonies in matrigel using stromal cell conditioned PrEGM 
medium containing mibolerone. Mibolerone is a synthetic androgen and unlike 5a-DHT 
(5a-dihydrotestosterone) is not metabolised. The results of these investigations suggest 
that Type II colonies, consisting of undifferentiated rapidly dividing cells, may be the 
progeny of prostate stem cells. The smaller Type I colonies may be the progeny of 
differentiated transit-amplifying populations (Hudson et al., 2000b).
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Another method used to isolate stromal or epithelial cells is the Percoll gradient. A 5- 
10% (increasing density) discontinuous Percoll gradient (Pharmacia) was used to 
separate different cell types by density after centrifugation (Kassen et a l, 1996b). 
Stromal cells separated at the 5% interface, while the epithelial cells were between the 5 
and 10% interfaces. Stromal cells were collected and cultured in phenol red-free RPMI- 
1640 and 10% FBS. Using this procedure, Kassen found that bFGF and BPE induced a 
concentration dependent proliferation of prostatic smooth muscle cells. DHT had a 
weak stimulatoiy effect on smooth muscle growth and in the presence of bFGF, and at 
low concentrations DHT was able to further stimulate smooth muscle growth. TGF0 
had an inhibitory effect on stromal cells.
The same method was later used to isolate stromal cells from normal and BPH patients 
of varying ages (Sensibar et al., 1999b). Less cell proliferation was observed in cultures 
from older patients.
1.4 IMMORTALISATION AND CHARACTERISATION OF PROSTATE 
CONTINUOUS CELL LINES
Primary cultures have a limited lifespan and therefore immortalised cell lines with an 
unlimited lifespan have advantages. Immortalised cell lines provide a uniform, 
standardized and reproducable source for study. These cells retain many properties of 
normal cells. Spontaneous immortalisation seldom occurs for normal human cells 
(Macieira-Coelho and Azzarone, 1988) and therefore viral transformation 
(immortalisation) is used. Primary cells are infected with a transforming virus and have 
an extended lifespan. The cells eventually reach a state called crisis, a period of 
balanced cell growth and cell death. Some cells survive crisis and gain additional 
genetic changes and consequently become immortal.
DNA tumour viruses such as SV40, adenovirus E1A and E1B, human papilloma virus 
(HPV) 16 and 18 have been used. It is also possible to immortalise cells by expressing 
cellular oncogenes such as myc, fos, pRb and p53 (Stamps et al., 1992b).
One of the main disadvantages of immortalisation is the loss of differentiated cell 
characteristics. The cells are driven by the viral gene or oncogene to divide and 
additional morphological and chromosomal changes develop (Steinberg and Defendi, 
1979; Taylor-Papadimitriou et al., 1982). Virally immortalised cells often become
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neoplastically transformed, likely to be due to genetic alterations. However, such cell 
lines have been exploited to study the neoplastic process.
Continuous cell lines (whether immortalised or derived directly from cancers) must be 
characterised and authenticated (table 1.1 and 1.2). Various immortalised normal 
prostate cell lines (table 1.3) have been developed.
Prostatic cells characterized as basal cells may express K5, K15, K14, K17 and K19 but 
are negative for K8 and K18 while more differentiated luminal-like cells can express 
K8, K18, K17 and K19 but are negative for K15 and K14. K17 and K19 can be 
expressed by basal and luminal cells. Smooth muscle cells are positive for vimentin, 
SM-actin, SM-myosin and SM-desmin. Myofibroblasts are positive for vimentin, SM- 
actin, SM-myosin and negative for SM-desmin. Fibroblasts are positive for vimentin 
and negative for SM-actin, SM-myosin and SM-desmin. The luminal epithelial and 
stromal cells can be positive for AR. Prostate specific characteristics include luminal 
epithelial cell expression of PSA, PSMA and PSAP (table 1.1 and 1.2).
The proportion of proliferating cells can be determined using Ki67 staining (table 1.1 
and 1.2). During transformation chromosomal alterations occur and karyotypic analysis 
can be used to identify large chromosomal alterations and to determine if a normal Y- 
chromosome is present (Stacey et al., 1990).
Neoplastic characteristics include the loss of anchorage dependence allowing growth in 
semi-solid agar and the development of xenografts in nude mice. The presence of the 
transforming gene can be detected (e.g. expression of SV40 large T-antigen).
1.4.1 Immortalised Epithelial Cell Lines
Two prostate epithelial cell lines from neonates, NP-2s and NP-2e, were established by 
immortalisation with HPV16 (Lechner et al., 1978). The cells have a typical epithelial 
phenotype with a "cobblestone" appearance. They have a normal human male 
karyotype, are non-tumorigenic and express 5a-R. Both cell lines became senescent 
after 30-35 population doublings. In order to extend the lifespan of NP-2s cells they 
were transformed with the SV40 virus (Kaighn, 1980). The transformed epithelial cell 
lines Tl, T2 and T5 consisted of small cells with a tendency to overlap and had altered 
morphological, ultrastructural, chromosomal and growth characteristics compared to
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NP-2s cells. The morphology of T2 was similar to PC-3, a prostate cancer cell line. All 
3 cell lines became anchorage independeant over time and had reduced serum 
requirements, although each line had a different response to growth factors. Kaighn later 
stated that these cell lines were not tumorigenic and were not immortalised (Kaighn et 
al., 1989). Further attempts to immortalise NP-2s cells used a plasmid, pRSV-9, 
containing the SV40 early region genes (Kaighn et al., 1989). Transformed cell lines 
267B1,272E1 and 272E4 were characterised as luminal epithelial cells, expressing PSA 
and PSAP markers. This pattern was similar to that seen in NP-2s cells, except for the 
fibroblast markers. The cell lines 267B1, 272E1 and 272E4 had ultrastructural features 
of epithelial cells, were pseudodiploid and non-tumorigenic. TGF-f3 and EGF stimulated 
growth in clonal assays. In conclusion, these 3 cell lines are immortalised non- 
tumorigenic human epithelial cell lines. However, these cell lines have been 
transformed twice and therefore a lot of chromosomal abnormalities are likely to have 
occured. The 3 cell lines are differentiated epithelial cells and are therefore of no use for 
the study of epithelial cell differentiation.
Primaiy cultures of normal prostatic luminal cells were established from a 35-year old 
male donor (Cussenot et al., 1991). Liposomal transfection with a plasmid, pMK16, 
containing the SV40 genome with a defective replication origin gene (SV40 ori-) 
resulted in an immortal cell line. The cell line, PNT1, expressed KL1, a luminal marker, 
SM cell markers and was weakly positive for PSA and PAP. The PNT1 cell line was 
used to develop a new cell culture model for studying the progression of non-malignant 
to malignant prostate cells (Degeorges A et al., 1995). Three cell lines, PNT1A and 
PNT1B from one patient, and PNT2 from another were. All the lines were positive for 
SV40 T-antigen, cytokeratin 8 and 18 and negative for cytokeratin 14. PNT2 was 
positive for cytokeratin 19 and negative for vimentin, while PNT1A and PNT1B were 
negative for cytokeratin 19 and positive for vimentin. All cell lines were non- 
tumorigenic. The population doubling times for PNT2, PNT1A and PNT1B were 36,30 
and 28 hours respectively. Their serum dependency was high, medium and low 
respectively and their EGF response was positive, positive and negative respectively. A 
fibroblastic cell line did not survive crisis. PNT2, PNT1A and PNT1B cell lines have no 
added advantage as a prostate epithelial cell line compared to 267B1,272E1 and 272E4 
cell lines, previousely described. PNT2 may be useful for studying intermediate 
epithelial cells due to its expression of K19.
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Human papilloma virus (HPV) type 18 DNA was used to transform cells isolated from 
the peripheral zone of a normal prostate (Weijerman et al., 1994). The resulting cell line 
PZ-HPV-7 had a typical epithelial morphology with small cuboidal cells in a 
cobblestone pattern. The cells were positive for cytokeratin 8 and 5 and negative for 
PSA. Karyotyping revealed a diploid pattern at passage 30, which became close to 
tetraploid at passage 99. Following xenotransplantation into nude mice, small growths 
made up of squamous cells developed. The majority of prostate cancers develop in the 
peripheral zone so this cell line may be useful for comparative studies of normal 
peripheral zone cells with peripheral zone cancer cells. To my knowledge there is no 
other normal prostate cell line specifically from the peripheral zone.
Another cell line was developed by immortalisation of cells isolated from BPH tissue 
with a construct containing the SV40 large-T antigen gene (Hayward et al., 1995). A 
single clone, BPH-1, grew as a monolayer culture and had a typical epithelial 
cobblestone appearance. These cells express markers of intermediate epithelial cells. 
Karyotyping demonstrated that the cells are aneuploid with a structurally normal Y 
chromosome. DNA cell cycle distribution for BPH-1 cells is 51% (Go/Gi), 26% (G2.M) 
and 23% (S phase). The cells are not tumorigenic in nude mice. Androgen receptor, 
PSA and PSAP are not detected by biochemical assays or RT-PCR. 
Immunocytochemical analysis shows weak staining for AR, while PSA and PSAP are 
undetectable. Cells proliferate in serum-free medium. Previousely described normal 
prostate cell lines were luminal epithelial cells. BPH-1, an intermediate epithelial cell 
line may be useful for the study of epithelial cell differentiation, although a basal cell 
line would be most advantageous. This cell line has been useful for the study of 
expression and effect of growth factors on prostate epithelial cells. EGF, TGFa, FGF1, 
aFGF and FGF-7 (KGF) increase and FGF2 (bFGF), TGFpi and TGFP2 inhibit BPH-1 
cell proliferation. Testosterone has no effect on proliferation rate.
Human prostate epithelial cells derived from a patient undergoing cystectomy for 
bladder cancer were transformed with a hybrid virus composed of adenovirus 12 and 
SV40, resulting in the cell line PWR-1E (Webber et al., 1996). Another cell line, 
RWPE-1, was established from non-neoplastic adult human prostatic epithelial cells 
immortalised with HPV 18 (Bello et al., 1997). The parental epithelial cells could not be 
maintained in culture beyond 5 passages. RWPE-1 was further transformed by the 
oncogene v-Ki-ras to establish a tumorigenic cell line, RWPE-2. RWPE-1 is positive for
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cytokeratin 8 and 18, and weakly positive for 5 and 14. Mibolerone is a synthetic 
androgen and unlike 5a-DHT (5a-dihydrotestosterone) is not metabolised. It was used 
to stimulate growth and PSA and AR expression. Cell growth was also stimulated by 
bEGF and bFGF, while it was inhibited by TGFJ3. The non-tumorigenic cell line 
RWPE-1 was also transformed with N-methyl-N-nitrosourea (MNU). Four cell lines 
were established called WPE1-NA22, WPE1-NB14, WPE1-NB11 and WPE1-NB26, in 
order of increasing malignancy (Webber et al., 2001). RWPE-1 has similar advantages 
to the BPH-1 cell line, as it also appears to be an intermediate epithelial cell line and 
may be useful for studying prostate epithelial cell diferentiation. In addition this cell 
line has the added advantage of successfully being transformeded from normal 
epithelial cells to maignant epithelial cells. They could be used for comparative studies 
of normal and malignant prostate epithelial cells.
BRF-55T is a human prostatic epithelial cell line developed from BPH tissue (Iype et 
al., 1998). Primary cultures were initiated from cellular outgrowths of explanted tissue, 
and immortalised with a pRSV-T plasmid. The cells are positive for cytokeratin 8 and 
18, PSA and AR markers. H-ras, K-ras and p53 are expressed. The cells are thought to 
be pre-malignant as they have some capacity for anchorage-independent growth.
Primary cell cultures obtained from radical prostatectomy specimens were immortalised 
with a recombinant retrovirus encoding the E6 and E7 genes of HPV-16 (Bright et al., 
1997b). 1532N, 1535N and 1542N cells have doubling population times of 32h, 41h 
and 48h respectively. The cells have a low serum requirement and are androgen 
insensitive. The cells do not form tumors in athymic mice and do not form colonies in 
semi-solid agar. This cell line does not appear to have any advantages over other 
immortalised epithelial cell lines, discussed above.
Although all of the above mentioned prostate epithelial cell lines retain some of their 
normal prostate characteristics, such as PSA and AR expression they all tend to be 
differentiated luminal epithelial cells. In order to study prostate epithelial cell 
differentiation it would be ideal to have a prostate basal cell line that has the ability to 
differentiate into luminal cells that should be able to express prostate specific 
characteristics. To my knowledge there is no such prostate cell line. The aim of this 
thesis was to develop such a prostate cell line using a temperature sensitive model.
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1.4.2 Immortalised Stromal Cell Lines
Relatively few immortalised human prostatic stromal cell lines have been established.
DuK50, a human prostate stromal cell line was stained positive for vimentin and 
fibronectin with weak smooth muscle alpha-actin staining (Roberson et al., 1995). 
Staining was negative for desmin antibody, epithelial cytokeratins and prostate-specific 
antigen, which ruled out contamination with prostatic epithelial cells. This staining 
pattern was suggestive of myofibroblasts. This cell line has a diploid karyotype and is 
non-tumorigenic in nude mice and does not form colonies in semi solid agar. Cell 
proliferation was stimulated by androgens.
A stromal cell line, WPMY-1 (Webber et al., 1999) was derived from the same prostate 
tissue specimen as the epithelial cell line, RWPE-1 (Bello et al., 1997). Immortalisation 
was carried out with the SV40 large-T antigen, using the pRSVT plasmid. The cells 
have an elongated, spindle-shape morphology and are characterised as myofibroblasts. 
WPMY-1 has a hyperdiploid karyotype with chromosome numbers of 58-68. These 
cells are stimulated in a dose-dependent manner with Mibolerone, EGF, b FGF, PDGF- 
BB and PDGF-AA. A dose dependent inhibition was observed with TGFp, in the 
presence and absence of serum, although it is thought that TGFp stimulates stromal 
growth. WPMY-1 cells did not form tumors in nude mice, but they did form colonies in 
soft agar. A differential of 0.7% CFE with 10% donor calf serum (DCS) compared to 
4.6% with 10% FCS shows that the serum type is an important factor when setting up 
cell culture experiments.
These two cell lines have been useful for studying expression and effect of growth 
factors on prostate stromal cells. As with prostate epithelial cells it would be useful to 
have a stromal cell line where stromal cell differentiation could be switched on. 
Although the main aim of this thesis was to develop a prostate epithelial model, a 
temperature sensitive prostate stromal cell line was developed along side the 
temperature sensitive epithelial cell line.
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Table 1.3: Characteristics of Immortalised Normal Prostate Cell Lines
Epithelial Cell 
Line Name
Reference Immortalising
Genes
Derivation Phenotype
NP-2s and NP- 
2e
NP2-T1, T2, 
T5
267B1, 272E1, 
272E4
(Lechner et al., 1978) 
(Kaighn, 1980) 
(Kaighn et al., 1989)
HPV 16, E6 & E7
SV40 vims 
SV40 oil
Normal
neonatal
Non-t, anc-d, epit. 
5aR+
Non-t, anc-d,
Imm, non-t, lum, 
PSAW+, PAPW+
PNT1
PNT1A, 
PNT1B, PNT2
(Cussenot et al., 
1991)
(Degeorges et al., 
1995)
SV40 ori' 
defective gene 
SV40 large T and 
small t antigens
Normal
adult
Luminal epit 
PSAW+, PAPW+ 
Imm, non-t, 
luminal
PZ-HPV-7 (Weijerman et al., 
1994)
HPV type 18 Normal
adult
Imm, non-t, epit 
PSA+
BPH-1 (Hayward et al., 
1995)
SV40 large T 
antigen
BPH Imm, non-t, 
I-luminal
PWR-1E (Webber et al., 1996) Adenovirus 12 
and SV40 Hybrid
Non­
neoplastic
Imm, epit
RWPE-1 (Bello etal., 1997) HPV type 18 Normal Non-t, anc-d, I- 
luminal, PSA+, 
AR+
BRF-55T (Iype et al., 1998) SV40 large T 
antigen
BPH Pre-mal luminal 
PSA+, AR+
1532N, 1535N, 
1542N
(Bright et al., 1997b) E6 & E7 genes of 
HPV-16
Normal Non-t, anc-d, epit.
Stromal Cell 
Line Name
Reference Immortalising
Gene
Derivation CeU
Characterisation
DuK50 (Roberson et al., 
1995)
Normal Non-t, anc-d, SM, 
AR+
WPMY-1 (Webber et al., 1999) SV40 large-T Non­
neoplastic
Non-t, anc-id, 
myofib, AR+
Non-tumorigenic (non-t); anchorage dependent (anc-d); anchorage independent (anc-id); 
epithelial (epit); luminal (lum); intermediate luminal (I-luminal); weak positive (w+); pre 
malignant (pre-mal); smooth muscle cells (SM); myofibroblast (myofib)
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1.5 3-DIMENSIONAL CULTURE SYSTEMS
In order to overcome the limitations of monolayer culture systems, co-cultures and 3- 
dimensional cultures of prostate epithelial and stromal cells have been developed.
Bayne and colleagues set up co-cultures in which epithelial and stromal cells derived 
from BPH were grown on opposite sides of microporous membranes (Bayne et al., 
1998). Although there was no direct interaction between stromal and epithelial cells, 
this culture system maintained many prostate characteristics, including response to 
androgens, secretion of PSA by epithelial cells and expression of 5a reductase types I 
and n. This co-culture model was used to study cellular interactions between BPH 
stromal and epithelial cells (Habib et al., 2000).
Although these co-cultures express prostate specific characteristics, they lack the 
architectural structure and cell-cell contacts of the stromal and epithelial cells in vivo. 
These culture systems also lack contact with a basement membrane (Drubin and Nelson, 
1996). Basement membranes are thin extracellular matrices underlying epithelial cells 
in tissue and are important for normal development (Kleinman et al., 1987b).
3-Dimensional in-vitro models have been developed to enable direct stromal and 
epithelial cell interaction. Matrigel culture systems provide a substitute for basement 
membrane components. Matrigel is extracted from the Engelbreth-Holm-Swarm (EHS) 
mouse sarcoma, a tumour that is rich in extracellular matrix proteins. Approximately 
60% of Matrigel consists of laminin, an essential component of the basement membrane 
(Malinda and Kleinman, 1996; Kleinman et al., 1987a). The remaining 40% of Matrigel 
is made up of collagen-IV, heparin sulphate proteoglycans, and nidogen. Matrigel also 
contains varying concentrations of growth factors.
Matrigel cultures of RWPE-1 (normal epithelial cell line) and RWPE-2 (tumorigenic 
epithelial cell line derived from RWPE-1) were used in a study of acinar differentiation 
(Webber et al., 1997). The normal prostate cells underwent acinar morphogenesis, but 
the tumorigenic cells had lost this ability.
Using rat prostatic epithelial cells, 3-dimensional collagen gel cultures were 
successfully constructed which provided a useful means for investigating prostatic 
disease and hormone and growth factor influences on prostate cells. Epithelial cells
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formed acinus-like structures in these models (Ma et al., 1997). Hall et al. used this 3-D 
collagen co-culture model to study the interaction of human benign (PNT1) and tumour 
(PC3) prostate cells with primary benign and tumor epithelial and stromal cells. 
Differences were observed between tumour and normal cells, in particular the formation 
and acinus-like structures. There was stronger expression of luminal markers by the 
immortalised cell lines and stronger basal expression by the primary cells. PSMA was 
present in all cultures, while PSA was positive in all cultures except the PC3 cell line 
(Hall et al., 2002).
1.6 IMMORTALISATION AND CONDITIONAL IMMORTALISATION
Polyoma viruses can cause infections in humans, often in the kidney, and can induce 
cancer in animals. Because these viruses have a simple structure and contain a small 
genome they are used in genetic engineering. One of the first polyoma viruses to be 
studied was the simian virus 40 (SV-40) (Carbone, 2001; Barton S, 2002; Watson et al., 
1992). Other viral genes that have been used to immortalize cells are adenovirus El a 
(Seigel GM, 1996), human papilloma virus (HPV) E6 and E7 (Peters et al., 1996; Le 
Poole et al., 1997) and Epstein Barr Virus (EBV) (Zeidler et al., 1996). Most of these 
genes probably act by blocking the inhibition of cell cycle progression by inhibiting the 
activity of genes such as CCIP-l/WAF-1/21, Rb, p53 and pl6, therefore giving cells an 
increased life span and allowing further mutations if desired. These viruses are 
relatively easy to maintain and work well in the laboratory, although health and safety 
rules should be adhered to when working with any of these viruses.
SV40 was first isolated from monkey kidney cells, hence its name (Carbone, 2001; 
Barton S, 2002; Watson et al., 1992). A Hind II restriction enzyme map of SV40 was 
produced in 1971 and it was shown that DNA replication always began at the same 
Hind II site and continued in two directions (Nathans and Danna, 1972; Danna and 
Nathans, 1971; Danna and Nathans, 1972; Bryan and Reddel, 1994).
The SV40 genome is a double-stranded circular DNA of 5243bp (figure 1.4). The 
genome is divided into two regions, the early and late genes. These regions are 
expressed respectively before and after DNA replication begins. The origin of DNA 
replication (ori) and the early and late promoters are situated between the coding 
sequence of the early and late gene regions (Saenz-Robles et al., 2001).
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The early region encodes three proteins, large T antigen (LTAg), small t antigen (stAg) 
and 17K T antigen (17KT) that are 708, 174 and 135 amino acids respectively. The 
LTAg, a 90kDa protein, has a number of functions, including DNA binding, nuclear 
localisation, ATPase activity and helicase activity. It binds to ATP, replication protein 
A and DNA polymerase a  for initiation of DNA synthesis (Domreiter et al., 1990; 
Smale and Tjian, 1986). LTag recognises the viral replication of origin (ori ) in the 
presence of ATP and acts as a DNA hilicase by opening the double helix. The LT Ag 
also interacts with the protein products of the retinoblastoma (Rb) and p53 tumour 
suppressor genes. Rb and p53, cell cycle regulatory genes are iactivated during 
immortalisation, probably by blocking the inhibition of cell proliferation caused by 
tumour suppressor genes. The product of the SV40 LT gene, the T antigen binds the 
P53 and Rb proteins and allows an extended proliferative life span of these cells, i.e. 
immortalisation. This action also restricts the DNA surveillance activity of genes like 
p53 (Finlay et al., 1989). Small t antigen, a 17kDa protein, is not essential for 
productive infection in cells. It is involved in activating protein phosphatase 2A, which 
stimulates cell proliferation through a protein kinase pathway. The role of the 17KT 
antigen in transformation is not fully understood (Saenz-Robles et al., 2001; Ali and 
DeCaprio, 2001; Pipas and Levine, 2001; Rundell and Parakati, 2001).
The late region of the SV40 gene encodes the viral coat proteins (VP1, VP2 and VP3). 
Immortalisation can be carried out using both early and late genes, although the late 
gene region is not required (Saenz-Robles et al., 2001; Ali and DeCaprio, 2001; Pipas 
and Levine, 2001; Rundell and Parakati, 2001).
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Figure 1.4: Schem atic D iagram  O f The SV 40 G enom e
Eco Rl Site
Direction of 
transcriptio
Origin of
The SV40 genome is divided into an early and late gene region. The early region consists of 
small and large T antigen proteins that are involved in DNA replication. The late region encodes 
for 3 viral coat proteins. The number o f nucleotides synthesised start and end at the origin of 
replication (ori). The green arrow indicates the direction o f DNA synthesis. Contains a single 
EcoRI site, 1700bps away from the DNA replication site. Schematic diagram o f the SV40 
genome -  information taken from text books (Brock and Madigan, 2002; Barton S, 2002).
DNA replication on the SV40 viral genome is initiated by the large T-antigen protein, 
which specifically recognises the viral origin o f replication in the presence of ATP 
(Dean et al., 1987b). The T-antigen, a product of the viral A gene, acts as a DNA 
helicase, opening the double helix as it moves along, forming a replication bubble. The 
host cell components o f the replication machinery assemble in the replication bubble 
and two replication forks are formed, which move away from the origin in the opposite 
direction (Parsons et al., 1990; Wessel et al., 1992; Dodson et al., 1987; Dean et al., 
1987a; Pipas and Levine, 2001).
The most important step for achieving immortalisation is the inactivation o f p53 and Rb 
cell cycle regulatory genes (Stamps et al., 1992a; Ozer et al., 1996). Other DNA tumour 
viruses also bind to these tumour suppressor genes and are sometimes used to 
immortalise cells. Adenovirus 5, E1B and HPV and E6 bind to p53 and adenovirus El A
K C^SV40Replication
mall t-antigen
Large T-antigen
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and HPV E7 bind to Rb causing inactivation of these cell cycle regulatory genes. SV40 
appears to be the most common DNA tumour virus used for immortalisation of cells.
The differentiated characteristics of cells, such as AR and PSA expression in prostate 
epithelial cells, tend to be lost in immortalised cells. The loss may be due to cells 
proliferating and not differentiating in culture (Parker et al., 1999), and this limitation 
might be overcome using temperature sensitive cell lines.
Temperature-sensitive mutants in LTAg (tsA mutants) were used to show that T antigen 
function is necessary to initiate and maintain immortalisation in cells. Several 
temperature sensitive mutants of the SV40 A gene have been established (Chou et al., 
1974; Tegtmeyer, 1972; Tevethia and Tevethia, 1977; Tevethia and Ripper, 1977). The 
temperature sensitive SV40 large T antigen behaves as wildtype LTag at permissive 
temperatures (33°C), initiating DNA replication. LTag becomes conformationally 
inactive at non-permissive temperatures (39°C) and can no longer initiate DNA 
replication due to the temperature sensitive A58 mutation inserted into the SV40 virus 
at 3504bp (Stamps et al., 1994). The cell line should proliferate at 33°C and this 
proliferation should be switched off at 39°C, allowing cell differentiation to occur. 
Using this technology it may be possible to maintain cell proliferation at the permissive 
temperatures and switch to cell differentiation at a non-permissive temperature and 
hence retain tissue specific characteristics.
This thesis describes the characterisation of two immortalised cell lines grown from 
BPH tissue, a stromal (S2.13) and epithelial (Pre2.8) cell line, derived from the same 
individual. The cells were immortalised by transfecting primary stromal and epithelial 
cells with the temperature sensitive immortalizing oncogene, Simian Virus 40 large T- 
antigen carrying both the tsA58 and U19 mutations (SV40U19tsA59). The Bgll-Hpal 
fragment of the early region of SV40 large T-antigen was inserted into the single 
BamHI restriction site of the pZipNeoSV(X)l shuttle vector, which replaces a region of 
the wildtype gene. The temperature sensitive mutants are on nucleotides 4364, 4345 
(U19) and 3504 (tsA58). The infected cells were selected with the antibiotic G418 
(Cepko et al., 1984; Jat and Sharp, 1989; Stamps et al., 1994) (figure 1.5).
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Figure 1.5: Schematic Diagram of the temperature-sensitive SV40 construct, 
ZipneoSVU19tsA58
SV40ori
LTR U19tsA58LT cDNA frw j neo J  pBRorT^B^LTR
The U19tsA58 LT virus was constructed by using the pZipNeoSV (X)l backbone and encodes a 
full-length LT cDNA from U19tsA58 and confers resistance to G418. The U19tsA58 LT is a 
combination the two mutants, U19, which encodes a LT that does not bind specifically to SV40- 
origin DNA sequences, and tsA58, which encodes a thermolabile LT antigen that is wild type at 
33.5°C but inactive at 39.5°C (O’Hare et al., 2001).
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1.7 RATIONALE FOR THIS STUDY
Until recently very little research has been carried out to study the human prostate and 
associated diseases. Primary cultures will only survive for a limited time and hence their 
usefulness as human prostate models is limited. For long-term studies immortalised cell 
lines are required, but there is a lack of representative in vitro models of the human 
prostate, particularly BPH. In this study immortalised epithelial and stromal cells, 
obtained from the same BPH patient, were immortalised using the temperature sensitive 
SV40 large T antigen (OHare et al., 2001). Temperature sensitive cell lines were 
established to try and overcome some of the problems associated with immortalisation 
procedures, i.e. loss of prostate specific characteristics. Because the T-antigen is 
switched off at 39°C, cell proliferation is switched off and cell differentiation may 
proceed and express prostate specific characteristics, such as PSA, PSMA and AR.
The first aim in this study was to authenticate and characterise this immortalised BPH 
epithelial cell line (Pre2.8) and determine to what extent they can express prostate 
specific characteristics. A comparison at 33°C, 39°C and 37°C, as an intermediate 
temperature was necessary to determine that these cells were temperature sensitive and 
that they do differentiate at 39°C. The cell lines were never passaged beyond 10 
passages to insure stability. A new vial of the same passage number was used after 
every 10 passages.
Stromal-epithelial interactions, is an important factor in prostate development and is one 
of the hypothesised theories (McNeal, 1978) for the development of BPH. Epithelial 
cells alone may not be sufficient to induce differentiation. They may require the 
presence of stromal cells.
The aim of the second part of this project was to recombine epithelial and stromal cells 
to produce a BPH model that mimics in vivo conditions. Initially the immortalised BPH 
stromal cell line (S2.13) should be authenticated and characterised. Once an appropriate 
co-culture method for recombining prostate epithelial and stromal cells has been 
established, characterisation at 33°C, 39°C and 37°C must again be carried out in order 
to determine its prostate specific capabilities.
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CHAPTER 2 
MATERIALS AND METHODS
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2.1 COSHH REGULATIONS
The COSHH (Control Of Substances Hazardous To Health) regulations require that 
before the start of any research project, the risks involved must be assessed and a code 
of practice drawn up by which the work may be carried out with the minimum amount 
of risk. All experiments were carried out following COSHH regulations, ensuring that 
the Departmental Code of Practice (containing Health and Safety regulations) was 
adhered to.
Immortalisation of cell lines, Pre2.8 and S2.13 was carried out by Pref M O’Hare, Dept 
of Surgery, Middlesex Hospital. Transformation with SV40 viral genes were carried out 
in Safety Level 3 tissure culture labs. Cell lines were not transferred to our laboratory 
until they were safe to work with, in a Safety Level 2 tissure culture laboratory. All 
GMO (genetic modified organisms) regulations were adhered to and GMO risk 
assessment forms were completed for all new lines generated.
2.2 CELL CULTURE
Cell culture is the growth and maintenance of cells, which have been established from 
pieces of tissue, in the laboratory. Various cell lines that were established from human 
prostate and one mouse cell line were used in this study and are detailed in table 2.1.
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Table 2.1: Details Of Cell Lines Used In Study
Cell Line Derivation Culture
medium
Routine
Temp
Reference
LNCaP Lymph node metastasis of prostate cancer RPMI-1640
+10%FCS
37°C (Horoszewicz 
et al., 1980)
DU145 CNS metastasis of prostate cancer RPMI-1640 + 
10%FCS
37°C (Stone et al., 
1978)
Pre2.8 SV40 large T antigen conditionally immortalised 
normal human epithelial cell line.
PrEGM 33°C This thesis
S2.13 SV40 large T antigen conditionally immortalised 
normal human epithelial cell line
DMEM + 
10%FCS
33°C This thesis
1542-
NPTX
Normal prostate epithelial cells immortalised with the 
E6 and E7 transforming proteins of human papilloma 
virus
Keratinocyte- 
SFM + 5%FCS
37°C (Bright et al., 
1997a)
1542-FT Normal prostate stromal cells immortalised with E6 
and E7 transforming proteins of human papilloma 
virus
RPMI-1640
+10%FCS
37°C (Bright et al., 
1997a)
3T3 The NIH/3T3, a continuous cell line of highly 
contact-inhibited fibroblast cells was established 
from NIH Swiss mouse embryo
DMEM + 
10%FCS
37°C (Todaro and 
Green, 1962)
MDA-
MB-435
Metastatic human breast cancer cell line RPMI-1640
+10%FCS
37°C (Glinsky et 
al, 1996)
PC3 Epithelial cell line from a human prostatic 
adenocarcinoma metastatic to bone.
RPMI-1640
+10%FCS
37°C (Kaighn et 
al, 1979)
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2.3 CELL LINE AUTHENTICATION AND PURITY
When a new cell line has been derived it is important to authenticate its origin and also 
to characterise the cell line in order to determine its functionality, purity and stability. 
The main problems associated with continuous cell lines are cross-contamination, 
microbial contamination and changes in phenotype.
2.3.1 Cross-Contamination
Cross-contamination between cell lines, particularly with HeLa cells has been the cause 
of misrepresented scientific data since the 1960s (King et al., 1994; Gartler, 1967; 
Nelson-Rees et al., 1981). Short tandem repeat (STR) profiling (Masters et al., 2001) 
was used to confirm origin of the cell lines used in this study (Table 2.1).
Procedure
DNA was extracted from a confluent 80cm2 flask of each cell line, using 
phenol/chloroform extraction procedures. DNA samples (lg/ml) were sent to the 
analytical centre, LGC (Queens Road, Teddington, Midddlesex TW11 OLW) for DNA 
profiling.
DNA Extraction from Cultured Cells
A confluent 80cm2 flask was trypsinised and washed with lx phosphate-buffered saline 
(PBS). Cells were lysed in 10ml lysis buffer, containing 100pi Protease K (final conc. 
1 mg/ml of PK), mixed well and incubated at 37°C, overnight. Sample was transferred to 
a 15ml polypropylene tube. Phenol was equilibrated in lOmM Tris-HCl (pH 8.0) and 
0.1% Hydroxyquinoline (yellow colour) was added. Chloroform was prepared adding 
lml Iso-Amyl alcohol to 24ml of chloroform and mixing. A solution with equal 
volumes of phenol and chloroform was prepared by mixing together. 5ml of 
phenol/chloroform (1:1) was added to sample, mixed well and centrifuged at 4°C, at 
9000 rpm for 20 min. Supernatant was transferred to a new tube. Extraction was 
repeated once with phenol/chloroform and centrifuged for 10 minutes and once with 
chloroform and centrifuged for 10 minutes. 10 pi of RNase (lOmg/ml) was added to the 
sample and incubated for lh at 37°C. DNA precipitation was carried out by adding 
equal volumes of isopropanol to the sample tube and then gently mixing, by inverting 
tube up and down. Precipitated DNA was lifted out using a blunted pasteur pipette and 
washed in lml of 70% ethanol and air dried. DNA was dissolved in 0.5 -1.0 ml of 
sterile water, depending on viscosity of DNA sample.
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Lysis buffer
150 mM NaCl, 10 mM Tris (pH 8.0), 10 mM EDTA (pH 8.0), 0.5% SDS 
Proteinase K
lOmg/ml stock solution in sterile water and stored at -20°C.
RNase
lOmg/ml solution in sterile water, boiled for 10 minutes, allowed to cool to room 
temperature and stored at -20°C.
Measurement o f DNA concentration
DNA concentrations were measured by UV spectophometiy using a DU650 series 
spectrophotometer (Beckman Ltd., UK), 5pi of DNA was diluted to 500pl with sterile 
water (1/100) and added to a clean cuvette. The spectrophotometer was blanked with 
water using a clean cuvette. The yield of DNA was calculated by measuring the optical 
density (OD) at 260nm and at 280nm and the DNA concentration was calculated as 
follows:
OD260 x 50pg/ml x dilution factor = DNA concentration pg/ml 
An absorbance of 1 unit at 260nm corresponds to 50pg/ml of DNA. The ratio of the 
readings at 260nm and 280nm provides an estimate of the purity of DNA with respect to 
contaminants that absorb in the UV spectrum, such as protein. The 260nm/280nm ratio 
of pure DNA in water is approximately 1.8.
STR Profiling
The DNA was analysed using two sets of primers: Second Generation Multiplex (UK 
Forensic Science Service) (Thomson et al., 1999) and Powerplex 1 (Promega) (Lins et 
al., 1998) by LGC to investigate the presence of cell line cross-contamination. STRs 
used had tetranucleotide repeat sequences. Multiplex PCR reactions were carried out 
using fluorescent dye-linked primers. PCR products for each cell line were separated 
and analysed using a Perkin-Elmer-ABI Prism 377 Genetic Analyser and Genescan and 
Genotyper analysis software. The amplified product is measured according to its 
fluroscence and is then converted to a representative peak on a graph. These peaks are 
assigned allele values corresponding to the number of repeat units. Cell lines originating
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from the same source should have 80% similarity for DNA profile, i.e. the same size 
peaks on a graph.
2.3.2 Mycoplasma Testing
Contamination of cell culture by microorganisms remains one of the major problems in 
routine tissue culture. One of the most problematic contaminants is mycoplasma, an 
organism that resides on or within individual cells presenting no overt signs of 
contamination like fungus or yeast.
Mycoplasma is one of the smallest living cells known. They are generally spherical in 
shape with a diameter varying from 0.3 to 0.8pm. Filament forms also exist with 
diameters of 0.1 to 0.3pm and lengths of up to 150pm. They have no cell wall and are 
therefore insensitive to cell wall-active antimicrobial agents. They have a small amount 
of genetic material and have limited biosynthetic capabilities, although they are 
cholesterol dependent. Their growth requires an enriched medium and they exist 
symbiotically with growing cells. There are more than 100 species, of which 
approximately 85% of all cell line infections can be attributed to 5 species (M. orale. M. 
arginini. M. hvorhinis. M. fermentans and Acholeplasma laidlawiO.
Mycoplasma contamination can lead to misleading data, wasting valuable time and 
resources. DNA, RNA and protein synthesis can be altered and changes in enzyme 
patterns. Selection of mutant mammalian cells can be interfered with and the host cell’s 
plasma membrane can be modified.
2.3.3 Mycoplasma Testing Of Cell Lines
Different companies and research scientists have established various kits and techniques 
to carry out mycoplasma testing. After investigating the possible use of various methods 
we concluded that the PCR based techniques were most efficient and reliable for our 
requirements. One technique was not sufficient to detect all types of mycoplasma 
contamination therefore two different PCR methods were used. The use of two different 
PCR methods also helps to overcome the disadvantages associated with PCR analysis. 
PCR is a very sensitive technique and in order to rule out any false positives it is always 
necessary to include a negative control. Cross contamination can be avoided by 
preparing template DNA in a separate room to where reagents are aliquoted. Amplified 
DNA should also be kept in a separate room. It is always an advantage to test your PCR
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samples in duplicate as false positives and cross contamination is less likely to be 
repeated in both samples. A reagent only sample at beginning of your sample 
preperation and at the end of your sample preperation should indicate any contamination 
that occured throughout your preparations. Pipette tips should be changed after every 
reaction tube. Nested PCRs are particularly sensitive and susceptible to cross 
contamination due to the involvement of a second amplification round, although the 
second round uses a separate set of primers. In addition to two different types of PCR 
methods being used to test for the presence of Mycoplasma contamination in cell lines, 
a Stratagene PCR was used to identify the type of Mycoplasma present. To my 
knowledge no other procedure can easily identify Mycoplasma type. A detailed 
description of PCR analysis can be found later in this chapter.
The supernatant from a confluent flask of cells (table 1.3) was used to extract DNA. 
This supernatant could be stored at 4°C for up 1 month. A “Coriell PCR” was used to 
check for the presence of mycoplasma and results were confirmed using a “Drexler 
Multiplex, Nested PCR”. The “Stratagene PCR” was used to determine the type of 
mycoplasma contamination. When a cell line is contaminated, ideally it should be 
thrown away, but alternatively this contamination can be treated with antibiotics to 
eliminate mycoplasma infection and re-tested for mycoplasma contamination after 
antibiotic treatment.
Procedure
Cell cultures were grown in antibiotic free medium, for at least 2 passages, until 
confluent. The supernatant was removed and stored at 4°C, until ready to use. DNA was 
extracted using “Strata-Clean” resin. Briefly, lOOpl of supernatant was transferred to a 
1.5ml tube, incubated at 95°C for 10 minutes and quickly spun to bring supernatant 
down from sides of tube. The Strata-Clean resin was vortexed for 30 seconds to 
resuspend resin and lOjul of resin was added to sample tube, well mixed and quickly 
spun to pellet resin. The final preparation was diluted 1:10 times and this was used as 
the DNA template for the PCR reaction.
13.3.1 Coriell PCR
Two highly conserved r-RNA sequences are used as primers. The expected size 
fragment, after amplification is approximately 500bps. (Toji et al., 1998)
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Primer Seqences:
Primer A -  5’ GGC GAA TGG GTG AGT AAC ACG 3’
Primer B -  5’ CGG ATA ACG CTT GCG ACC TAT G 3’
PCR Reaction
A 25jli1 PCR reaction was prepared in a 200 pi tube by adding;
lx Reaction Buffer, 1.5mM MgCk, 200pm of each dNTP, 0.6U Taq Polymerase,
0.2pM of each Coriell primer, dtbO up to 25pi and lOpl DNA template.
Perkin Elmer Thermocycler conditions for Coriell PCR 
1 Cycle 95°C - 5 min
55°C -  1 min 45 sec 
3 Cycles 72°C -  3 min
94°C - 45 sec
55°C - 1 min 45 sec
40 Cycles 72°C - 3 min
94°C - 45 sec
55°C - 45 sec
1 Cycle 72°C -  10 min
27°C -  10 min and Hold @ 4oC
233,2 Drexler Multiplex, Nested PCR
A number of different primer sequences were chosen from the 16S r-RNA gene region. 
These oligonucleotide sequences do not cross-react with non-mycoplasma contaminants 
or with eukaryotic DNA from the cell lines. The 5 most common mycoplasma species + 
20 additional species can be detected. The expected size fragment for Round I is 500 -  
520bp. The expected size fragment for Round II is 310 -  330bp. (Hopert et al., 1993b; 
Hopert et al., 1993a)
Primer Sequence
Outer primers: Mvco 9 (A. B. C. D. E and F)
CGC CTG AGT AGT ACG TTC GC 
CGC CTG AGT AGT ACG TAC GC 
TGC CTG AGT AGT ACA TTC GC 
CGC CTG GGT AGT ACA TTC GC
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CGC CTG AGT AGT ATG CTC GC 
TGC CTG GGT AGT ACA TTC GC 
Mvco 3 64. B and C)
GCG GTG TGT ACA AGA CCC GA 
GCG GTG TGT ACA AAA CCC GA 
GCG GTG TGT ACA AAC CCC GA 
Inner primers: Mvco 8 (A and B)
TGG TGC ATG GTT GTC GTC AG 
TGG TGC ACG GTT GTC GTC AG 
Mvco 5 (A. B. C. D. E. F and G)
GAA CGT ATT CAC CGC AGC ATA 
GAA CGT ATT CAC CGT AGC GTA 
GAA CGT ATT CAC CGC AGC GTA 
GAA CGT ATT CAC CGC AAC ATG 
GAA CGT ATT CAC CGC AGT ATA 
GAA CGT ATT CAC CGC GAC ATA 
GAA CGT ATT GAC CGC GAC ATG
Reaction mix
For Round 1 of the Nested PCR, a 25 pi reaction was prepared in a 200pl tube by 
adding:
lx Buffer (inc. 1.5mM MgCk), 1.5mM MgCU, 200|nM of each d NTP, 90nm of each 
primer (outer & inner Drexler primers), 1.25U Taq Polymerase, ctt^O up to 50pl per 
reaction and lOpl of DNA template.
For Round 2 of Nested PCR, a 25pl reaction was prepared in a 200pl tube by adding; 
lx Buffer (inc. 1.5mM MgCk), 1.5mM MgCb, 200pM of each d NTP, 90nm of each 
primer (outer & inner Drexler primers), 1.25U Taq Polymerase, CIH2O up to 50pl per 
reaction and 10 pi of the first round product.
Perkin Elmer Thermocycler conditions:
1 Cycle 90°C -  10 min
30 Cycles 94°C-30sec
60°C -  30 sec 
72°C -  60 sec 
1 Cycle 72°C -  lOmin and Hold @ 40°C
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2.33.3 Stratagene PCR Catalogue Number: 302007
The Stratagene PCR kit is used to determine the type of Mycoplasma found.
A different fingerprint pattern distinguishes between the 5 most common causes of 
contamination, as follows;
If an unrecognised fingerprint is obtained, the cell line may be infected with a strain that 
has not been characterised yet or with an organism other than Mycoplasma. An internal 
control and a positive control are provided with the kit.
Reaction mix
A  50pl PCR reaction was set up by adding the following:
IX buffer, 1.5mMMgCl2,0.2mMofeachdNTP, 1U of Taq DNA polymerase, ddf^O up 
to 50pl volume and lOpl of DNA template.
Thermocycler conditions for Stratagene PCR 
1 Cycle 95°C - 5 min
55°C -  1 min 45 sec 
3 Cycle’s 72°C -  3 min
M. orale 
M. hyorhinis 
M. fermentans 
M. arginine
Acholeplasma laidlawii 
Internal Control 
Kit pos control 
House control (KK47)
600bp
700bp, 620bp, 280bp 
630bp
600bp, 230bp 
280bp, lOObp 
420bp
600bp, 230bp 
600bp, 230bp
94°C - 45 sec
55°C - 1 min 45 sec
40 Cycle’s 72°C - 3 min
94°C - 45 sec
55°C - 45 sec
1 Cycle 72°C- 10 min
27°C -  10 min and Hold @ 4°C
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Thermocycler Type
The same thermocycler, a Perkin Elmer 2800 was used for all PCR optimisations and 
sample testing. By consistently using the same type of thermocycler, for all PCR 
reactions, the need for further optimisation required when using different PCR machines 
was avoided.
2.4 CELL LINE MAINTENANCE
Complete medium was stored at 4°C. The cell lines were media-changed 2 or 3 times 
per week. Cultures were examined under an inverted light microscope to check for 
bacterial or fungal contamination. The medium additives were thawed at 37°C, added to 
500ml of medium and mixed. See table 2.2 for details of medium used and additives 
required for the different types of medium. The medium was aspirated and replaced 
with the appropriate volume, carefully pipetted into the flask or plate. The cell cultures 
were returned to a 5% CO2 incubator with the lid loosened (vented lids were not used 
due to extra expense) one half turn in order to allow gas exchange. Only one cell line 
was allowed at a time in the flow cabinet, in order to avoid the risk of cross- 
contamination.
45
Table 2.2: Cell Culture Medium
Medium Type Additives (nutrients) Additive
Quantity
PrEGM (500mL)
Prostate Epithelial cell medium 
Supplier:
Cambrex (BioWhittaker)
Bovine Pituitary Extract (BPE)
Insulin
human-Epidermal Growth Factor (h-EGF)
Transferrin
Retinoic Acid
Gentamicin sulfate amphotericin-B (GA)
Epinephrine
Hydrocortisone (HC)
Triiodothyronine (T3)
2ml
0.5ml
0.5ml
0.5ml
0.5ml
0.5ml
0.5ml
0.5ml
0.5ml
RPMI-1640 w/o L r Glutamine 
(500mL) For mammalian cells 
Supplier: Invitrozen (Gibco BRL. 
Life Technologies)
8% Foetal Calf Serum (FCS) 
2mM of L-Glutamine
40ml
5ml
DMEM (500mL)
Dulbeccos Modified Eagle 
medium for mammalian cells 
Supplier: Invitrozen (Gibco BRL. 
Life Technologies)
8% Foetal Calf Serum (FCS) 
2mM of L-Glutamine
40ml
5ml
Keratinocyte-SFM (SOOmL)
Supplier: Invitrozen (Gibco BRL. 
Life Technologies)
1.5 ml Bovine Pituitary Extract (BPE) 
2.5pg Epidermal growth factor (EGF) 
4% Foetal Calf Serum (FCS)
Opti-MEM 1
Reduced serum medium 
Supplier: Invitrozen (Gibco BRL. 
Life Technologies)
No additives
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2.4.1 Cell Line Passaging
The cell lines were passaged when necessary. The cultures were washed with lx PBS 
and detached using a trypsin-versene (T/V) (contains 0.5g/L trypsin 1:250 and 0.2g/L 
versene in a buffered saline solution) treatment. l-2ml of lx T/V was carefully added, 
spread across the monolayer and removed by aspiration. The culture vessel was 
transferred to an incubator for a period of a few minutes to allow cells to detach. The 
cells were resuspended in the required volume of fresh medium.
/
Pre2.8 cells were treated differently because they grow in serum-free medium. 2-5ml of 
T/V was carefully pipetted onto cells and spread across the monolayer and flasks 
transferred to a 33°C incubator for up to 15 minutes to allow the cells to detach. The 
cells were suspended in 20ml of PrEGM medium (diluting tiypsin/versene) and 
centrifuged at 1000 x g. The supernatant (containing T/V) was removed. Therefore 
inactivation of trypsin was not required. Cells were resuspended in the required volume 
of fresh PrEGM medium.
A single cell suspension was obtained by pipetting the cell suspension up and down 
approximately 5 times. For routine maintenance, the cell lines were split at appropriate 
ratios, depending on their growth rate. Pre2.8 cells are slow growing and density 
dependent and therefore they were split at an approximate ratio of 1:3. S2.13 cells are 
fast growing and were therefore split at a ratio of 1:20. New culture vessels were 
labelled with cell line name, passage number and date. Cell cultures were inspected 
daily.
2.4.2 Haemocytometer Cell Counting
The haemocytometer (improved Neubauer) must be clean and free of grease. If 
necessary, the surface of the counting chamber and the coverslip can be cleaned using a 
70% alcohol-soaked tissue. When the coverslip has been correctly attached on top of the 
counting chamber, a rainbow effect ("Newton's rings") should be seen on either side of 
the central chamber.
After a single cell suspension was obtained, an equal volume (e.g. 0.2ml) of this 
suspension was added to 0.4% trypan blue (e.g. 0.2ml) and sample was thoroughly 
mixed. Trypan blue is a viability stain and is excluded by viable cells. This relates to 
cell semipermeability. Trypan blue enables exclusion of dead cells from the count.
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Using the tip of a pipette a small volume from the mixture was transferred to the edge of 
the coverslip and drawn under the coverslip by capillary action. Inaccuracies in cell 
distribution will occur if the chamber is overfilled or underfilled. Both sides of the 
chamber were loaded. The grid lines of the haemocytometer chamber were focused and 
viable cells were counted at low power (10X objective), using a light phase microscope. 
For fewer numbers o f viable cells all 9 large squares were counted and for larger
numbers of cells, counting the 4 large comer squares was sufficient (figure 2.1). For
#  ^
routine subculture 100-300 cells per mm should be counted. The more cells that are
counted the more accurate the count will be. This was repeated for both sides of the
haemcytometer.
Figure 2.1: Schematic Diagram Of A Haemocytometer Chamber
The chamber is divided into 9 large squares and each large square is divided into 16 small 
squares. There are 2 chambers on a haemocytometer.
Calculation o f  cell numbers 
The formula is:
Number o f cells counted number o f large squares counted x 2 x 104 
This gives the number o f cells/ml of the cell suspension.
This is derived from the following:
The area o f each square is 1mm and the depth of the counting chamber is 0.1mm. 
Therefore, the volume of each large square is 0.1mm3 i.e. 10'4 ml 
The cell suspension is diluted at a ratio of 1:1 in trypan blue therefore, the cell count 
must be multiplied by 2 to allow for this (Cell Number = mean x 2 x 104). The desired 
cell concentrations can then be calculated and the assay set up.
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2.5 MEASUREMENT OF CELL GROWTH RATES
Growth curves for Pre2.8 cells were obtained using two procedures, an MTT assay and 
cell counts, while growth curves for S2.13 cells were carried out using cell counts only.
2.5.1 MTT Assay - Growth Curves
The MTT assay is a relatively rapid colorimetric assay using a dye that is reduced only 
by viable cells. The dye, a tetrazolium salt (MTT, (3-4,5-dimethylthiazol-2-yl)-2,- 
diphenyltetrazolium bromide), is reduced by mitochondrial dehydrogenase to purple 
formazan crystals. The crystals are dissolved in dimethyl sulphoxide (DMSO) and the 
intensity measured colorimetrically to give an estimate of the relative number of viable 
cells.
The appropriate number of cells was added in a volume of 150pl of medium to the 
selected wells of a 96-well plate. 150pl of medium without cells was added to column 1 
in order to provide a “blank” for background subtraction.
A stock of MTT reagent at a concentration of 5mg/ml in medium was prepared and 
filter-sterilised using a 0.22pm filter. The stock was stored at 4°C in the dark for no 
more than 3 weeks.
The final MTT concentration (0.5mg/ml, l.Omg/ml or 5.0mg/ml) was optimised for 
each cell line used. The medium was removed from each well, being careful not to 
dislodge the cells, 100pi of 0.5-5.0mg/ml MTT reagent was added and the plate was 
incubated at 37°C for 3 hours. Supernatant was gently removed and plate was blotted on 
tissue paper to ensure that all solution was removed. lOOpl of DMSO was then added 
and incubated on a tilting platform at room temperature for 30 minutes to allow the 
precipitate to dissolve. The plates were read at 540nm (filter 6) on an ELISA reader 
(Titertek Multiskan MCC/340). Results were saved onto a disc and “Macro-transposed” 
(computer program to subtract blank results from sample results) and a graph of optical 
density (OD) versus cell seeding number was obtained (table 2.3 and figure 2.2).
The experimental conditions were optimised for each cell line, including cell number 
and MTT concentration. The columns (8 wells) of a 96-well plate were seeded with 
1250, 2500, 5000, 10000, 15000, 20000, 30000, 40000, 50000 and 60000 cells in a 
volume of 150pl of medium per well and grown for 2 days (table 2.3). MTT
concentrations o f 0.5mg/ml, l.Omg/ml and 5.0mg/ml were prepared. 50pl o f medium 
was removed from each well and replaced withlOOpl o f 0.5mg/ml MTT for the first 2 
rows o f the 96-well plate. lOOpl o f 1 .Omg/ml MTT was added to the row 3, 4 and lOOpl 
of the 5.Omg/ml MTT was added to the last 3 rows o f the 96-well plate (table 2.3).
Table 2.3: Experimental Lay Out For MTT Optimisation
MTT conc. 
(mg/ml)
Pre2.8 cell number per well
0.5 0 1250 2500 5000 10000 15000 20000 30000 40000 50000 60000
0.5 0 1250 2500 5000 10000 15000 20000 30000 40000 50000 60000
1.0 0 1250 2500 5000 10000 15000 20000 30000 40000 50000 60000
1.0 0 1250 2500 5000 10000 15000 20000 30000 40000 50000 60000
5.0 0 1250 2500 5000 10000 15000 20000 30000 40000 50000 60000
5.0 0 1250 2500 5000 10000 15000 20000 30000 40000 50000 60000
5.0 0 1250 2500 5000 10000 15000 20000 30000 40000 50000 60000
Figure 2.2: Optimsation of MTT Assay for Pre2.8 Cells
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Optimisation of cell number and MTT concentration for the MTT assay with Pre2.8 cells. MTT 
results were obtained at 540nm on an ELISA reader and sample results were subtracted from 
blank results. A graph o f optical density versus cell seeding number was obtained. The best 
results were obtained with 0.5mg/ml and 1 mg/ml of MTT solution. Results from 5mg/ml had 
very large standard errors and there was no linearity. 1 mg/ml o f MTT solution was chosen as 
the optimum concentration for an MTT assay with Pre2.8 cells. Optical densities were linear 
between 2500 and 40,000 cells with MTT concentrations o f 0.5mg/ml and 1 mg/ml. 10,000 
Pre2.8 cells were chosen as an optimum seeding concentration for Pre2.8 MTT assays.
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The plates were then processed as described above. This optimisation assay was 
repeated twice and the mean and standard deviation was calculated for each 
concentration of MTT solution. A graph of optical density versus cell number seeded 
for each MTT concentration was obtained using Microsoft Excel. The optimum seeding 
number for Pre2.8 cells and the optimum MTT concentration were determined (figure 
2 .2).
The best results were obtained with 0.5mg/ml and 1 mg/ml of MTT solution. Results 
from 5mg/ml had very large standard errors and there was no OD linearity, lmg/ml of 
MTT solution was chosen as the optimum concentration for an MTT assay with Pre2.8 
cells. Optical densities were linear between 2500 and 40,000 cells with MTT 
concentrations of 0.5mg/ml and lmg/ml. 10,000 Pre2.8 cells were chosen as an 
optimum seeding concentration for Pre2.8 MTT assays. The OD for 10,000 cells was 
estimated taking into account the length of time it takes for the number of cells seeded 
to be regenerated (a certain number of cells seeded will die). Calculation: If 10,000 cells 
are seeded and it is expected that after 2 days, approximately the same number of cells 
(10,000) is present, then the ELISA OD reading can be estimated using the MTT assay. 
The mean OD for 10,000 cells from both plates was obtained (0.123 +0.084 = 0.207) 
(0.207/2=0.104). The OD for 10,000 cells is approximately 0.104nm.
Optimised Assay
In order to construct a growth curve using the MTT assay, 10,000 Pre2.8 cells were 
seeded in quadruplicate. Separate plates were incubated at 33°C, 39°C and 37°C. The 
cells were harvested at days 3, 5, 7,10,12,14 and 18, using 1.Omg/ml MTT reagent for 
colour development. The mean colour intensity was calculated for the four replicates at 
each time point. The experiment was repeated 4 times. The mean and standard deviation 
were calculated for each assay.
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2.5.2 Cell Counts -  Growth Curves
Cell counts were used to obtain a growth curve for Pre2.8 and S2.13 cells. Triplicate 
T25 flasks were seeded with 100,000 Pre2.8 cells or 200,000 S2.13 or FT cells and 
incubated at 33°C, 39°C and 37°C. The medium was changed three times weekly and 
the cells were harvested after 3, 5,7,10,12,14 and 17 days incubation. The experiment 
was repeated three times. Viable cells (trypan blue exclusion) were counted on an 
inverted phase microscope using a haemocytometer. The mean cell number was 
calculated for each set of triplicate samples and the mean, standard deviation and 
standard error was calculated.
2.5.3 Statistics
In general there are 2 types of statistics: (i) descriptive or (ii) inferential. No conclusions 
are drawn from descriptive statistics. They simply reduce the acquired information to a 
manageable size and present a summary of the data. Inferential statistics draw 
conclusions from the data, e.g. the conclusion that there is a significant difference in 
some measurable response between two drugs. The mean and standard deviation was 
calculated using Microsoft Excel software and from these results the standard error was 
calculated using a standard formula.
Average
An “average” is a general term used to describe a value of a variable that is typical or 
representative of the data. Common types of average are arithmetic mean, median and 
mode. Excel returns the average (arithmetic mean) of the numbers. The arithmetic mean 
is the sum of all the observations divided by the number of observations (an average 
number is obtained by adding two or more amounts together and dividing the total by 
the number of amounts).
Standard deviation
Excel estimates standard deviation based on a sample. The standard deviation is a 
statistical measure of how widely values are dispersed from the average value (the 
arithmetic mean). It is calculated as the square root of the variance (a measure of the 
spread or variation of a group of numbers in a sample, equal to the square of the 
standard deviation). The more widely the values are spread out, the larger the standard 
deviation. For example, say we have two separate lists of exam results from a class of
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30 students; one ranges from 31% to 98%, the other from 82% to 93%, then the 
standard deviation would be larger for the results of the first exam.
Standard Error
Standard error is a measure of variability, calculated by dividing the standard deviation 
of the sample in a frequency distribution by the square root of the number of values in 
the sample. It is a measure of the variability that a constant would be expected to show 
during sampling.
SE = SD/Vn
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2.6 CELL SIZE DISTRIBUTION
Cell size distribution for Pre2.8 and S2.13 prostate cells were measured using a 
Graticule under a light phase microscope and using a Beckman “Z2 Coulter Counter 
and size analyzer”.
2.6.1 Graticule And Light Phase Microscope
Flattened cells growing on a petri dish were measured using a 1mm grid graticule, 
showing markings of 0.01mm on a slide. This grid is equated to similar unlabelled 
markings on a microscope eyepiece grid (graticule) at the different magnifications on 
the Light Phase Microscope.
Procedure
Semi-confluent plates of Pre2.8 and S2.13 cells, incubated at 33°C, 37°C and 39°C at 
day seven in culture were used for measurement. The grid on the eyepiece graticule was 
used as a guide for a straight line. The diameter of the cell was measured by making a 
note of the number of markings for each cell and its nucleus, along this line. This was 
repeated until a minimum of 100 cells for each cell line was measured. The number of 
markings was then converted to mm using the measurements worked out for that 
particular magnification. These figures were entered onto a Microsoft Excel worksheet 
and the mean and standard deviation was calculated for each group. A graph of “cell 
number versus size” was obtained from these measurements.
2.6.2 Beckman Z2 Coulter Counter And Size Analyzer
Cells are in suspension when size is measured using a Coulter Counter. Unlike older 
counters the Beckman Z2 does not require calibation. It has an analogue display and the 
lower threshold can be set manually on th read-out, usually at 7pm, while the upper is 
normally set at 30pm or infinity. After completing a trial run with Pre2.8 cells grown at 
33°C, a size range was set between Cl and C2 (e.g. 10pm and 30pm) in order to avoid 
counting debris. This range can be altered depending on cell type. A digital display unit 
displays the total number of cells counted within this size range, the number of cells 
counted per ml, the mean, median, mode and standard deviation of cell size.
Beckman Coulter Counter
Particles suspended in a weak electrolyte solution are drawn through a small aperture 
separating two electrodes between which an electric current flows. The voltage applied
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across the aperture creates a “sensing zone”. As each particle passes through the 
aperture (or “sensing zone”) it displaces its own volume of conducting liquid, 
momentarily increasing the impedance (resistance of an electric circuit to the flow of 
current) of the aperture. This change in impedance produces a tiny but proportional 
current flow into an amplifier that converts the current fluctuation into a voltage pulse 
large enough to measure accurately. The amplitude of this pulse is directly proportional 
to the volume of the particle that produced it. Scaling these pulse heights in volume 
units enables a size distribution to be acquired and displayed. In addition, if a metering 
device is used to draw a known volume of the particle suspension through the aperture, 
a count of the number of pulses will yield the concentration of particles in the sample.
Procedure
A single cell suspension was obtained using 0.5ml of trypsin for Pre2.8 cells grown at 
33°C, 37°C and 39°C, and for S2.13 cells grown at 33°C. Cells were resuspended in 
9.5ml of medium. A suitable dilution of this cell suspension was prepared in an isotonic 
(having the same or equal osmotic pressure - usually used with regards to describing 
solution on either side of a membrane.) electrolyte (e.g. PBSA). An electrolyte is a 
substance that, when dissolved in water, gives a solution that can conduct electricity. A 
minimum of 100,000 cells was sufficient for the Coulter counter. A graph of “cell 
number versus size” was obtained from results produced by the Coulter counter.
2.7 ANCHORAGE INDEPENDENT GROWTH IN AGAR
Anchorage independent growth is a suspension cloning procedure. Pre2.8 and S2.13 
prostate cells were tested for their ability to grow in semi-solid agar, an indication of 
neoplastic transformation (Honjo et al., 2001; Menter et al., 2000). A breast cancer cell 
line, MDA-MB-435 (Glinsky et al., 1996) was used as a positive control. The assay was 
carried out in 6-well plates. Semi-solid agar was prepared at a concentration of 0.75% 
(base agar) and 0.28% (top agar) in RPMI-1640 medium.
Base Agar
Agar, 1.5% (DNA grade) was melted in a microwave and then cooled to 40°C in a 
waterbath. Appropriate medium was warmed to 40°C in a waterbath and allowed to 
equilibrate for at least 30 minutes. Equal volumes of the two solutions were mixed to 
give 0.75% Agar in medium, 1.5ml was added per 35mm petri dish and allowed to set.
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The plates could be stored at 4°C for up to 1 week. It is best to remove the base agar 
plates from 4°C 30minutes before adding top agar.
Top Agar and Cell Preparation
Agar, 0.5% (DNA grade agar) was melted in a microwave and cooled to 40°C in a 
waterbath. Medium was warmed to the same temperature. A single cell suspension of 
Pre2.8, S2.13 and MDA-MB-435 was obtained from semi-confluent T80 flasks. Cell 
concentrations of 1.25xl04,2.5xl04,5.0xl04 and 1.0x10s were prepared in triplicate, for 
each cell line and 0.1ml was added per 15ml conical tube. Equal volumes of medium 
and 0.5% agar was added to each 15ml conical tube and contents were gently mixed. 
1.5ml of each sample was added per base agar plate. The assays were incubated at 37°C 
for 10-13 days. Colony formation was examined under a light microscope.
2.8 COLONY FORMING ASSAYS
The colony forming efficiencies (CFE), a monolayer cloning procedure, of Pre2.8 cells 
were measured at 33°C and 39°C. A single cell suspension of Pre2.8 cells was prepared 
and resuspended in 10ml of PrEGM medium. From this suspension 10,000, 15,000 and 
20,000 cells were added, in triplicate to 5cm petri dishes and incubated at 33°C and 
39°C for at least 14 days. Each experiment was repeated a minimum of 3 times. The 
cultures were fixed with 70% IMS for 5 minutes and stained with 10% Giemsa for 30 
minutes. Colonies containing greater than 50 cells per colony were counted under a 
dissecting microscope. The average of each triplicate set was determined and the 
percentage colony forming efficiency (%CFE) was calculated.
2.9 IMMUNOHISTOCHEMISTRY
2.9.1 Cultures On Coverslips
Preparation of coverslips for growing cells for immunocytochemical staining, 3ml of 
7X detergent was added to 1 litre of deionised water, mixed and added to a microwave 
bowl. Coverslips were added to the boiling solution and microwaved for 10 minutes. 
They were then cooled and rinsed in 10 changes of water, the first 3 times with tap 
water and the last 7 with deionised water. Finally, the coverslips were rinsed once with 
95% ethanol, dried and sterilised by autoclaving.
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To grow cells on the coverslips, the desired numbers of coverslips were placed into 
individual wells of a 24-well plate. A single cell suspension of the selected cell line was 
prepared and added to each well. To fix the cells, the medium was carefully aspirated 
and the monolayers washed twice with PBS. The cells were then fixed in ice-cold 
methanol and acetone (1:1 ratio) for 10 minutes, on ice. For storage, lml of a 0.1% 
sodium azide solution was added and the fixed cells were stored at 4°C until use. The 
preservative solution was prepared by dissolving O.lg of BSA and O.lg of sodium azide 
in 100ml of PBS. This reagent was stored at 4°C.
2.9.2 Cutting Paraffin Sections For Immunohistochemistry
The paraffin blocks were placed faced-down on ice for half an hour and 7- 10pm 
sections cut on a microtome and collected on Vectabond coated slides. The slides were 
incubated at 60°C for 20 minutes to remove water and soften the wax to aid adherence 
to the glass. The slides were stored at room temperature until use.
When required, the tissue sections were de-waxed twice in xylene for 3 minutes. They 
were then rehydrated by incubating twice in 100% alcohol for 1 minute, followed by 2 
incubations in 70% alcohol for 1 minute. The sections were then washed twice for 1 
minute in distilled water and stored in water. The tissue sections were circled with a 
Dako resin pen to delineate the area for immunocytochemisty.
Antigen retrieval of paraffin embedded tissue sections was required for most of the 
antibodies used. The retrieval, using a chemical reaction was carried out using a 
Vector™ Antigen Unmasking Solution. The specific chemical identity of the chemical 
in this product is withheld as a trade secret. The protocol for laboratory made citrate 
buffer, for antigen retrieval is a final concentration of 0.01M sodium citrate made in 
distilled water to pH 6.0 with concentrated HC1.
2.9.3 Antigen Unmasking Solution
Based on a citric acid formula, this solution is can reveal antigens in formalin-fixed, 
paraffin-embedded tissue sections when used in combination with a high temperature 
treatment procedure. The Antigen Unmasking Solution is supplied as a concentrated 
stock at pH 6.0. Rehydrated slides were placed in glass racks and carefully lowered into 
boiling retrieval solution and microwaved at full power for 15 minutes. The slides were 
then washed twice for 5 minutes in PBS and stored in lx  PBS until the next step.
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2.9.4 Monoclonal Antibodies
Antibodies are immunoglobulins (Ig) produced by the body’s immune system. Each 
antibody is produced by lymphocytes as a result of exposure to specific chemical 
substances called antigens, usually on the outside of an invading organism. They are 
proteins of molecular weight 150,000 - 900,000 kd, consisting of two heavy chains and 
two light chains. The structure of their antigen binding sites has great variation, which 
enables different antibodies to bind to structurally different epitopes. There are 5 classes 
(isotypes) of immunoglogulin: IgM, IgG, IgA, IgD and IgE, plus 4 subtypes of IgG 
(IgGl-4), and 2 of IgA (IgAl, IgA2).
Cesar Milstein and co-workers developed monoclonal antibodies for use in the 
laboratory (Kohler et al. 1975). They overcame the problem that lymphocytes cannot be 
grown independently in the laboratory. Briefly, an animal (e.g. a mouse) is exposed to a 
foreign substance, which after a few days results in the production of a mixture of 
antibodies in response to the antigens responsible. White cells are then extracted from 
the animal and are fused with cells taken from a cancerous tumour (for rapid growth), 
usually an immortal myeloma cell line. The hybrids are then cloned. Each clone is then 
tested to see if they are producing antibodies for the particular target substance. Since 
the cells in the clone are genetically identical, all the cells produce the same antibody, 
which builds up in the nutrient medium surrounding the cells. This is purified, resulting 
in a product containing molecules of a single antibody.
Due the specificity of their binding properties, monoclonal antibodies may have a wide 
variety of possible uses. We have used monoclonal antibodies in our studies (table 2.4), 
for immunocytochemistry and for flow cytometry procedures.
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Table 2.4: Primary Antibodies For Immunocytochemistry And Dilutions Used In
This Study
Antigen Gone Species Source
Working
Dilution
Ig
Subtype
Androgen receptor (AR) F.39.4.1 Mouse Biogenex
1/200 (DAB) 
1/100
IgGl
Prostate specific antigen 
(PSA)
ER-PR8 Mouse Dako M0750
1/30 (DAB) 
1/20
IgGl
Prostatic acid Phosphatase 
(PAP)
PASE-4LJ Mouse Dako
1/100 (DAB) 
1/50
IgGl
Kappa
Cytokeratin 8 (K8) 350H11 Mouse Dako
1/100 (DAB) 
1/200 (Fluores)
IgM
Cytokeratin 14 (K14) LL002 Mouse Gift, EB Lane 1/20 (Fluores) IgG3
Cytokeratin 17 (K17) E-3 Mouse Sigma 1/100 (Fluores) IgG2b
Cytokeratin 19 (K19) Rckl08 Mouse Gift, EB Lane 1/50 (Fluores) IgGl
Cytokeratin 18 (K18) LE61 Mouse Gift, EB Lane 1/10 (Fluores) IgGl
Smooth muscle actin 
(SMA)
1A4 Mouse Sigma
1/100 (DAB) 
1/200 (Fluoers)
IgG2a
Vimentin VIM-13.2 Mouse
Vim 13.1 -  
Sigma
1/200 (Fluores) IgM
Fibroblast A002 Gift, M O’Hare (Fluores) IgM
Ki67 Anti-Ki67 Rabbit Dako 1/100 (Fluores) IgG2A
Abbreviations: Fluores - luorescence; Ig -  Immunoglobulin
2.9.5 Immunocytochemistry Using The Vectastain Elite ABC Kit
The Vectastain Elite ABC kit, based on the avidin biotin method of immunostaining 
was used. Briefly, this method employs unlabelled primary antibody, followed by 
biotinylated secondary antibody and an Avidin and Biotinylated horseradish peroxidase 
macromolecular complex.
Fresh 0.3% hydrogen peroxide in 70% methanol was prepared for each experiment. 
300pl of hydrogen peroxide was added to 100ml of 70% methanol in PBS and kept at 
4°C. This solution was used to saturate endogenous peroxidase, in order to avoid non- 
specific background staining. The peroxide solution was added to each coverslip or 
slide, and incubated for 30mins at room temperature, followed by two washes in lx
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PBS for 5mins each. Normal horse serum (NHS) was used to block non-specific 
antibody binding and was added for 20 minutes at room temperature. Then primary 
antibody (mouse anti-human Ab) diluted in NHS was added at a volume of 50jli1 of 
antibody to each coverslip or 100-200pl to each slide and incubated for l-2hrs at room 
temperature, followed by three 5 minute washes in PBS.
Biotinylated secondary antibody was diluted and 50pl added per coverslip, or 100- 
200pl added per slide and incubated for 30 minutes at room temperature. Vectastain 
ABC reagent was prepared 30mins before use. One drop was added to each coverslip 
and 2 drops to each slide and then incubated for 30 minutes, followed by three washes 
in PBS for 5 minutes each.
The coverslips or slides were incubated in ABC reagent for 30mins at room 
temperature, followed by two washes in PBS for 5 minutes each. Peroxidase substrate 
(3,3’-diaminobenzidine tetrahydrochloride) was prepared following DAB kit 
instructions and 50pl was added to each coverslip or 100-200jli1 was added to each slide. 
Once the preparation was stained, the DAB was pipetted from the coverslips or slides 
and placed in a universal containing 12% (w/v) sodium hypochlorite solution for 
disposal. The coverslips or slides were carefully washed in tap water, as there is some 
evidence that DAB is carcinogenic.
The preparations were counterstained with Mayer’s haematoxylin for about 30 seconds 
and then carefully washed with tap water, and then dehydrated by immersing twice in 
70% alcohol for 5mins each, twice in 100% alcohol for 5mins each and twice for 5 
minutes in xylene. Coverslips were mounted cell side down on a slide with a drop of 
DPX and slides were mounted with a coverslip with DPX.
Immimofluorescent staining
Paraffin-embedded sections were dewaxed and rehydrated and cells on coverslips were 
fixed before staining. PBS containing 10% foetal calf serum (FCS)/foetal bovine serum 
(FBS) is required for blocking of non-specific antibody binding and also for antibody 
dilution. Serum used should contain sufficient immunoglobulins to competitively inhibit 
the binding of antibodies (being tested) to cells, via interactions not involving the 
specific recognition of an epitope by the antigen binding region of the antibody (being 
tested), referred to as non-specific or background staining. Each section or coverslip
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was covered with a suitable volume (50pl-300pl) for 30 minutes. Primary antibody was 
diluted in serum solution. 50jj,1 was added per coverslip and 50-200pl was added per 
tissue section and incubated at 4°C overnight, followed by two washes in PBS for 5 
minutes each. The secondary antibody was diluted and applied to sections or coverslips 
and incubated in the dark for 45 minutes, followed by two washes in PBS for 5 minutes 
each. Hoechst (25mg/ml) nuclear stain was applied and incubated in the dark at room 
temperature for 5 minutes, followed by two washes in PBS for 5 minutes each. The 
slides were mounted in Gelvatol and stored in the dark at 4°C until ready to examine 
under the fluorescence microscope.
Hoechst nuclear stain
Hoechst 33258, chemically known as bisbenzimide is a DNA intercalator that excites in 
the near UV (350 nm) and emits in the blue region (450 nm). Hoechst 33258 binds to 
the AT rich regions of double stranded DNA. It is a membrane-permeable fluorescent 
DNA stain, only when cells are fixed and it has low cytotoxicity.
Gelvatol Mounting Medium
Gelvatol is a product of the “Monsanto Indian Orchard” plant. Mounting solution was 
prepared by mixing 6g of Glycerol and 2.4g of Gelvatol in 6ml of distilled water in a 
50ml tube. The mixture was incubated at room temperature for 30 minutes and then 
12.5ml of a 200mM Tris (pH 8.5) buffer was added and heated at 50°C for 10 minutes. 
This process was repeated 4 times and the solution was placed on a rotating platform 
overnight at room temperature. The solution was then cenrifuged at 400rpm, the 
supernatant removed, and stored at 4°C until required.
2.10 FLUORESCENCE MICROSCOPY AND DATA CAPTURE
Fluorescence describes light emission that continues only during the absorption of the 
excitation light by a chromophore or other conjugated molecule that is capable of 
emitting secondary fluorescence. A fluorescence microscope uses high-energy, short- 
wavelength light (usually ultraviolet) to excite electrons within certain molecules inside 
a specimen, causing those electrons to shift to higher orbits. When they fall back to their 
original energy levels, they emit lower-energy, longer-wavelength light (usually in the 
visible spectrum), which forms the image.
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Ultraviolet Light Action
A fluorescence microscope uses a mercury or xenon lamp to produce ultraviolet The 
light comes into the microscope and hits a dichroic mirror, a mirror that reflects one 
range of wavelengths and allows another range to pass through. The dichroic mirror 
reflects the ultraviolet light to the specimen. The ultraviolet light excites fluorescence 
within molecules in the specimen. The objective lens collects the fluorescent- 
wavelength light produced. This fluorescent light passes through the dichroic mirror and 
a barrier filter (that eliminates wavelengths other than fluorescent), going it to the 
eyepiece to form the image.
Fluorescence-microscopy techniques are useful for seeing structures and measuring 
physiological and biochemical events in living cells. Antibodies that are specific to 
various biological molecules can be chemically bound to fluorescent molecules and 
used to stain specific structures within cells.
Fading or bleaching of fluorescence in specimens during exposure limits the time 
available to examine stained samples and hence limits its usefulness. To minimize the 
effects of photobleaching, fluorescence microscopy combined with phase contrast 
illumination was used for this work. This was achieved by locating the specific area of 
interest in a specimen using the non-destructive contrast enhancing technique (phase) 
then, without relocating the specimen the microscope was switched to fluorescence 
mode. Adobe Photoshop 5.0 was the software used to transform the captured image into 
the fluorescent photograph.
2.11 CYTOGENETICS
The normal karyotype of humans consists of 23 pairs of chromosomes. During the 
development of cancer and immortalisation of normal cells, chromosomal changes can 
occur. Identification of chromosome patterns can be carried out using fluorescent 
staining methods. A standard map of the banding pattern of each chromosome was 
established for the human chromosome from the prometaphase stage of mitosis.
The cytogenetics was carried out by Dr R McLeod, DSMZ, Braunschweig, Germany. 
Cytogenetic harvesting, slide preparation, trypsin G-banding (GTG) and fluorescence 
in-situ hybridisation (FISH) were performed as described previously (MacLeod et al., 
2000). FISH was performed according to manufacturers’ protocols using single-locus
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and whole-chromosome (‘painting’) probes, including Octachrome paints obtained from 
Cambio (Cambridge, UK), AGS (Heidelberg, Germany), Vysis (Bergishe Gladbach, 
Germany), Q-Biogene (Illkirch, France), and Roche Molecular Biochemicals 
(Mannheim, Germany).
Preparations were counterstained with 4' 6-diamidino-2-phenylindole (DAPI) (Camon, 
Wiesbaden, Germany). Probe signals were detected directly (Octachrome) or indirectly 
using anti-digoxigenin-FITC (Q-Biogene) or avidin-Texas-Red (AGS). Octachrome 
FISH enables panoptic analysis of all 24 chromosomes on a single slide using 8 triplet 
probe combinations. For more detailed analysis based on G-banding and Octachrome 
analysis, FISH was performed using optimised single locus and painting probe 
combinations.
2.12 FLOW CYTOMETRY AND FLUORESCENT ACTIVATED CELL 
SORTING (FACS) ANALYSIS
Flow cytometery is a generic term, while FACS (Fluorescence Activated Cell Sorter) is 
a trademark of the Becton-Dickinson Corporation. Flow cytometiy uses fluorescent 
probes which bind to specific cell associated molecules, allowing measurements of 
various phenotypic, biochemical and molecular characteristics of individual cells (or 
particles) suspended in a fluid stream. As the cells flow past a focused laser beam of 
appropriate wavelength, the probes fluoresce and the emitted light is collected and 
directed to appropriate detectors. These detectors, in turn, translate these light signals 
into electronic signals, proportional to the amount of light collected. Information 
regarding the relative size and granularity of a cell, for example, is also obtained as 
these characteristics influence the deflection (or scattering) of laser light as the cell 
passes through the laser beam. Flow cytometers have the ability to evaluate cells at an 
extremely rapid rate (e.g. up to 20,000 events per second).
Flow cytometric data can be displayed using either a linear or a logarithmic scale. The 
simplest type of experiment involves an immunofluorescent marker to look for a 
positive sub-population of cells. For example, when lymphocytes are stained with an 
inappropriate antibody (figure 2.2A), there is no cell expression and when lymphocytes 
are stained with an appropriate marker, for example CD3-FITC (figure 2.2B) the 
percentage of cells expressing the specific marker can easily be determined by 
subjectively applying a marker (Ml).
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Figure 2.3: Example O f Flow Cytometric Data
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Distinguishing between non-expression and expression of antibodies for the same cell. Graph A 
shows distribution when a particular cell does not express an antibody. Graph B shows 
distribution when it expresses a particular antibody. Figures were taken from FACS Laboratory 
(Cancer Research) website.
Cytometry becomes more complicated when the level o f fluorescence is required (figure 
2.3). It may be necessary to determine the level o f expression o f two different 
populations o f cells in a particular group o f cells.
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Figure 2.4: Example O f Flow Cytometric Data
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Graph showing distribution of two different levels of fluorescence. Figures were taken from 
FACS Laboratory (Cancer Research) website.
One o f the problems associated with FACS is achieving a single cell suspension, which 
could potentially cause inaccurate readings (figure 2.4B top & bottom). Good cell 
preparations are necessary for accurate results. When large clumps are present the flow 
cytometer will stop counting until the block is cleared, which is achieved by flushing 
the system. Smaller clumps, such as two cells stuck together will pass through the 
capillary but the flow cytometer has the ability to exclude these cell doublets (figure 
2.4A). A single cell will have a smaller width than a cell doublet passing through the 
beam consecutively (figure 2.4B).
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Figure 2.5: Flow Cytometric Data Distribution
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Effect o f graph distribution when cell doublets are present when put through the flow cytometer. 
A, shows gating of cell doublets from single cells in order to achieve accurate readings. B top, 
shows cell distribution when cell doublets are not gated out, compared to B bottom, showing the 
distribution when only single cells are counted. Figures were taken from FACS Laboratory 
(Cancer Research) website.
FACS and Cell Cycle Distribution
The measurement o f the DNA content of cells was one o f the first major applications of 
flow cytometry. The DNA content o f the cell provides information about the cell cycle 
and ploidy (the basic number o f chromosomes can vary within an organism) o f the cell. 
Ideally all cells in the G1 phase should take up the same amount o f dye and all fluoresce 
in a single channel, but there can be minor conformational variations in the DNA 
leading to slightly different amounts of dye being taken up. This is quantified by using 
the coefficient o f variation (CV) of the G1 peak. It is assumed that by measuring 
fluorescence from a DNA-binding fluorochrome, it is the same as DNA content. 
Although propidiurn iodide is probably the most commonly used dye to quantitatively 
assess DNA content, there are several different dyes that are available which bind 
stoichiometrically to DNA. Using a DNA binding dye such as propidiurn iodide a 
successful DNA profile, or cell cycle distribution can be achieved (figure 2.5).
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Figure 2.6: Example O f A Successful DNA Profile Using Propidiurn Iodide
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Figures were taken from FACS Laboratory (Cancer Research) website.
Once a single cell population has been obtained an estimate o f the percentage of cells in 
G l, S phase and G2/M can be determined. This can be determined by subjectively 
applied markings (figure 2.6A) or by using a program that will mathematically construct 
a DNA histogram and thus give a more accurate measurement o f the percentage of cells 
in each phase. The method used in this study was by subjectively applying markings 
(Ml, M2, and M3) equivalent to cell cycle stages (Gl, S, and G2/M).
Figure 2.7: Cell Cycle Distribution Using Propidiurn Iodide With And Without 
Markings
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A, shows the gating of peaks in order to distinguish between Gl, S and G2/M. B, shows 
example of cell cycle distribution pattern and percentages, without markings. Figures were 
taken from FACS Laboratory (Cancer Research) website.
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2.13 CELL CYCLE DISTRIBUTION
For studies of the cell cycle distribution, T80 flasks of Pre2.8 cells were cultured at 
33°C, 37°C and 39°C for 7 and 10 days. The cells were harvested and a single cell 
suspension was obtained, counted and washed in cold PBS. After centrifuging at 1500 x 
g for 5 minutes, the cells were resuspended in 800jil of PBS at -20°C and, while 
vortexing, 80Opl of 70% ethanol (-20°C) was added. The cells were then stored at 4°C.
Prior to analysis, the cells were centrifuged at 2500 x g for 5 minutes and resuspended 
in 800jll1 of PBS. 100p i of lmg/ml of RNase and lOOpl of 400pg/ml propidiurn iodide 
were added and the cells were incubated at room temperature for 30 minutes.
For studies of keratin distribution, Pre2.8 cells were incubated at 33°C, 37°C and 39°C 
for 4 days. The cells were harvested, single cell suspensions obtained and cell counts 
carried out. The cells were then centrifuged and resuspended in lOOpl of PBS 
containing 10% serum, before fixation in 4% paraformaldehyde on ice for 10 minutes. 
The cells were centrifuged at 1200 x g for 5 minutes, resuspended in lOOpl saponin 
buffer (from Quillaja bark, it permeabilises cells) and incubated on ice for 10 minutes. 
Non-specific staining was blocked by incubating the cells in 50pl of LI 5 medium 
containing 10% serum for 30 minutes and then 50pl of primary antibody (see table 2.4) 
was added and incubated on ice for 45 minutes. The cells were washed in lOOpl of 
saponin buffer three times. 50pl of secondary antibody (see table 2.4) in saponin buffer 
was added and the cells were incubated on ice, in the dark for 30 minutes. 50pl of 
saponin buffer was added to cells to produce a final volume of lOOpl. The cells were 
washed twice in saponin buffer and twice in PBS and resuspended in lOOpl of saponin 
buffer and stored at 4°C for a maximum of 48 hours.
2.14 3-DIMENSIONAL CULTURES
For Matrigel cultures, pipette tips and 24-well plates were cooled to -20°C for lhr 
before use. 200pl of Matrigel, diluted 1:1 with culture medium was added per well and 
allowed to set at 39°C for 30mins. Epithelial and stromal cell suspensions were placed 
on top of the Matrigel. Cultures were incubated at 33°C, 39°C and 37°C for different 
periods. The medium was changed three times a week and the cultures were monitored 
routinely using an inverted phase microscope.
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For fixation, the cultures were washed twice with PBS and fixed with 4% formaldehyde 
for 30 minutes at room temperature, followed by 2 washes with PBS. For processing, 
the gels were wrapped in single ply tissue paper and placed in an embedding cassette 
and stored in 70% ethanol overnight. The following day, the gels were dehydrated and 
then embedded in increasing percentages of molten paraffin. Paraffin blocks were 
allowed to solidify and 7-10pm sections were cut on a microtome. Haematoxylin and 
eosin (H&E) staining (Hine, 1981) was carried out on a sample section from each 
paraffin block. Immunohistochemistry was used to study prostate specific markers, 
cytokeratins and proliferation markers (table 2.4). Normal prostate tissue sections were 
used as positive controls. Sections from fixed 3-D paraffin blocks were used as negative 
controls (primary antibody was omitted from these sections, leaving staining with only 
secondary antibody).
Ethical approval was obtained for all tissue used in these experiments and the correct 
process for obtaining tissue samples were adhered to. These experiments were covered 
under study number 98/0082: “development of conditionally immortalized cell lines 
from human prostate tissue”, which was approved by Joint UCL/UCLH committees on 
the ethics of human research.
In pilot studies, Matrigel and monolayer cultures were set up using mixtures of 100,000 
Pre2.8 cells and 25,000 S2.13 cells in equal volumes of PrEGM and DMEM (8% FCS + 
1% Glutamine) and incubated at 33°C, 39°C and 37°C for 18 -  20 days. Mibolerone, a 
synthethetic androgen was added to half the cultures at a final concentration of 10'8 or 
10‘9M in 0.0001% ethanol. Frozen stocks of Mibolerone were prepared in 100% ETOH 
to a final concentration of 10'8M. Unlike dihydrotestosterone (DETT), mibolerone in not 
metabolised, i.e. there are no enzymes in the cells to break it down. It works like DHT, 
binding AR and secreting PSA and PAP in the same way. Mibolerone simply mimics 
the effect of natural androgens.
A comparison was made of different media (PrEGM, PrEGM/DMEM and S2.13 
supernatant) using reduced growth factor Matrigel. Incubation was carried out at the 
permissive (33°C) and semi-permissive (37°C) temperatures for 23 days. Matrigel 
cultures were paraffin embedded and 7pm sections were cut. Immunohistochemistry 
was carried out (table 2.4).
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To prepare the supernatant from S2.13 cells, PrEGM medium was added to an 80cm2 
flask, containing S2.13 cells and incubated for 3 days at 33°C. The medium was 
collected, designated as S2.13 supernatant and stored at 4°C for no longer than 1 week.
Few S2.13 cells survived in the 3-dimensional culture pilot studies. Therefore different 
proportions of S2.13 cells were tested. In addition, mouse 3T3 cells were co-cultured 
with Pre2.8 cells. For comparison each cell line was cultured in Matrigel alone. Cultures 
were set-up following the procedures described above and incubated at 37°C for 3 
weeks (table 2.5).
Table 2.5:3-D Experimental Variations
Cell Line Ratio Cell concentration Medium
Pre2.8/S2.13 4 1 1x 105/2.5x 104 Equal volumes of
1 1 1x 105/ 1x 105 PrEGM/DMEM
1 4 1x 105/4x 105
1 8 1x 105/8x 105
1 10 1x 105/10x 105
Pre2.8/3T3 1 1 lxloVlxlO5 Equal volumes of
1 4 1x 105/4x 105 PrEGM/DMEM
Pre2.8 only lxlO5 PrEGM only
S2.13 only 1x10s
4xl05
10x10s
DMEM only
3T3 only 1x10s
4x10s
DMEM only
2.15 RT-PCR
RT-PCR can provide a semi-quantitative measure of gene expression at the mRNA 
level. This technique involves an enzyme, reverse transcriptase that has the ability to 
synthesise complementary DNA (cDNA) from mRNA. The cDNA is then used as a 
template for PCR analysis. PCR selectively amplifies a region of DNA, using 
oligonucleotide primers synthesised from a selected sense and an antisense DNA 
sequence. Codes of practice (for example, wearing gloves) should be carried out to 
ensure that RNases are not introduced during RNA extraction procedures.
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2.15.1 RNA Extraction
Ribonucleases (RNases) are very stable and active enzymes that do not require cofactors 
to function. Since RNases are difficult to inactivate and even minute amounts are 
sufficient to destroy RNA, it is important that all materials are RNase free.
RNA was extracted from the Matrigel cultures using the silica-gel-based RNeasy Mini 
kit (Qiagen Ltd., UK). MatriSperse Cell Recovery solution was used to remove cells 
from Matrigel matrix for mRNA isolation. The MatriSperse solution depolymerises 
Matrigel at 2-8°C without enzymatic digestion. Manufacturer instructions were 
followed except for two minor modifications. 0.5ml of MatriSperse was added per well 
instead of the 2ml suggested, and 1ml of MatriSperse solution was added per dish for 
rinsing.
The RNeasy mini kit was used to isolate up to lOOpg of total RNA. A high-salt buffer 
system enables RNA at least 200 bases long to bind to a silica-gel membrane. The 
protocols provided by the manufacturer, Qiagen were followed.
RNeasy Mini kit
Cells were harvested by trypsinisation and then lysed in the presence of a denaturing 
guanidine isothiocyanate (GITC) and p-mercaptoethanol containing buffer (RLT buffer) 
(350pl added to maximum 5xl06 cells) that inactivates RNases to ensure isolation of 
intact RNA. The RLT buffer is highly denaturing and immediately inactivates RNases 
to ensure isolation of intact RNA. Complete lysis or disruption of plasma membranes of 
cells and organelles is required to release all the RNA contained in the sample 
(incomplete disruption results in significantly reduced yields).
The cell lysate was homogenized using a “QIA shredder” spin column (manufactured 
by Qiagen). Homogenization is necessary to reduce the viscosity of the cell lysates 
produced by disruption. Homogenisation shears the high molecular weight genomic 
DNA and other high-molecular-weight cellular components to create a homogeneous 
lysate, so that a pure solution of RNA can be extracted. Incomplete homogenization 
results in inefficient binding of RNA to the RNeasy membrane and therefore 
significantly reduces yield. The lysate (maximum volume of 700jul) was loaded onto a 
“QIAshredder” spin column in a 2ml collection tube. The column was centrifuged for 2
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minutes at 13,000rpm in a microcentrifuge and the homogenized lysate was collected. 
One volume of 70% Ethanol was added to the homogenate, mixed and added to the 
RNeasy mini spin column (on a 2ml collection tube) and spun at 10,000 rpm for 15 
seconds.
The RNeasy mini column was transferred to a new tube and washed twice with 500 jlx1 of 
RPE buffer (solution containing ethanol) to remove sheared genomic DNA and protein 
contaminants by centrifuging at 10,000 rpm for 15 seconds. The column was then 
transferred to a dry 1.5ml tube and 30pl of RNase-free water was added and the column 
was centrifuged at 10,000 rpm for 1 minute. RNA samples were stored at -20°C until 
ready to use.
2.15.2 Measurement of RNA concentration
RNA concentrations were measured by UV spectrophometry using a DU650 series 
spectrophotometer (Beckman Coulter Ltd., UK). 4pl of eluted RNA was diluted with 
sterile water to 400pl (1/100) and added to a clean cuvette. The spectrophotometer was 
blanked with water using a clean cuvette. The yield of RNA was calculated by 
measuring the optical density (OD) at 260nm and at 280nm and the RNA concentration 
was calculated as follows:
OD260 x 40pg/ml x dilution factor = RNA concentration pg/ml 
An absorbance of 1 unit at 260nm corresponds to 40pg/ml of RNA. This relation is 
valid only for measurements in water. The ratio of the readings at 260nm and 280nm 
provides an estimate of the purity of RNA with respect to contaminants that absorb in 
the UV spectrum, such as protein. The 260nm/280nm ratio of pure RNA in water is 
approximately 2.0.
2.15.3 Reverse Transcription
lpg of RNA was reverse transcribed into cDNA in a 20pl reaction volume, lp l Oligo 
(dT)12-18 (500|iig/ml) and lpg RNA were made up to 12pi with distilled water. This 
mixture was heat-inactivated at 70°C for 10 minutes, rapidly chilled on ice and spun 
down. 4pl of 5x first strand buffer, 2pl of 0.1M DTT and ljul of lOmM dNTP mix were 
added and gently mixed and incubated at 42°C for 2 minutes, lpl of 200units of 
Superscript II was added and mixed gently and incubated for 50 minutes at 42°C. The
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reaction was terminated by heat-inactivation at 70° C for 15 minutes. The cDNA was 
stored at -20°C.
2.15.4 PCR
The polymerase chain reaction (PCR) is an in vitro technique, which allows the 
exponential amplification of a specific region of deoxyribose nucleic acid (DNA) by 
repeating a 3 step process of denaturation, annealing and synthesis.
2.15.4.1 Primer Design
A poorly designed primer can result in little or no product due to non-specific 
amplification and/or primer-dimer formation. Several variables must be taken into 
account when designing PCR Primers. Among the most critical are primer length, 
specificity, complementary primer sequences, G/C content and polypyrimidine (T, C) or 
polypurine (A, G) stretches and 3’-end sequence. It is important to take time at the 
beginning to optimise PCR conditions to ensure efficient amplification of PCR product. 
See table 9 for sequences of primers used in this study.
Specificity, temperature and time of annealing are partially dependent on primer length. 
In general, oligonucleotides between 18 and 24 bases are sequence specific if the 
annealing temperature is optimal. The optimal annealing temperature tends to be at least 
50°C. The annealing temperature tends to be 5°C below melting temperature, therefore 
an optimal primer melting temperature (Tm) tends to be 55°C. The easiest way to find 
the best annealing temperature is by using a gradient thermal cycler.
Primers should have a unique sequence within the template DNA that is to be amplified. 
A primer designed with a highly repetitive sequence may result in a smear when 
amplifying genomic DNA
Primers need to be designed with no intra-primer homology beyond 3 base pairs. If a 
primer has a region of self-homology partially double-stranded structures can occur 
which will interfere with annealing to the template. Inter-primer homology may cause 
partial homology in the middle regions of two primers that can interfere with 
hybridization. If the homology occurs at the 3' end of either primer, primer-dimer 
formation may occur which could prevent the formation of the desired product due to 
competition.
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Primers should have between 45% and 55% GC content. The primer sequence should 
be chosen so that there are no G or C stretches that can cause non-specific annealing. A 
and T stretches should also be avoided as they could open up stretches of the primer- 
template which can lower the efficiency of amplification. The addition of a G-C 
complex at the 3’end of a primer will ensure correct binding at the 3' end due to the 
stronger hydrogen bonding of G/C residues.
2,15,4,2 PCR analysis
For PCR analysis, primers that had previously been optimised in our laboratory were 
used. All primers were synthesised by Invitrogen (GibcoBRL, UK) and supplied as 
lyophilised samples. Each primer was reconstituted in sterile water to a stock 
concentration of lOOpM. 2pl of cDNA from a 20pl reverse transcriptase reaction was 
added per 10pi PCR reaction. PCR amplification was carried out on a Perkin Elmer- 
Gene Amp 2400 thermal cycler (Perkin Elmer Ltd., UK).
A typical PCR reaction mixture contained lx  PCR reaction buffer, 1.5mM magnesium 
chloride, 0.2mM dNTP, 5U Red Hot Taq polymerase, 50% Glycerol, antisense primer, 
sense primer, distilled water and cDNA. All “thermal cycling” conditions started with a 
denaturation step at 94°C for 10 minutes and a final annealing step at 72°C for 5 
minutes (table 9). P-Actin is present in all eukaryotic cells and was used as a PCR 
loading control, to confirm that RNA was present in equal concentrations in all samples.
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Table 2.6: Primer Sequences And Their PCR Conditions
Name Sequence 5’—>3’ Cycling
conditions
Cycle
No
PCR
product
ARS
ARA
CGAAATGGGCCCCTGGATGGATAG
AGTCGGGCTGGTTGTTGTCGTGTC
94°C for 30 sec 
65°C for 30sec 
72°C for 40sec
40 524bp
PSAS 
PSA A
ACTGCATCAGGAACAAAAGCGTGA
CGCACACACGTCATTGGAAATAAC
94°C for 30 sec 
65°C for 30sec 
72°C for 40sec
40 362bp
Keratin 5 S 
Keratin 5 A
GGGGTGTCGGCCTAGGTGG
ACTGCGGCACGGGAGACC
94°C for 30 sec 
60°C for 60sec 
72°C for 90sec
35 350bp
Keratin 14 S 
Keratin 14 A
GAGCCGCATTCTGAACGAG
GTGCACATCCATGACCTTGG
94°C for 30 sec 
60°C for 60sec 
72°C for 90sec
35 525bp
Keratin 8 S 
Keratin 8 A
CAGCAGAAGACGGCTCGAAGC
TCTCAGTCTTTGTGCGCCGC
94°C for 30 sec 
60°C for 60sec 
72°C for 90sec
35 538bp
Keratin 18 S 
Keratin 18 A
GACCGTGGAGGTAGATGCCCC
CACTATCCGGCGGGTGGTG
94°C for 30 sec 
60°C for 60sec 
72°C for 90sec
35 544bp
5a-R2 A 
5a-R2 S
CCACCCATCAGGGTATTCAG
CCTTGTACGTCGCGAAGC
96°C for 90 sec 
52°C for 60sec 
72°C for 90sec
35 350bp
5a-Rl A 
5a-Rl S
GTTGGCTGCAGTTACGTATTC
TGCTGATGACTGGGTAACAG
96°C for 90 sec 
52°C for 60sec 
72°C for 90sec
35 170bp
P-Actin s 
p-Actin a
GCCGAGCGGGAAATCGTGCGTG
CGGTGGACGATGGAGGGGCCG
94°C for 30 sec 
60°C for 60sec 
72°C for 90sec
35 266bp
GAPDHA
GAPDHS
CCACCCATGGCAAATTCCATGGCA
TCTAGACGGCAGGTCAGGTCCAC
94°C for 45sec 
65°C for 45sec 
72°C for 60sec
25 597bp
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2.15.5 Gel Electrophoresis
Agarose gel electrophoresis was used to visualise PCR products. For PCR products, the 
amplified DNA was run on a 2% agarose gel in a horizontal gel tank (Hybaid, UK), 
using lx TAE buffer. The required amount of agarose was dissolved in lx TAE buffer 
in a microwave oven, cooled to 60°C, supplemented with lpg/ml ethidium bromide, 
poured onto a gel plate and allowed to set at room temperature. DNA loading buffer (5x 
dilution in lx TAE buffer) was added to the DNA samples prior to loading. The gels 
were loaded and run at 150volts for 1 hour and then viewed on a UV transilluminator. 
Images were captured using a Gel Documentation System (Quantity One software, 
Biorad Ltd., UK) and printed on thermal paper (Mitsubishi P91 thermal printer). Each 
gel was loaded with appropriate controls and with electrophoresis size markers, either 
<pX174 DNA digested with Hae El marker or a 1 kb DNA marker. The fragment size of 
these markers (in base pairs) were as follows:
cpX174 DNA marker: 
lkb DNA marker:
1353,1078, 872,603,310,281,271,234,194, 118, 72 
12216, 11198, 10180, 9162, 8144, 7126, 6108, 5090, 
4072, 3054, 2036, 1636, 1018, 517, 506, 396, 344, 298, 
220,201,154,134, 75
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2.16 APPENDIX: MATERIALS AND SOURCES
Company
Griffith & Nielsen
Radleys
VWRI (Merck)
VWRI (Merck)
Materials
10ml, 25ml, 50ml pipettes 
2.5ml Pasteur pipette 
30ml Universal tubes 
5ml bijous tubes
CLP lOjil, 200pl, lOOOpl tips
CLP aerosol barrier IOjliI, 200jul, lOOOpl tips
200pl, 500pl, 1.5ml tubes 
50ml polypropelene tubes 
15ml polypropelene tubes 
0.22pm sterile filters 
Nunc 60mm dishes 
Nunc 25cm2 flasks 
Nunc 80cm2 flasks 
Nunc 6-well plates 
Nunc 24-well plates 
Nunc 96-well plates 
Agarose 
Formaldehyde 
Absolute Ethanol 
Methanol (Analytical grade)
Acetone
Giemsa’s stain
DPX mounting medium
Formamide
Glacial acetic acid
Harris’ haemotoxylin
0.4% Trypan Blue
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Xylene
Sodium hydroxide
Chloros, a solution of sdium hypochloride
Invitrogen DMEM medium
(Gibco BRL, Life T echnologies) RPMI-1640 medium
10X Phosphate buffered saline (PBS) 
Opti-MEM 1 medium 
Keratinocyte-SFM medium + supplements 
L-Glutamine (0.2M sterile solution)
10X Trypsin (2.5%)
Versene 
100mm dNTPs
Superscript II (RT-PCR system)
Oligo dT (12-18 primer) (kit) 
lkb DNA marker
(pX174 DNA digested with Hae HI marker
BioWhittaker Clonetics prostate epithelial cell growth medium 
(PrEGM medium + supplements)
Imperial Laboratories 
Andover, Hants, UK
Foetal calf serum (Heat Inactivated)
AB Gene
(Advanced Biotechnologies)
Red Hot Taq DNA polymerase 
lOx PCR reagent buffer 
Magnesium chloride
Unichem Hibiset
Sigma MTT (3-4,5-dimethylthiazol-2-yl-2-
diphenyltetrazolium bromide) 
5a-Dihydrotestosterone
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Collagenase Type 1A (C9891)
EDTA
Ethidium Bromide 
Mineral oil for PCR 
Formaldehyde 
Propidiurn iodide 
Sodium Azide 
Sodium chloride 
Saponin buffer 
DMSO 
Glycerol
Hydrogen Peroxide 
Hoechst Stain
Vector Laboratories Vectastain Elite ABC kit / DAB substances
Antigen Unmasking Solution
Haematoxylin Counterstain
Vectashield Mounting Medium for Fluorescence
(DAPI)
Vectabond Reagent
Marathon Laboratory Supplies 
Dako
Becton Dickinson 
Qiagen
National Diagnostics
Basement membrane matrigel 
Dako Resin Pen
MatriSpere Cell Release Solution
RNeasy Mini Kit 
QIAshredder
Histoclear
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Stratech Scientific Matrigel
Matri Sphere Cell Recovery Solution
Gelvatol
DPX
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CHAPTER 3
RESULTS
DERIVATION AND AUTHENTICATION
AND PURITY
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3.1 INTRODUCTION
Two new BPH cell lines, Pre2.8 epithelial and S2.13 stromal cells have been established 
using a construct containing a temperature sensitive SV40 large T antigen gene. This 
mutant viral gene produces a protein that is conformationally normal at permissive 
temperatures (33°C) and is conformationally inactivated at non-permissive temperatures 
(39°C) (Stamps et a l, 1994), Consequently the cells should replicate under the influence 
of the LTAg at the permissive temperature, but at the non-permissive temperature, stop 
dividing and differentiate. This chapter describes the derivation of the cell lines. The 
presence of the viral gene was confirmed using immunocytochemistry.
Authentication is essential when a new cell line is established. It must be demonstrated 
that the cell line has been derived from the individual claimed. The cell line may be 
authenticated using DNA profiling (Masters et a l, 2001), a method that measures the 
sizes of a number of alleles containing short tandem repeat (STR) sequences. The 
number of times the sequence is repeated varies from person to person. The STR profile 
of the two cell lines was compared with that of the patient from whom the cells were 
derived and shown to be identical.
Contamination of cell lines with microorganisms is a potential problem with tissue 
culture. Unlike bacteria, yeasts, fungi and moulds, mycoplasma can not be readily 
detected under the microscope. Mycoplasma exists parasitically with growing cells, 
mostly in parasite form, growing on the cell membrane and exerting a pathological 
effect on the host cell. These infections can alter DNA, RNA and protein synthesis, 
change enzyme patterns, interfere with the selection of mutant mammalian cells and 
modify the host cell’s plasma membrane. Hence it is important to ensure that cell lines 
are free of mycoplasma. PCR was used to confirm the absence of mycoplasma.
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3.2 DERIVATION OF PRE2.8 EPITHELIAL AND S2.13 STROMAL CELL 
LINES
3.2.1 Prostate Tissue
Human prostate tissue was obtained from a 71 year-old male with symptoms of BPH, 
undergoing transurethral resection of the prostate (TURP). A diagnosis of BPH was 
subsequently confirmed by histopathology. The biopsy was transferred to a 30ml 
Universal plastic container containing RPMI-1640 medium supplemented with 20mM 
HEPES, 5% fetal calf serum (FCS), 1% penicillin - streptomycin, 1% fungizone 
(Amphotericin B) and 1% L-glutamine. Some of the original biopsy was frozen for 
future analysis, such as DNA STR profiling. Remaining tissue was used to establish 
immortal cell cultures.
Ethical approval was obtained for all tissue used in these experiments and the correct 
process for obtaining tissue samples were adhered to. These experiments were covered 
under study number 98/0082: “development of conditionally immortalized cell lines 
from human prostate tissue”, which was approved by t Joint UCL/UCLH committees on 
the ethics of human research.
3.2.2 Primary Culture
The tissue was minced into small fragments less than 1mm3 using crossed scalpel 
blades, rinsed twice in PBS and incubated in serum-free L-15 medium with 0.3% 
collagenase type 1A for 3.5h on a rotating platform. The partly digested tissue was 
filtered through 70 and 40pm filters and the filtrate was centrifuged. The cells were 
plated in prostate epithelial growth medium (PrEGM) medium in 25cm2 flasks and 
grown at 37.5°C with 5% CO2. Primary cell cultures were transferred to safety level IE 
for retroviral transduction, which was carried out by Professor Michael O’Hare, 
Department of Surgery, Middlesex Hospital. GMO (genetic modified organisms) risk 
assessments for this work were completed by personnell within the Department of 
Surgery. Potentially immortalised cell cultures established and returned to our 
department, by Professer M O’Hare were no longer under safety level ID risk. They 
were rendered safe to work with and were transferred to the safety level II tissue culture 
laboratory.
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3.2.3 Transduction
Semi-confluent proliferating cultures (labelled LWEO) were exposed to filtered (0.4pm) 
supernatants from the retroviral packaging line, Clone8/8PB (a clone of the virus- 
producing cell line that was selected with 0.5mg/ml G418). The retroviral construct 
consisted of a defective SV40 oncogene, pZipSVtsa58 plasmid (figure 1.5). Infection 
was carried out for 18h with 8pg/ml polybrene and cells were grown to confluency. 
Infected cells were selected with 0.5mg/ml G418. Infection and selection was carried 
out at 33.5°C. Successful growth of epithelial-type cells was obtained.
3.2.4 Development Of Epithelial Cell Line (Pre2.8)
A semi-confluent monolayer of epithelial-like cells was obtained approximately 3 
weeks after G418 had been withdrawn. These cells (passage 1) were split into two tissue 
culture flasks (25cm2) and grown at 33°C. When these cells were semi-confluent, one 
flask of cells was frozen (briefly, PBS wash, trypsin, aspirate off, 10% DMSO in 
medium, frozen on dry ice) and the remaining cells were passaged as passage 2 (p2) at 
1:2, 1:4 and 1:8 dilutions in PrEGM medium at 33°C. As these cells became confluent, 
growth slowed and many of the cells developed a squamous phenotype (large flat cells 
with a tendency to lift off the substrate).
In addition to the passaging on plastic, passage 1 cultures were also split at a 1:200 
dilution on irradiated mouse 3T3 cells, as clone 1 passage 0 (cllpO). The mouse 3T3 
cells are used as a feeder layer, providing growth factors and extracellular matrix 
support for clonal growth of epithelial cells. See figure 3.1 for summary of derivation of 
Pre2.8 cells.
3.2.5 Development Of Stromal Cell Line (S2.13)
The cells grown on 3T3 feeder layers had both epithelial and stromal phenotypes. 
Surplus cells from cllpO were replated as cllpl at dilutions of 1:2 and 1:4 without 
feeders in PrEGM medium. After approximately 2 months the Cllpl cells had grown 
enough to freeze the 1:2 dilution flask. Cells from the 1: 4 dilution flask were 
differentially trypsinised to rapidly detach the stromal cells, leaving the epithelial cells 
attached to the dish. The stromal cells were replated as p2 in DMEM/FCS, in 12.5cm2 
flasks. See figure 3.2 for summary of derivation of S2.13 cells.
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Figure 3.1: Derivation O f Pre2.8 Cells
1:200 diln on irradiated mouse 3T3 cells
passaged at low density
1 month
passaged with irradiated 3T3 cells in 75cm2 
dishes @ 1:100, 1:200
1:200 split on 3T3 cells
1:400 split
semi confluent after ~ 3 weeks; cells looked  
good; passaged a t  low density
passaged at low density
50 cells/plate was ring-cloned; 8 discrete  clones passaged  onto 
irradiated 3T3 cells in 75cm2 flasks.  Grew well; refed with PrEGM  
containing 0.25 ug/ml G418 (removal o f  residual feeders)
ring-clones were passaged a t  1:10, in 25cm2 flasks
passaged into 75cm2 f lasks after I month
passaged into 180cm2flasks after 1 month
all p4  flasks were frozen (10% DMSO on dry ice) after 1 month; Pre2.8  
chosen as best grow ing o f  the epithelial ring clones and  passaged on in 
75cm2 flask.
Pre2.8 cells wer transferred to our department. M y  work started from here.
P8
P2
P5
P3
P7
P6
P4
clone 1 passage 1 (P I )
passagel o f  ring clones
P2 renamed
Pre2.2, 2 .3 , 2 .4 , 2 .5 , 2 .7 , 2.
Pre2.2, 2 .3 , 2 .4 , 2 .5 , 2.7 , 2.
Pre2.2, 2 .3 , 2 .4 , 2 .5 , 2 .7 , 2.
LWEO (primary cells) - C lone8/8PB (a 
clone o f  the virus producing cells)
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Figure 3.2: Derivation O f S2.13 Cells
LWEO (primary cells) - C lone8/8PB (a clone o f  the virus producing cells)
1 :200  diln on i rra d ia ted  mouse 3T3 ce l ls
c lo n e l  passage 0 (cllpO)
^  su rp lus  ce l ls  rep la ted  a t  1:2 & 1:4 without f e e d e r s
c lo n e l  passage 1 ( c l l p l )
Cllp2
p3
—
A.
p5
p6
P7
IE
P8
IE
p9
plO
Pi
p2
labelled S2 .10 -16
p3
P*
_E_
p5
- Z J I  .
S2.13 - p6
1:2 f la sk  frozen; 1:4 f lask  d ifferen tia l ly  tryps in ised  a n d  
re p la te d  in DM E M  in 12 .5cm 2 f lasks ,  after 2 month
sp l i t  @  1:2, 1:4, 1 :8 dilution after 2-3 w e e k s
p a s s a g e d  into 25cm2 f la sk s  @  1:2 diln
confluent after 1 month; co m p le te ly  strom al;  fa i r ly  
heterogeneous m orphology;  no “h i l l - v a l le y s ”; p a t c h e s  o f  
chunky fib rob lasts;  sp l i t  into 75cm2 f la sk  a t  1:3 diln
p a s s a g e d  a t  onto 180cm 2 f la s k s  in D M E M  medium
“chunky “ f ib ro b la s t s  s t i l l  no t  confluent after 18  
days;  p a s s a g e d  @  1:2 diln
ce l l s  grow  ing faster, confluent after 15 days;  sp l i t  @  1:3
sp l i t  onto 180cm 2flask  a t  1:3 after 1 month  
p a s s a g e d  o n to  75cm2 f la sk  a t  1:5 diln, after 1 month
confluen t after 9 days;  c lo n ed  in 96-w e ll  p la te s  a t  
5/2/1  / 0 .5 cells/well  a t  10% and 5% 0 2, a t  33 .5°C .  
Stro m a l  ce l l s  grow be tte r  a t  low 0 2
5% 0 2 c lo n es  p ick ed  on to  24-welt  p l a t e s  in 5% 0 2 and  
D M E M /F C S  a t  3 3 .5 °C
7 c lo n e s  p ick e d  onto 25 cm 2 f la sk s  in normal 0 2
p a s s a g e d  on to  75cm2 f la sk s  after 11 d a y s
C lo n e  2.11 and 2.13 c lones  p a s s a g e d  onto 75cm 2 f la s k s  in 
DM E M , a f ter  12days;  rem ain ing  c lo n e s w e r e  frozen
C lo n e  2.13 p a ssa g ed  on a t  1:20 in 75cm 2 flasks;  
rem ain in g  c lones  were  frozen
S 2 .1 3 chosen as typical,  r e g u la r  f ib ro b la s t  cells;  
sp l i t  a t  1:20 after 10 d a y s
A l l  fu r th er  p a s s a g e s  were c a rr ie d  out a t  a 1:40  d iln
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3.3 MORPHOLOGY OF LIVING CELLS
3.3.1 Pre2.8 Cells
Pre2.8 prostate epithelial cells were grown as a monolayer on plastic at 33°C, 37°C and 
39°C. PrEGM medium (table 2.1 and 2.2) was used for growing prostate epithelial cells 
(Fry et al., 2000b). The epithelial cells, Pre2.8, attach slowly to the surface o f culture 
plates and are relatively slow growing cells. At 33°C and 37°C the cells are small, 
tightly compact and irregular in shape with a cobblestone appearance (figure 3.4). When 
cells are transferred to 39°C the morphology alters. The cells become irregular in shape, 
no longer grow as tightly compact cells, and increase in size.
Figure 3.4 Morphology Of Pre2.8 Cells
A B
33°C
37°C
39°C
Day 6 Pre2.8 epithelial cells growing on plastic tissue culture flasks, at seeding densities of 
200,000 cells/T25 flask, at 33°C, 37°C and 39°C.
Phase contrast microscopy; Original magnification: (A) x200 and (B) x400
■ m .
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3.3.2 S2.13 Cells
S2.13 prostate stromal cells were grown as a monolayer on glass coverslips at 33°C, 
37°C and 39°C. RPMI/FCS (table 2.1 and 2.2) was used for growing prostate stromal 
cells. The stromal cells, S2.13, rapidly attach to the surface o f culture plates and are fast 
growing cells relative to Pre2.8. They are slightly elongated in appearance, which is 
more pronounced at 37°C and 39°C than at 33°C and are loosely associated until they 
become confluent (figure 3.5).
Figure 3.5: Morphology Of S2.13 Cells
33°C
37°C
39°C
A B
Day 4 S2.13 stromal cells grown on coverslips, at seeding densities o f 40,000 
cells/coverslip, at 33°C, 37°C and 39°C. Original magnification (A) x200 and (B) x400
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3.4 PRESENCE OF SV40 LARGE T-ANTIGEN
Immunocytochemistry for Large T antigen (LTag) was carried out to confirm the 
presence o f SV40 large T-antigen. Using DAB, Large T-antigen shows brown nuclear 
staining. Pre2.8 and S2.13 cells expressed SV40 large T antigen at 33°C (figure 3.6).
Figure 3.6: Pre2.8 And S2.13 Large T Antigen Expression
A B
SV40 expression o f Pre2.8 at 33°C (A) and S2.13 cells at 33°C (B). Immunocytochemistry 
shows positive staining o f LTag (brown). Original magnification of A and B was x200
3 .5  D N A  P R O F I L I N G
DNA profiling was carried out on Pre2.8 and S2.13 cells and the tissue of origin by the 
LGC (Laboratory Government Chemist, Teddington, Middlesex) to confirm the origin 
of these cells from the individual who provided the BPH tissue.
DNA profiling was carried out by amplification o f STR (short tandem repeats) regions 
using the Second Generation Multiplex (SGMPlus) System (United Kingdom Forensic 
Science Service). The number of repeats at each locus was determined by 
electrophoresis o f the PCR products and analysed using Perkin Elmer Genescan 
andGenotyper computer software. STR profiling consisted of a number of primers for 
the loci, D18S51, D21S11, D8S1179, HUMFIBRA (FGA), HUMTHOl,
HUMVWFA31/A and the sex chromosome marker amelogenin, HUMAMGX/Y (see 
table for description o f markers).
The same STR profile was found for Pre2.8 and S2.13 cells, which was identical to 
DNA o f the patient they were derived from (table 3.1). The three samples were 
heterozygous for D18S51 and D21S11, and homozygous for HUMAMGX/Y, D8S1179, 
HUMFIBRA (FGA), HUMTHOl and HUMVWFA31/A loci.
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STR locus name and allele designation
Source
Sex marker ch Amelogenin, 
HUMAMGX/Y (Xp22.1-22.3 
& Ypll.2)
D18S51 (18q21.3)
D2JSI1 (21qll.2- 
lq21)
D8S1179
(Ch8)
a  Fibrinogen,
HUMFIBRA
(4q28)
HUMTHOl
(llpI5.5)
(Von WiUebrand factor, 
vWA) HUMVWFA31/A 
(12pl2pter)
A m g l Amg_2 D18_l D18_2 D21_l D21_2 D8_l FGA_1 TH_1 VW_1
DNA from 
Pre2.8 Cell 
Line
X Y 12 14 29 30 13 20 9 17
DNA from 
S2.13 CeU 
Line
X Y 12 14 29 30 13 20 9 17
DNA from 
original 
Patient 
Tissue
X Y 12 14 29 30 13 20 9 17
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3.6 MYCOPLASMA SCREENING
Pre2.8 and S2.13 cells were negative for mycoplasma using both the Coriell PCR and the 
Drexler nested PCR. See figures 3.7, 3.8, 3.9 and 3.10 for results. Reagent only controls 
were negative and the expected size bands were present for positive controls (in-house 
control, KK47) in all PCR analyses, 500bps for Coriell PCR, 500-520bp for round 1 
Drexler PCR. and 310-330bp for round 2 Drexler PCR. The Drexler nested PCR 
sometimes produces two bands in round n, a 500bp -  520bp band being the outer primer 
product of round I and a 3 lObp -  330bp band being the inner primer product of the second 
PCR round. PCR results are shown in figure. All samples were carried out in duplicate.
The mycoplasma contaminating the positive control, KK47 is one of the 5 most common 
mycoplasma associated with cell line infections, Acholeplasma laidlawii. This was 
determined using the Stratagene multiplex PCR kit, producing a 280bp and a lOObp PCR 
fragment. The Stratagene kit was used to determine mycoplasma species when positive 
samples were detected using the Coriell and Drexler PCR screening procedures.
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Figure 3.7: Coriell PCR Results For Pre2.8 Cells
PhiXl 74 
Hae III
Figure 3.8: Drexler PCR (Round I And II) Results For Pre2.8 Cells
Round I
PhiXI74 Hae III
Round II
Duplicate Pre2.8 and control DNA PCR products run on a 3% agarose gel, after amplification with 
Coriell PCR primers (fig. 3.7) and Drexler nested PCR primers (fig. 3.8). Product size determined against 
a known DNA marker (M), phiX174 Hae III. In-house positive (Pos), KK.47 and reagent only controls 
were used. The in-house positive control is a mycoplasma contaminated, human bladder-cancer cell line, 
KK47 which was previousely used in our laboratory. The letters representing each lane are M (marker), P 
(positive control), Pre (Pre2.8 cells) and RO (reagent only). Although the positive controls in figure 3.7 
are a bit faint the test is repeated with the Drexler nested PCR, producing strong positive bands and 
confirming a negative result for the test samples. NOTE: Pre2.8 test samples and controls shown in 
figure 3.7 and figure 3.8 are from the same gel. These large gels also contained other test samples from 
different cell lines. They were removed in order to avoid any confusion.
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Figure 3.9: Coriell Results For S2.13 Cells
PhiX174 Hae 
HI
SObpDNA
marker
Figure 3.10: Drexler PCR (Round I And II) Results For S2.13 Cells
R ound I
PhiXl 74 Hae III 
bp
1351
1078
872
603
Round II
PhiX174 Hae HI
Duplicate S2.13 and control DNA PCR products run on a 3% agarose gel, after amplification with Coriell 
PCR primers (fig. 3.9) and Drexler nested PCR primers (fig. 3.10). Product size was determined against a 
known DNA marker (M), phiX174 Hae III and a 50bp marker (fragments every 50bps). In-house positive 
(Pos), KK47 and reagent only controls were used. The in-house positive control is a mycoplasma 
contaminated, human bladder-cancer cell line, KK47 which was previousely used in our laboratory. The 
letters representing each lane are M (marker), P (positive control), S2 (S2.13 cells) and RO (reagent 
only). The band observed for reagent only in fig. 3.10 was seen in the first round o f the nested PCR 
(samples were negative) but not in the second round. NOTE: S2.13 test samples and controls shown in 
figure 3.9 and figure 3.10 are from the same gel. These large gels also contained other test samples from 
different cell lines. They were removed in order to avoid any confusion.
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CHAPTER 4
RESULTS
CHARACTERISATION
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4.1 CYTOGENETICS
Cytogenetic analysis was carried out by Dr Rod McLeod (DSMZ, Braunschweig, 
Germany) using slide preparation trypsin G-banding (GTG) and fluorescence in situ 
hybridisation (FISH). Dr Rod McLeod provided all of the Cytogenetic results and 
photography. Pre2.8 (passage 50) and S2.13 (passage 14) cells displayed significant 
cell-to-cell variation and some cells carried numerical and occasional structural 
rearrangements additional to those described in the consensus karyotypes, described 
'below.
4.1.1 Pre2.8 Cells
46<2n>X, -Y, +5, i(8)(ql0)xl-2, der(9) (9qter—>p 11: :4q25—»q33:: 8p 10-»pter), 
der(14)ins(14;20)(pl2;ql), der(15)t(10;15)(q25;pl 1), der(20)dup
ins(20;14)(ql Iql3;pl2), der(21)(qter->pl l::4ql l-»q25:)
4.1.2 S2.13 Cells
93-97<4n>XXYY/XXYYY, +Y, der(2)t(2;16)(p25;pl2), +3, der(3)(3qter-+pll::ish20 
(wcp20+) :: 19ql0—»qter:: 19ql 0-»qter::hsr:: 10q24->qter), der(3)t(3; 10)(p24.2;q24.2), 
der(3)t(3;17)(q27;q23.), +4, +5, -8, der(8)(8pter->q24::hsr::5q23-^qter), +9, +14, +14, 
+15, +17, +18, der(19)(19pter-»qll::hsr), +20, i(20)(pl0) + mar.
The chromosome structures of both cell lines carry relatively few changes, although 
both are dominated by rearrangements leading to amplification of chromosome 20.
GTG karyotypes representing typical metaphase chromosome spreads from Pre2.8 and
S2.13 are presented in figures 4.1 and 4.2 respectively.
Pre2.8 cells displayed a near diploid karyotype with mostly straightforward numerical 
and structural rearrangements, including loss of the chromosome Y and formation of an 
isochromosome for the long arm of chromosome 8, i(8q). In addition, however, 
genomic amplification of part of chromosome 20 had been generated via a pair of 
apparently related rearrangements. GTG staining properties (figure 4.1) show material 
derived from the long arm of chromosome 20 inserted into the short-arm (pl2) region of 
one chromosome 14, together with partial duplication of one chromosome 20 homolog 
(figure 4.3). Demarkating this duplication was a short piece of material from 
chromosome 14 (figure 23 inset) shown to be derived from pl2, by silver staining and 
specifically detects the rDNA repeat clusters present at the p i2 regions of the
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acrocentric chromosomes. These findings imply that both der(14) and der(20) changes 
had participated in a complex non-reciprocal exchange resulting in a net increase of 
material derived from chromosome 20q. A second complex change involved 
redistribution of material covering 4q among two markers, der(9) and der(21).
The karyotype of S2.13 was hypertetraploid and in addition to numerical and several 
minor structural changes included three highly complex marker chromosomes bearing 
sizeable homogeneous staining regions (HSR), add(3)(pll), add(8)(q24) and 
add(19)(qll) (figure 4.2 arrows). The HSR in these markers appeared dissimilar in G- 
banded preparations and FISH analysis and showed all three to derive from distinct 
intercalary (inserted between) gains of material, in each case from chromosome 4, 19 
and 20 (figure 4.4), terminating in two of these markers with segments deriving from 
chromosome 5q and lOq. FISH analysis showed that the most intense signals were those 
detected by the chromosome 20 probe. Comparison of FISH images (figures 4.3 and 
4.4) revealed decidedly greater amplification in S2.13 than in Pre2.8 cells.
Summary
Cytogenetics of Pre2.8 and S2.13 cell lines exhibited multiple rearrangements, although 
amplification of material from chromosome 20 was the most striking change in both cell 
lines. Genetic instability is common in cell lines due to immortalisation procedures, but 
genetic instability is also associated with tumorigenesis. The amplification of material 
within HSR in tumor cell lines can imply selective amplification targeting genes, 
particularly oncogenes. Mechanisms underlying HSR formation is poorly understood, 
but may implicate unstable repeat DNA sequences susceptible to slippage (Macleod et 
al., 2000). Other research groups have associated isochromosome formation in 
chromosome 8 (i(8)) and alterations in chromosome 20q, particularly gain of 
chromosome 20 have been associated with many cancer types including prostate, 
bladder, melanoma, colon, pancreas and breast (Brothman et al., 1990; Richter et al., 
1998; Bastian et al., 1998; Korn et al., 1999; Mahlamaki et al., 1997). It may be useful 
to repeat this analysis at a later passage level in order to show cell stability and to 
determine if passaging produces further chromosomal alterations.
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4.1.3 Figure Legend For Figure 4.1,4.2,4.3 and 4.4
Cytogenetic analysis showing amplification of chromosome 20. Dr Rod McLeod 
(DSMZ, Braunschweig, Germany) provided all of the Cytogenetic analysis and 
photography.
Karyograms illustrating dominant clones present in Pre2.8 (figure 4.1, 4.3) and S213 
(figures 4.2 and 4.4) cell lines where rearrangements leading to amplification of chr.20 
are indicated by large arrows.
The main colour figures show FISH analysis with probes for chr. 20 (red fluorescence) 
together with chr. 14 (green fluorescence) in figure 4.3 and chr. 19 (green fluorescence) 
in figure 4.4, however the inset in figure 4.3 shows chr. 20 hybridised with green 
fluorescence.
The markers are indicated as follows: in Pre2.8 cells (figure 4.3), ders(14) / (20) (red 
and yellow arrows, respectively); and in S2.13 cells (figure 4.4), ders(3) / (8) / (19) (red, 
yellow and green arrows, respectively).
Interestingly both Pre2.8 and S2.13 utilise intercalary chromosomal material (co­
amplification) to facilitate amplification of chr. 20 rDNA (shown black, inset figure 4.3) 
and material derived from chr. 19 (green fluorescence in figure 4.4) together with 
material from chr. 4 (data not presented).
FISH analysis and immunodetections were performed according to manufacturers’ 
protocols and slides counterstained using DAPI. Monochrome FISH images were 
captured, merged and enhanced using Vysis Quips imaging system (Applied Imaging, 
Sunderland UK) configured to a Zeiss Axioplan microscope equipped with a Ludl 
filterwheel using narrow bandpass filters.
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4.2 CELL PROLIFERATION
Analysis of cell cycle distribution was carried out for Pre2.8 cells initially using 
propidium iodide staining and Flow Cytometry analysis to determine the percentage of 
cells at Gl, S (proliferating cells) and G2/M phases. In order to clarify flow cytometry 
results, immunocytochemistry for Ki-67, proliferation-associated antigen was carried 
out and quantified to determine percentage of cells proliferating at 33°C, 37°C and 
39°C.
4.2.1 Flow Cytometry
Consistent results were not obtained for repeated FACS analysis of PI stained cells at 
33°C, 37°C and 39°C. Experiments were repeated 3 times and once by a second party.
10,000 events (cells) were analysed for the initial experiment, while 20,000 events were 
analysed for remaining experiments (including the example shown in table 4.1 and 
figure 4.5). This inconsistency may be due to loss of larger, differentiated cells not 
getting through the capillary tube or to inaccurate gating caused by greater amounts of 
granularity at 39°C. It was difficult to accurately gate between Gl, S and G2/M phases. 
An example given (table 4.1 and figure 4.5) shows that there was no clear variation in 
percentage of Pre2.8 proliferating cells at the three temperatures. In this example cell 
population was gated for Gl-phase and G2 and S phases together.
4.2.2 Ki-67 Expression
Pre2.8 cells were grown on coverslips at a seeding density of 1x10s cells per well at 33°C, 
37°C and 39°C and stained with Ki-67 antibody after 4 days in culture. Total number 
and Ki-67 positive cells were counted from 3-4 coverslips at 33°C and 37°C, while 5-7 
coverslips were counted at 39°C due to fewer cells per coverslip at this temperature. 
The average of these cells were calculated. This assay was repeated 3 times, the average 
and standard error calculated (table 4.2) and a histogram (figure 4.6) of percentage Ki- 
67 positive Pre2.8 cells obtained (photograph in figure 4.7).
There is a 60% decrease in growth when Pre2.8 cells are transferred from 33°C (93% 
proliferating cells) to 37°C (26% proliferating cells) and a further 10% decrease at 39°C 
(15% proliferating cells).
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4.2.3 Summary
Results from PI stained cells using flow cytometry were unreliable with this cell line in 
comparison to counting of Ki-67 stained Pre2.8 cells. Proliferation is being switched off 
at 37°C and to a greater extent at 39°C.
It would be of interest to compare the substantial Pre2.8 proliferating population with 
the original tissue and with S2.13 cells, at a later stage (were mainly concentrating on 
characterisation of Pre2.8 cells in the time allowed for this thesis).
Table 4.1: Percentage Of Cells In G l And G2/S Phases Of Proliferation In Pre2.8 
Cells
Cell Proliferation 33°C 37°C 39°C
Gl Phase 59% 77% 55%
G2/S Phase 25% 18% 35%
One example of Pre2.8 cells from 33°C, 37°C and 39°C which were fixed and stained with 
propidium iodide (PI) and analysed on a Fluorescent Activated Cell Sorter (FACS) for 
percentage of cell proliferation, S-phase of the cell cycle.
Table 4.2: Percentage Of Ki-67 Positive Pre2.8 Cells
Cell Population 33°C 37°C 39°C
Ki-67 positive 420 174 58
Ki-67 negative 38 468 296
Total number 458 641 354
% Ki-67 positive (±SE) 93±2 26±2 15±2
Ki-67 immunocytochemistry of Pre2.8 cells, grown on coverslips at 33°C, 37°C and 39°C. 
Three separate assays were carried out and each assay consisted counts on 3-4 coverslips at 
33°C and 37°C, and 5-7 coverslips at 39°C. Mean and standard error (SE) for each cell 
population, and percentage Ki-67 positive cells with standard error (SE) are displayed in table.
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Figure 4.5: Percentage O f Cells In G2/S Phases Of Proliferation In Pre2.8 Cells
40% -I 
35%
Pre2.8
One example of Pre2.8 cells from 33°C, 37°C and 39°C which were fixed and stained with 
propidium iodide (PI) and analysed on a Fluorescence Activated Cell Sorter (FACS) for 
percentage of cell proliferation, S-phase of the cell cycle. No error bars are present, as this is 
just one example and not an average of a number of experiments.
Figure 4.6: Percentage Of Ki-67 Positive Pre2.8 Cells
120 I------------------------------------------------------------------------
</>
Pre2.8 cells
Histogram showing percentage of Ki-67 positive Pre2.8 cells with standard error (SE). 
Immunocytochemistry of Ki-67 antibody was carried out on Pre2.8 cells, grown on coverslips at 
33°C, 37°C and 39°C. Three separate assays were carried out and each assay consisted counts 
on 3-4 coverslips at 33°C and 37°C, and 5-7 coverslips at 39°C. Mean and standard error (SE) 
for each cell population, and percentage Ki-67 positive cells with standard error (SE) are 
displayed in table.
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Figure 4.7: Ki-67 Expression In Pre2.8 Epithelial Cells At 33°C, 37°C And 39°C
* * i?
&
r
A
Immunoperoxidase stain of Pre2.8 cells at 33°C (A), 37°C (B) and 39°C (C) showing positive 
staining of the proliferative marker Ki67. Experiments were setup on coverslips with a seeding 
density of lxl(E cells per well for each temperature and harvested for Ki67 staining at day 4. 
Negative (secondary antibody only) control (D) was setup using a coverslip from 33°C.
Ki67 stain -  DAB/peroxidase (brown); Nuclear stain -Hoechst (blue)
Magnification: original magnification x20
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4.3 GROWTH RATES
Growth curves were constructed by plating 100,000 cells per 25cm2 flask in triplicate. 
Cell numbers were estimated at 2-3 day intervals up to 17 days using a haemocytometer 
(table 4.3 and figure 4.8).
4.3.1 Pre2.8 Growth Assays Using Cell Counts
Pre2.8 cells grow at a similar rate at 33°C and 37°C for the first 11 days. At 37°C cell 
numbers plateau after 11 days, while at 33°C cell number continues to increase 
exponentially. At 39°C, proliferation continued over the 17-day culture period at a slow 
rate.
Table 4.3: Proliferation Of Pre2.8 Cells, Showing The Mean And Standard Error 
Of Cell Numbers Derived From Three Independent Experiments
Days in Culture Cell Number x 10s (±SE)
33°C 37°C 39°C
3 1.04 ±0.09 1.77 ±0.38 0.54 ±0.06
5 2.56 ± 0.48 8.13 ±0.33 0.78 ± 0.25
7 7.85 ± 3.02 18.03 ±1.33 1.50 ±0.60
10 21.72 ±4.86 24.34 ±2.47 1.87 ±0.25
12 32.08 ±4.01 30.01 ±4.35 2.85 ±0.60
14 38.98 ±7.12 29.17 ±6.43 3.39 ±0.64
17 52.37 ± 3.27 26.67 ±2.91 3.67 ± 0.63
4.3,1.1 Mean Population-Doubling Time for Pre2.8
The mean population doubling for Pre2.8 cells, derived from growth curves using a 
logarithmic scale was 36 and 24 hours, at 33°C and 37°C respectively. Cells do not 
grow exponentially at 39°C. Figure 4.9, below shows extrapolation of data from the 
exponential phase of a log curve of Pre2.8 cells.
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Figure 4.8: Growth Curve O f Pre2.8 Prostate Epithelial Cells
6 0 0 0 0 0 0
5 5 0 0 0 0 0 33°C
39°C
37°C
5 0 0 0 0 0 0
4 5 0 0 0 0 0
4 0 0 0 0 0 0
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O  2 5 0 0 0 0 0
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Days in Culture
Pre2.8 cell counts for 3 separate growth assays, at 33°C, 37°C and 39°C. Cells were set up in triplicate at a density o f  100,000 cells per 25cm 2. The mean and standard error were 
calculated and a growth curve was obtained.
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Log plot of the increase in cell concentration (y-axis) versus days in culture (x-axis), following subculture from cultures counted on regular intervals. The 
population-doubling time (PDT) was extrapolated from the straightest area of the exponential phase. A straight line was drawn from a particular cell count, on the y- 
axis in the log phase, to the plotted line. Then another straight line was drawn from a point that was double the first cell count on the y-axis to the plotted line. These 
two lines were then continued from the plot towards the x-axis in a straight line. The distance between these two points on the x-axis represents the length of time for 
one cell population to double. This was carried out at 33°C, 37°C and 39°C.
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4.3.2 S2.13 Growth Assays Using Cell Counts
Growth curves were constructed by plating 200,000 cells per 25cm2 dish in triplicate 
and cells were counted at 2-day intervals up to 10 days. Assays grown at 33°C and 37°C 
were repeated 3 times and replicated twice at 39°C, and the mean and standard errors 
obtained (table 4.4). A graph of cell count versus days in culture was obtained (figure 
4.10). At 33°C cells grow slowly until approximately day 6 and then start growing at an 
exponential rate. S2.13 cells also go through a lag phase at 37°C, until day 6 and then 
grow at an exponential rate, but they have fewer cell numbers than at 33°C. Cells grown 
at 39°C were dead by day 5.
Table 4.4: Proliferation Of S2.13 Cells, Showing The Mean And Standard Error 
Of Cell Numbers Derived From Three Independent Experiments
Days in Culture Cell Number x 10s (±SE)
33°C 37°C 39°C
2 1.71 ±0.22 1.99 ±0.25 1.58 ±0.068
4 3.04 ±0.88 1.91 ±0.33 0.52 ±0.00
5 4.79 ± 0.69 2.52 ±0.02 0.45 ±0.08
8 12.66 ±03.54 10.61 ±3.49
10 21.0 ±5.0 16.45 ±3.85
4.3.2.1 Mean Population-Doubling Time for S2.13 Cells
The mean population doubling for S2.13 cells from the exponential phase of cell count 
assays, using a logarithmic scale is 48 and 36 hours, at 33°C and 37°C respectively. 
Cells do not grow exponentially at 39°C. Figure 4.11, below shows extrapolation of 
data from the exponential phase of a log curve of S2.13 cells.
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Figure 4.10: Cell Count Growth Curve Of S2.13 Stromal Cells
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2,750,000 33°C
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S2.13 cell counts for 3 separate growth assays, at 33°C, 37°C and 39°C. Cells were set-up in triplicate at a density of 200,000 cells per 25cm2. The mean and 
standard error were calculated and a growth curve was obtained.
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Figure 4.11: Extrapolation Of Mean Population-Doubling Figures For S2.13 Cells
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Log plot of the increase in cell concentration (y-axis) versus days in culture (x-axis), following subculture from cultures counted on regular intervals. The 
population-doubling time (PDT) was extrapolated from the straightest area of the exponential phase. A straight line was drawn from a particular cell count, on the y- 
axis in the log phase, to the plotted line. Then another straight line was drawn from a point that was double the first cell count on the y-axis to the plotted line. These 
two lines were then continued from the plot towards the x-axis in a straight line. The distance between these two points on the x-axis represents the length of time 
for one cell population to double. This was carried out at 33°C, 37°C and 39°C.
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4.3.3 Comparison Of The Growth Patterns Of Immortalised (1542-NPTX) And 
Conditionally Immortalised (Pre2.8) Prostate Epithelial Cell Lines
The growth patterns of the conditionally immortalised prostate epithelial cell line Pre2.8 
was compared with those of the immortalised cell line 1542-NPTX, in order to confirm 
the differences in response to temperature shift.
Cells were plated at a density of 10,000 per well in 96-well plates, and MTT assays 
were used to estimate growth after 3 and 10 days in culture. The results are shown in 
figures 4.12 and 4.13.
After 3 days growth, the 1542-NPTX cells had grown fastest at 39°C and slowest at 
33°C. In contrast, the Pre2.8 cells had grown fastest at 37°C, but there were few 
surviving cells at 39°C.
After 10 days growth, 1542-NPTX cell number at 39°C was similar to that at 3 days, 
indicating that the high temperature had inhibited cell growth in the longer term. At 
37°C, the optical density was 3-4 times that seen at 3 days, indicating exponential 
growth at this temperature. In contrast and as expected, the greatest increase in growth 
of Pre2.8 cells was seen at the permissive temperature, 33°C.
4.3.5 Comparison of the growth patterns of immortalised (1542-FT) and 
conditionally immortalised (S2.13) prostate stromal cell lines
Cells were plated at 200,000 cells per 25cm2 flask and grown for 5 and 9 days at 33°C, 
37°C and 39°C in triplicate. The results are shown in figures 4.14 and 4.15, and are 
similar to those obtained with the epithelial cells. 1542-FT cells grew best at 37°C, 
while S2.13 cells grew best at 33°C after 5 and 9 days in culture.
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Figure 4.12: Comparison Of Pre2.8 Cells With 1542-NPTX At Day 3
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Pre2.8 and 1542-NPTX cells were seeded at a density of 10,000 cells per well and harvested 
after 3 days for analysis using the MTT assay. The mean and standard error of optical density 
for 3 experiments were calculated and a histogram with each cell line at 33°C, 37°C and 39°C 
was obtained.
Figure 4.13: Comparison Of Pre2.8 Cells With 1542-NPTX At Day 10
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Day 10
Pre2.8 and 1542-NPTX cells were seeded at a density of 10,000cells per well and harvested 
after 10 days for analysis using the MTT assay. The mean and standard error of optical density 
for 3 experiments were calculated and a histogram with each cell line at 33°C, 37°C and 39°C 
was obtained.
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Figure 4.14: Comparison Of S2.13 Cells With 1542-FT At Day 5
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S2.13 cells and 1542-FT cells were seeded at a density of 200,000 cells per 25cm2 flask and 
harvested after 5 days for analysis using cell counts. The mean and standard error of cell counts 
for 3 experiments were calculated and a histogram with each cell line at 33°C, 37°C and 39°C 
was obtained.
Figure 4.15: Comparison Of S2.13 Cells With 1542-FT At Day 9
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S2.13 cells and 1542-FT cells were seeded at a density of 200,000 cells per 25cm2 flask and 
harvested after 10 days for analysis using cell counts. The mean and standard error of cell 
counts for 3 experiments were calculated and a histogram with each cell line at 33°C, 37°C and 
39°C was obtained.
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4.4 CELL SIZE DISTRIBUTION
Cell size was determined using a Coulter Counter to measure Pre2.8 cells in suspension. 
These results were compared to cell size of Pre2.8 and S2.13 cells growing on plastic, 
using a graticule eyepiece on an inverted microscope.
4.4.1 Beckman Coulter Counter
A size comparison of Pre2.8 cells at 33°C, 37°C and 39°C was carried out using a 
Coulter Counter. The mean size for 14,767, 14,140 and 8,991 cells measured is 
13.25pm, 16.23pm and 16.57pm at 33°C, 37°C and 39°C respectively (figure 4.16). 
The histogram (figure 4.16) of cell size (pm) shows a significant 22% and 25% increase 
in cell size (13.25pm to 16.23pm and 16.57pm) when Pre2.8 cells are transferred from 
33°C to 37°C and 39°C respectively. No significant difference was seen when cells 
were transferred to 37°C compared to 39°C. The cell size difference between 37°C and 
39°C appeared to be greater by observation under the inverted microscope (figure 3.4). 
It may be possible that some of the larger cells at 39°C are not able to pass through the 
Coulter Counter’s capillary tube, therefore producing an inaccurate mean cell size 
value. Alternatively it is possible that highly differentiated cells may not survive 
trypsinisation as whole cells. This would also account for lack of increase in Pre2.8 cell 
size at 39°C, using the coulter counter.
The cell size distribution of these cells clearly shows a shift. The majority of cells 
grown at 33°C are between 10pm and 13pm, which are at the smaller end of the scale 
(10pm to 21pm). When Pre2.8 cells are transferred to 37°C and 39°C this large peak is 
not seen. The majority of these cells are distributed between a scale of 13pm and 17pm 
(figure 4.17).
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Figure 4.16: Pre2.8 Cell Size In Suspension
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Using a Cell Coulter Counter the mean and standard error for cell size (pm) was calculated for
14,767 Pre2.8 cells in suspension, at 33°C, 37°C and 39°C. A significant increase in cell size of
22% and 25% (13.25pm to 16.23pm and 16.57pm) was observed when Pre2.8 cells were 
transferred from 33°C to 37°C and 39°C respectively. Unexpectedly no significant difference 
was observed when cells were transferred to 37°C compared to 39°C.
Figure 4.17: Dot Plot Of Pre2.8 Cell Size Distribution
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Using a Cell Coulter Counter the cell cycle distribution (cell number versus cell size in pm) was 
determined for Pre2.8 cells in suspension, at 33°C, 37°C and 39°C.
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4.4.2 Graticule And Inverted Microscope
At x200 magnification on the light phase microscope one marking on the graticule 
eyepiece was equivalent to 5.71pm on the coverslip graticule. The diameter of 100 
viable cells and their nuclei were measured from monolayer cultures on a tissue culture 
plate at 33°C, 37°C and 39°C.
S2.13 stromal cells are much larger than Pre2.8 epithelial cells, 55pm compared to 
40pm at 33°C, 64pm compared to 43pm at 37°C and 88pm compared to 52pm at 39°C 
(see histograms, figure 4.19 and 4.21 for Pre2.8 and S2.13 respectively). Similar 
comparisons were observed for nucleus size, although the mean nucleus size was 
approximately half the size of the mean cell size.
4.4.2.1 Pre2.8 Cells
A distribution of cell number versus cell size was determined (figure 4.17). There is a 
shift in size distribution for Pre2.8 cells. The majority of cells at 33°C and 37°C range 
between 31pm and 70pm in size while at 39°C cells range between 31pm and 100pm in 
size.
A histogram of the mean and standard error for 100 Pre2.8 cell and nucleus diameter 
was determined (figure 4.18). There is a 7% and 12% increase in cell size (40pm to 
43pm and 52pm) when Pre2.8 cells are transferred from 33°C to 37°C and 39°C 
respectively. A 12% and 30% increase in nucleus size of these cells, increasing from 
17pm to 19pm and 22pm when transferred from 33°C to 37°C and 39°C respectively.
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Figure 4.18: Pre2.8 Cell Size Distribution
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Comparison of whole cell (WC) size distribution for Pre2.8 cells after 7 days grown at 33°C, 
37°C and 39°C. Flattened cells were measured using a Graticule under an inverted microscope. 
The mean and standard error of 100 cells was calculated.
Figure 4.19: Comparison Of Pre2.8 Whole Cell And Nucleus Size At 33°C, 37°C 
And 39°C
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Comparison of whole cell (WC) size and nuclei size (N) for Pre2.8 cells after 7 days grown at 
33°C, 37°C and 39°C. Flattened whole cells and their nucleus were measured using a Graticule 
under an inverted microscope. The mean and standard error of 100 cells was calculated. There is 
a greater increase in Pre2.8 nuclei size (12% and 30%) than Pre2.8 whole cell size (7% and 
12%) from 33°C to 37°C and 37°C to 39°C respectively.
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4.4.Z2 S2.13 Cells
A graph of cell size distribution (figure 4.20) shows a size shift when S2.13 cells are 
transferred from 33°C to 37°C and 39°C. Cells range in size from approximately 30pm 
to 100pm at 33°C and 37°C and 35pm to 120pm for S2.13 cells.
A histogram of mean and standard error of S2.13 cell and nucleus diameter size shows a 
16% and 60% increase when cells are transferred from 33°C to 37°C and 39°C 
respectively (figure 4.21). The average cell size increases from 55pm to 64pm and 
88pm. There is no change in nucleus size from 33°C to 37°C, while a 37% increase is 
observed when cells are transferred from 33°C to 39°C (25pm to 34pm).
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Figure 4.20: S2.13 Cell Size Distribution
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Comparison of whole cell (WC) size distribution for S2.13 cells after 7 days grown at 33°C, 
37°C and 39°C. Flattened cells were measured using a Graticule under an inverted microscope. 
The mean and standard error of 100 cells was calculated.
Figure 4.21: Comparison Of S2.13 Whole Cell And Nucleus Size At 33°C, 37°C 
And 39°C
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Comparison of whole cell (WC) size and nuclei size (N) for Pre2.8 cells after 7 days grown at 
33°C, 37°C and 39°C. Flattened whole cells and their nucleus were measured using a Graticule 
under an inverted microscope. The mean and standard error of 100 cells was calculated.
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4.5 COLONY FORMING EFFECIENCY ON PLASTIC AND IN SOFT AGAR
4.5.1 Colony Forming Efficiency For Pre2.8 Cells On Plastic
Colony forming assays were set up for Pre2.8 cells at a density of 5,000,10,000,15,000 
and 20,000 cells in triplicate at 33°C and 39°C. The colonies were fixed after 14 days 
culture (previously optimised protocol for commonly used cell lines within our 
laboratory) and then counted under a dissecting microscope. In order to avoid counting 
secondary colonies, only colonies with greater than 50 cells/colony were counted. The 
results of 5 independent assays are shown in table 4.5. No colonies developed at 39°C. 
At 33°C, colonies did not develop at a seeding of 5,000 cells, although some cells 
survived. At a plating density of 20,000 per 5cm dish, the colonies had begun to merge 
by 14 days and could not be counted. The mean colony forming efficiency was 2.5% 
and 3.1% for 10,000 and 15,000 cells respectively.
Table 4.5: Colony Forming Efficiency For Pre2.8 Cells At 33°C
10,000 15,000
2.78%±0.10 2.70%±0.29
0.22%±0.18 3.80%±0.50
5.90%±0.43 2.78%±0.22
0.26%±0.17 3.28%±0.39
3.09%±0.10
2.45%±0.20 3.14%±0.35
4.5.2 Anchorage-Independent Growth
The ability of Pre2.8 cells (passage 50) to grow in an anchorage-independent manner 
was compared with a breast cancer cell line, MDA-MB-435 (Glinsky et al., 1996) and a 
prostate cancer cell line, PC3 (Kaighn et al. 1979). Cancer cells are known to posess 
anchorage-independent growth. PC3 cells show anchorage-independent growth in 
monolayer and soft agar suspension and produce subcutaneous tumors in nude mice 
(Kaighn et al. 1979). It has previoulely been shown, in our laboratory that MDA-MA- 
435 and PC3 cell lines produce colonies in semi-solid agar, i.e. anchorage-independent 
growth, hence they were chosen as good positive controls for these experiments. MDA- 
MA-435 and PC3 cells were suspended in semi-solid agar in triplicate at 33°C and 37°C 
at a range of densities. Colony formation was observed after 15 days. Pre2.8 and S2.13 
cells did not produce colonies in semi-solid agar, while the MDA-MB-435 and PC3 
cancer cell lines had colony-forming ability in agar (data not shown).
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5.1 INTRODUCTION
Pre2.8 and S2.13 cell lines, immortalised using a temperature sensitive SV40 T-antigen 
construct, were successfully authenticated and characterised (described in chapter 4 and 
5). These cell lines should proliferate at 33°C and stop dividing at 37°C or 39°C. The 
aim of this section is to determine to what extent the cells differentiate when 
proliferation ceases.
Immunofluorescent and immunocytochemical analyses were carried out to characterise 
the Pre2.8 and S2.13 cells. Pre2.8 cells were grown on coverslips at 33°C, 37°C and 
39°C for 7 days. S2.13 cells were grown at 33°C and 37°C only, as the cells died within 
7 days at 39°C. Fluorescent staining was examined using a Hg-arc Zeiss Axiophot 
fluorescent microscope and extent and intensity of staining was estimated by eye.
5.2 Stromal Cell Markers
Antibodies to vimentin, smooth muscle actin (SMA) and a fibroblast cell surface marker 
(AS02) were used to identify stromal cell subtypes (table 5.1 and figure 5.1).
Pre2.8 cells were negative for these markers at all temperatures. S2.13 cells were 
positive for vimentin and anti-fibroblast antibody (figure 5.1) and negative for SMA. 
This staining pattern is characteristic of fibroblast cells. There was no background 
present for SMA or vimentin antibodies. Faint background was seen for fibroblast 
(AS02) antibody.
5.3 Epithelial Cell Markers
Cytokeratin expression was used to confirm epithelial cell origin and to look for basal 
cell (K14 and K17), intermediate cell (K19) and luminal cell differentiation (K8 and 
K18) cells at 33°C, 37°C and 39°C.
The prostate cancer cell line LNCaP stained for K8 and K18, was weakly positive for 
K19 and negative for K14 and K17. S2.13 cells were negative for K14 at 33°C and 
37°C, while results were inconclusive for K17 (table 5.1). Positive staining was found 
for K17 which is unexpected as keratins are epithelial cell markers and not stromal.
Nearly all Pre2.8 cells were positive for K14 at all three temperatures. Although all 
Pre2.8 cells appear to express K17 (figure 5.2), there is a clear intensity difference. At
33°C most cells are only faintly positive whereas at 37°C and 39°C most of the cells 
express K17 strongly. The number of cells expressing both K14 and K17 (yellow in 
colour) (figure 5.2) has clearly increased at 37°C and 39°C compared to 33°C. In areas 
where K17 is most intense, K14 is less intense. The intensity of K14 staining decreased 
at the two higher temperatures.
K19, an intermediate epithelial marker shows occasional staining at 37°C and 39°C only 
(figure 5.3). K14+ K19‘ staining was observed at 33°C compared to K14+ K19+ found at 
37°C and 39°C (figure 5.3). There were small patches of strong K19+ K14’ expression in 
densely populated Pre2.8 cells at 37°C and 39°C (most obvious at 37°C), indicative of 
further differentiation at the higher temperatures. K19 and K8 antibodies were sparsely 
expressed in different cells, when double stained at 37°C compared to extremely sparse 
co-expression (yellow cells) at 39°C (figure 5.4). All cells at 33°C were negative for 
K19 with some K8 staining.
The luminal cell markers K8 and K18 were expressed in fewer Pre2.8 epithelial cells at 
33°C than at 37°C and 39°C. In double stains for K19 and K8 (figure 5.4) an increase in 
K8 expression was observed at 37°C and 39°C compared to 33°C. A similar pattern was 
seen with K14 and K8 (figure 5.5). There appear to be fewer K14+ cells expressing K18 
(figure 5.6) than K8 at 33°C and 37°C. Co-expression of K14 and K8 is apparent at 
33°C, while K8+ cells are K14' at 37°C.
Pre2.8 cells have a basal phenotype at 33°C and differentiate into intermediate epithelial 
cells at 37°C.
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5.4 Androgen Expression And Prostate Specific Characteristics Of Pre2.8 And
S2.13 Cells
In order to determine if the cells express prostate specific characteristics 
immunocytochemical staining was carried out for AR, PSA and PAP and results 
observed under the Nikon Diaphot inverted microscope (table 5.1). Both isoforms of 
5a-reductase (type 1 and 2) were examined by RT-PCR.
There was no expression of 5a-R2 (figure 5.7), AR, PSA or PSAP in Pre2.8 or S2.13 
cells at any temperature (table 5.1). LNCaP cells were positive for AR, PSA and PSAP 
antibodies by immunocytochemistry and BPH tissue was positive for 5a-R2, producing 
a 350bp RT-PCR product (figure 5.7). 5a-R type 1 was expressed in Pre2.8 and S2.13 
cells at 33°C, 37°C and 39°C, producing a 170bp fragment (figure 5.7). GAPDH was 
positive for all Pre2.8 and S2.13 PCR samples, producing a 597bp product.
Table 5.1: Differentiation Pattern Of Pre2.8 Epithelial And S2.13 Stromal Cells
Markers
Positive Control Neg
Control
Pre2.8 S2.13
LNCaP 3T3 33°C 37°C 39°C 33°C 37°C
K14 - nt - +++ +++ +++ - -
K17 - nt - ++ +++ +++ inc inc
K19 - nt - - + + - -
K8 +++ nt - + +/++ +/++ nt nt
K18 | +++ nt - + ++ ++ nt nt
SMA nt +++ - - - - - -
Vimentin nt +++ - - - - +++ +++
Fibroblast
(AS02) nt +++
Faint
background +++ +++
AR +++ nt - - - - - -
PSA +++ nt - - - - - -
PAP +++ nt - - - - - -
Abbreviations: (nt) not tested; (-) negative expression. Positive staining is expressed as +, ++ or 
+++ which refers to an estimated amount o f  staining or quantity o f  positive stained cells 
(occasional, moderate or nearly all).
LNCaP and 3T3 cells were only used as positive controls to show that antibodies were active 
and working correctly. Since LNCaP and 3T3 cells were not being investigated it was not 
necessary to test them for variation in marker expression at temperatures other than their routine 
culture temperature.
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Figure 5.1: Vimentin And Fibroblast Expression In S2.13 Cells
(A) Vimentin
(B) Fibroblast (ASQ2)
(C) Fibroblast (ASQ2)
Immunofluorescence (A and B) and immunocytochemistry (C) staining o f S2.13 
stromal cells (passage 14) that were grown on glass coverslips at 33°C. Nuclei were 
stained with Hoechst (blue) in A and B. Cells were stained with (A) vimentin (green), 
(B) A S02 anti-fibroblast antibody (red) or (C) A S02 anti-fibroblast antibody (brown). 
Original magnification was x40 (fluorescence microscope -  objective lens).
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Figure 5.2: K14 K17 Expression In Pre2.8 Cells
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Immunofluorescence staining of Pre2.8 epithelial cells (between passage 48 and 58) 
grown on glass coverslips at 33°C, 37°C and 39°C. Nuclear Hoechst (blue) staining is 
shown with K14 and K17 alone, but is not shown with K14/K17 together. Keratin 14 is 
stained with FITC (green). Keratin 17 is stained with Rhodamine (red). When epithelial 
cells are double stained with K14 and K17 the colour tends to be yellow (mixture of 
FITC and Rhodamine). Original magnification was x40 (fluorescence microscope -  
objective lens).
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Figure 5.3: K14 K19 Expression In Pre2.8 Cells
33°C 37°C 39°C
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K19r
Immunofluorescence staining of Pre2.8 epithelial cells (between passage 48 and 58) grown on 
glass coverslips at 33°C, 37°C and 39°C. Nuclear Hoechst (blue) staining is shown with K14 
and K19 alone, but is not shown with K14/K19 together. Keratin 14 is stained with FITC 
(green). Keratin 19 is stained with Rhodamine (red). When epithelial cells are double stained 
with K14 and K19 the colour tends to be yellow (mixture of FITC and Rhodamine). Original 
magnification was x20 (fluorescence microscope -  objective lens).
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Figure 5.4: K19 K8 Expression In Pre2.8 Cells
K8g K19r K8g/K19r
33°C
37°C
39°C
LNCaP
Immunofluorescence staining o f Pre2.8 epithelial cells (between passage 48 and 58) grown on 
glass coverslips at 33°C, 37°C and 39°C. Nuclear Hoechst (blue) staining is shown with K8 and 
K19 alone, but is not shown with K8/K19 together. Keratin 8 is stained with FITC (green) and 
Keratin 19 with Rhodamine (red). When epithelial cells are double stained with K8 and K19 the 
colour tends to be yellow (mixture o f FITC and Rhodamine). LNCaP (metastatic prostate cells) 
luminal cells were used as a positive control for K8 expression. Original magnification was x40 
(fluorescence microscope -  objective lens).
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Figure 5.5: K14 K8 Expression In Pre2.8 Cells
33°C 37°C 39°C
K 14g /K 8r
Immunofluorescence staining o f Pre2.8 epithelial cells (between passage 48 and 58) 
grown on glass coverslips at 33°C, 37°C and 39°C. LNCaP (metastatic prostate cells) 
luminal cells were used as a positive control for K8 expression. Nuclear Hoechst (blue) 
staining is shown with K14 and K8 alone, but is not shown with K14/K8 together. 
Keratin 14 is stained with FITC (green). Keratin 8 is stained with Rhodamine (red). 
When epithelial cells are co-stained with K14 and K8 the colour tends to be yellow 
(mixture o f FITC and Rhodamine). Original magnification was x40 (fluorescence 
microscope -  objective lens).
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Figure 5.6: K14 K18 Expression In Pre2.8 Epithelial Cells
K14g K18r K14g/K18
33°C
37°C
LNCaP
Immunofluorescence staining o f Pre2.8 epithelial cells (between passage 48 and 58) 
grown on glass coverslips at 33°C and 37°C. LNCaP (metastatic prostate cells) luminal 
cells were used as a positive control for K18 expression and as a negative control for 
K14. Nuclear Hoechst (blue) staining is shown with K14 and K18 alone, but is not 
shown with K14/K18 together. Keratin 14 is stained with FITC (green). Keratin 18 is 
stained with Rhodamine (red). Original magnification at 33°C and with LNCaP cells 
was x40. Original magnification at 37°C was x20 (fluorescence microscope -  objective 
lens).
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Figure 5.7: 5a-Reductase Expression
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Pre2.8 (between passage 48 and 58) and S2.13 cells (passage 14) were grown in monolayer 
cultures at 33°C, 37°C and 39°C. Reverse transcribed cDNA was amplified using; 5a-Reductase 
type 1 primers (A), type 2 primers (B) and GAPDH primers (C). The expected PCR product 
was 170bp, 350bp and 597bp for 5a-R l, 5a-R2 and GAPDH respectively. Abbreviations: 
reagent only sample (RO), DNA marker (M), benign prostate hyperplasia (BPH)
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6.1 INTRODUCTION
The aim of the studies described in Chapter 6 was to investigate the capacity of the 
Pre2.8 and S2.13 cell lines to form 3-dimensional (3-D) structures in vitro and in vivo, 
and to determine to what extent these structures reflect the morphology and 
differentiation of prostate tissue.
Primary cultures of prostate epithelial cells develop 3-D structures in Matrigel in the 
presence of S2.13-conditioned medium, with evidence of prostate morphology and 
differentiation (Hudson et al., 2000b). Consequently Matrigel was chosen for this study. 
Matrigel consists of approximately 60% laminin and other essential components of the 
basement membrane such as collagen-IV, heparin sulphate proteoglycans, nidogen and 
varying concentrations of growth factors (Malinda and Kleinman, 1996). Pre2.8 cells 
were routinely grown in a commercially available serum-free prostate epithelial 
medium, PrEGM. It has previously been determined that this culture medium supports 
the growth of prostate epithelial cells (Fry et al., 2000c). S2.13 cells were routinely 
grown in DMEM (Life Technologies) supplemented with 10% foetal calf serum (FCS). 
Stromal cells tend not to grow in the absence of serum (Peehl and Stamey, 1986b; Peehl 
et al., 1988a).
In this chapter attempts to optimise growth conditions for co-cultures of Pre2.8 and
S2.13 cells are described. 3-D structures were compared for varying culture conditions. 
The role of the stroma in the development of 3-D culture by Pre2.8 was investigated. 
The morphology of the 3-D cultures was studied using immunofluorescence staining for 
cytokeratins, immunocytochemistiy staining for stromal cell markers and prostate- 
specific differentiation was studied at both protein and mRNA levels. The influence of 
androgen on the development of 3-D structures by Pre2.8 cells was also studied.
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6.2 COMPARISON OF GROWTH OF PRE2.8 AND S2.13 CELLS IN VARIOUS 
TISSUE CULTURE MEDIA
Before setting up co-cultures of Pre2.8 and S2.13 cells, it was necessary to find a 
medium that both cell types could happily grow in.
6.2.1 Growth Of Pre2.8 Cells In Serum-Free PrEGM And RPMI-1640 Medium In 
The Presence And Absence Of Serum
PrEGM is an expensive specialised serum-free epithelial growth medium, whereas 
RPMI-1640 is a cheap, general-purpose growth medium. To try to reduce costs, the 
growth of Pre2.8 cells in PrEGM medium was compared to growth in serum-free RPM3 
and RPMI containing 8% FCS serum (RPMI/FCS) at 33°C, 37°C and 39°C. 
Comparisons were made of the morphology and cell number after 4 days culture.
Pre2.8 cells died within a few days in serum-free RPMI medium at 37°C and 39°C. At 
33°C the epithelial cells were alive after 14 days in serum-free medium, but did not 
survive passaging. The Pre2.8 cells survived in RPMI/FCS medium at 33°C and 37°C, 
while at 39°C cells proliferated for about 6 days, but then stopped dividing and were 
dead by day 20.
The morphology of Pre2.8 cells changed when grown in RPMI/FCS, particularly at 
37°C and 39°C (figure 6.1). Some cells were elongated at 33°C and this appearance was 
more frequent at higher temperatures. At 37°C and 39°C the cells tend to grow as 
discrete colonies in RPMI/FCS, in contrast to their more scattered appearance in 
PrEGM.
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Figure 6.1: Comparison Of Pre2.8 Cell Morphology In PrEGM And RPMI/FCS 
Media
PrEGM RPMI
33°C
37°C
39°C
Monolayer cultures of Pre2.8 epithelial cells grown in PrEGM or RPMI/FCS medium for 10 
days at 33°C, 37°C and 39°C. Original magnification x20
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6.2.2 Proliferation Of Pre2.8 Cells In Various Media
Pre2.8 cells were grown in 4 media: PrEGM, RPMI/FCS, KGM (Keratinocyte-SFM 
medium), DMEM/FCS and mixtures o f these media for 4 days at 33°C. The growth 
rates were compared using the MTT assay. All assays were repeated 3 times.
RPMI/FCS and DMEM/FCS medium alone and a mixture containing equal volumes of 
both resulted in the highest growth rates (figure 6.2). PrEGM and KGM, alone or in 
combination resulted in the lowest growth rates (figure 6.2). Equal volumes of 
DMEM/FCS (routine S2.13 growth medium) and PrEGM (routine Pre2.8 growth 
medium) produced approximately half the maximum rate o f proliferation achieved with 
RPMI/FCS alone or DMEM/FCS with RPMI/FCS (figure 6.2).
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The average and standard error of 3 replicate experiments to compare the growth of Pre2.8 cells 
with different media combinations. Abbreviations: D/P -  DMEM/PrEGM; R/P -  RPMI/ 
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6.2.3 Proliferation Of S2.13 Cells In Various Media
The growth of S2.13 cells was compared in RPMI/FCS, DMEM/FCS (routine S2.13 
growth medium), PrEGM (routine Pre2.8 growth medium), DMEM/FCS with PrEGM, 
RPMI/FCS with PrEGM or RPMI/FCS with KGM (Keratinocyte-SFM medium) 
medium. The cells were plated at a density of 500,000/T25 flask and grown at 33°C and 
37°C. Because S2.13 cells metabolise MTT poorly, comparisons were made using cell 
counts (figures 6.3 and 6.4). All assays were repeated 3 times.
The highest cell numbers were obtained with a combination of DMEM/FCS with 
PrEGM and RPMI/FCS with KGM medium at 33°C (figure 6.3). Similar results were 
obtained at 33°C and 37°C (figure 6.3 and 6.4, respectively).
Conclusion
Pre2.8 and S2.13 grew best in RPMI and DMEM, but RPMI-1640 altered the 
morphology of Pre2.8 cells. Equal volumes of PrEGM (routine growth medium for 
Pre2.8 cells) and DMEM (routine growth medium for S2.13 cells) produced similar 
rates of proliferation for Pre2.8 and S2.13 cells in monolayer cultures, and therefore this 
mixture was selected for further study.
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Figure 6.3: Comparison O f S2.13 Cell Proliferation In Different Media At 33°C
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Figure 6.4: Comparison Of S2.13 Cell Proliferation In Different Media At 37°C
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The average and standard error of 3 replicate experiments for comparison of S2.13 cell growth 
with different media combinations, after 7 days in culture at 33°C (top histogram) and 37°C 
(bottom histogram).
□ DMEM
■ RPMI
□ PrEGM
□ DMEM/PrEGM
■ RPMI/PrEGM
□ RPMI/KGM
Day 7
□ DMEM
■ RPMI
□ PrEGM
□ DMEM/PrEGM
■ RPMI/PrEGM
□ RPMI/KGM
Day 7
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6.3 EFFECT OF STROMAL CELLS AND CONDITIONED MEDIUM ON THE 
GROWTH OF PRE2.8 CELLS IN 3-DIMENSIONAL CULTURE
A comparison of the growth of Pre2.8 cells in matrigel (3-D) cultures with equal 
volumes of PrEGM and DMEM/FCS or PrEGM only was carried out when mixed with
52.13 cells, 3T3 mouse fibroblasts or S2.13 conditioned medium.
Because S2.13 stromal cells grow approximately 4 times faster than Pre2.8 epithelial 
cells in monolayer culture, initially a Pre2.8/S2.13 ratio of 4:1 was used. Pre2.8 
epithelial and S2.13 stromal cells were mixed at a ratio of 4:1 and grown in Matrigel at 
33°C, 37°C and 39°C. The morphology of the 3-D cultures was examined under the 
light phase inverted microscope for up to 20 days of culture (figure 6.5).
Three main types of 3-D structures were observed at each temperature (figure 6.5). At 
33°C the cells formed a lattice, consisting of dark clumps of cells connected by fainter 
tube-like structures. At 37°C cells accumulated together in fewer, larger interconnected 
organoids. At 39°C the cells formed many small organoids. The co-cultures tended to 
form lattices in PrEGM alone, and mixtures of small and large organoids in the presence 
of serum.
The replacement of S2.13 cells with conditioned medium (S2.13 supernatant -  cells 
grown in PrEGM medium) at 33°C and 37°C (table 6.1) (figure 6.6) produced lattices. 
3-D structures did not develop when S2.13 cells were grown alone in Matrigel. Very 
small organoids were seen when Pre2.8 cells only were grown in Matrigel at 33°C and 
37°C (figure 6.6). These structures were compared to larger interconnected organoids 
seen when Pre2.8 and S2.13 cells (ratio of 4:1) were grown in Matrigel in equal 
volumes of PrEGM and DMEM/FCS (figure 6.6). Similar results were obtained for 
each of these conditions in the presence and absence of mibolerone. The addition of 
mibolerone at either 10*8 or 10'9M tended to favour the production of small and large 
organoids (table 6.1, figure 6.6).
The development of 3-D structures was not improved by increasing the concentration of
52.13 cells. When larger numbers of cells (ratios of 1:8 and 1:10) were present the 
matrigel contracted into a ball.
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When 400,000 mouse 3T3 fibroblasts were grown alone in matrigel (3-D) cultures or as 
a mixture with 100,000 Pre2.8 cells in matrigel cultures, the matrigel contracted into a 
ball. A ratio of 1:1 for Pre2.8/3T3 cells in matrigel produced 3-D structures similar to 
Pre2.8/S2.13 matrigel cultures.
Most stromal cells died in Pre2.8/S2.13 matrigel cultures with PrEGM only medium 
and with equal volumes of PrEGM and DMEM/FCS. Epithelial cell markers (e.g. 
figures 6.8) stain nearly all cells present in sections of the organoids, except for a few 
unstained cells (Hoechst*) around the edge of each organoid that are likely to be stromal 
cells.
6.3.1 Stromal Cell Marker Expression Of 3-Dimensional Cultures
Pre2.8/S2.13, Pre2.8/3T3, S2.13 only and 3T3 only cells grown in matrigel were 
positive for vimentin and negative for smooth muscle actin (SMA) (table 6.2 and figure 
6.7). Pre2.8 only cells were vimentin negative. Prostate tissue sections, NPro2 were 
vimentin and SMA positive and no background was observed in negative controls. 
Stromal cells were distributed in an unorganised manner throughout the matrigel.
6.3.2 Keratin Expression Of Pre2.8 Cells In 3-Dimensional Culture
Pre2.8 epithelial and S2.13 stromal cells were mixed at a ratio of 4:1 and grown in 
Matrigel at 33°C, 37°C and 39°C. 3-Dimensional structures obtained after 20 days in 
culture were formalin fixed and 7- 10pm sections were prepared. Sections were used for 
immunohistochemistry. All experiments were repeated at least three times. The stained 
sections were used to study the morphology and degree of differentiation of the 3D 
structures. RNA was extracted from 3-D structures at 37°C and synthesised into cDNA 
by reverse transcriptase for PCR analysis of basal and luminal keratin expression.
Pre2.8/S2.13 matrigel cultures had the same cytokeratin pattern at 33°C, 37°C and 39°C 
(table 6.2). Limited immunocytochemistry could be carried out on 39°C sections due to 
the small size of spheroids. All secondary antibody controls were negative (table 6.2). 
Sections of BPH tissue were used for positive controls.
K14/K17 expression
The basal (outer) layer of the organoids was positive for K14 and K17 at 33°C and 37°C 
(figure 6.8) using double immunofluorescence. K17 was more intensely positive in the
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central (luminal) areas of the organoids (figure 6.8). Almost all the cells stained for K17 
throughout the organoids.
Pre2.8/3T3 and Pre2.8 only matrigel cultures were positive for K14 and K17 
immunofluorescent double staining at 37°C (table 6.2 and figure 6.9). Architecture was 
similar to Pre2.8/S2.13 organoids, with an outer basal layer and an inner luminal layer.
52.13 and 3T3 cells grown alone were negative for K14 and K17 (not included in 
figures). Prostate tissue sections were positive and there was no background present in 
negative controls (table 6.2 and figure 6.9).
RT-PCR was carried out to confirm the expression of a basal cell marker at the RNA 
level. Pre2.8/S2.13 co-cultures (1:1 and 1:4) and Pre2.8 only (lxlO5 cells) RNA was 
positive for K5, producing a 350bp fragment as predicted (table 6.4 and figure 6.15).
52.13 alone (lxlO5 and 4x105 cells) and LNCaP and DU145 cell lines were negative for 
K5, as expected. The reagent only samples were negative. The level of RNA expression 
for K5 was not affected by increasing concentrations of S2.13 stromal cells.
K19 expression
There was limited K19+ stained cells, approximately 1% (figure 6.10).
K8 expression
The percentage of K8 positive cells was difficult to estimate due to difficulty in
obtaining satisfactory K8 staining. Immunofluorescent of K8 showed that
approximately 10% of the cells are intensely K8 (figure 6.11). Using
imunocytochemistry, K8 staining was positive at 33°C and 37°C, although there was
faint background staining in the negative control (table 6.2) (figure 6.12). Highly
«
structured organoids at 37°C clearly shows an inner luminal layer with an unstained 
outer layer, likely to be basal cells (magnification, figure 6.12).
K14/K8 expression
Co-staining of K14 and K8 produced similar results at 33°C, 37°C and 39°C (figures
6.13 and 6.14). These two keratins did not co-stain in the absence of mibolerone, 
although in the presence of mibolerone K8 was weakly positive in association with K14
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(figures 6.13 and 6.14). The difference in K14/K8 co-staining in the presence of 
mibolerone is particularly clear in cells at 39°C (compare figures 6.13 and 6.14).
K18 Expression
K18 (a luminal epithelial cell marker) immunocytochemistry was negative for all 
samples including normal prostate tissue sections (NPro2). No conclusion could be 
made from these results. RT-PCR was carried out to determine K18 expression in 
Matrigel cultures, Pre2.8/S2.13 (1:1 and 1:4), S2.13 only (lxlO5 and 4xl05 cells) and 
Pre2.8 only (lx l05 cells) matrigel cultures (table 6.4 and figure 6.15). A 544bp size 
fragment was expected. LNCaP cells were positive for K18, but all organoids 
(Pre2.8/S2.13, S2.13 only and Pre2.8 only) and the DU145 cell line were negative. 
Reagent only samples were negative.
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6.4 EXPRESSION OF PROSTATE-SPECIFIC CHARACTERISTICS BY PRE2.8 
CELLS IN 3-DIMENSIONAL CULTURE
Ideally a model of BPH should express nuclear AR and cytoplasmic PSA and PAP in 
luminal epithelial cells, with secretion of PSA into the medium. Pre2.8 epithelial and
S2.13 stromal cells were mixed at a ratio of 4:1 and grown in Matrigel at 33°C, 37°C 
and 39°C. 3-Dimensional structures obtained after 24 days in culture were formalin 
fixed and 7-10pm sections were prepared. Sections of the 33°C and 37°C co-cultures 
were used for immunohistochemistry. Immunohistochemistry could not be carried out 
on the organoids grown at 39°C, due to their small size. All experiments were repeated 
at least three times.
RT-PCR was carried out to look for AR and PSA RNA expression in Pre2.8/S2.13 (1:1 
and 1:4), S2.13 only (lxlO5 and 4xl05 cells) and Pre2.8 only (lxlO5 cells) matrigel 
cultures. The expected size fragments on an electrophoresis gel are 526bp (AR) and 
362bp (PSA). P-Actin PCR was carried out on all samples to provide PCR amplification 
and loading controls. The metastatic prostate cell line, LNCaP was used as a positive 
control for AR and PSA. DU145, a metastatic cell line was included as a negative 
control for AR and PSA, but it turned out to be weakly positive for both. Reagent only 
(no template RNA) was used as a PCR contamination control.
6.4.1 Androgen Receptor (AR)
Pre2.8/S2.13 Matrigel sections were positive for AR at 33°C and 37°C in the absence 
and presence of mibolerone (table 6.2) (figure 6.16). The staining pattern for AR was 
nuclear and cytoplasmic and it was expressed in all the cells. S2.13 cells alone were 
unsuccessful and Pre2.8 only sections were negative. Benign prostate sections, NPro2 
were positive for AR in the nucleus and there was no background staining in the 
secondary antibody negative control (figure 6.16).
AR expression was also tested by RT-PCR. The expected size fragment for AR primers 
is 526bp. The correct size band was found for Pre2.8/S2.13 co-culture, S2.13 only 
samples and LNCaP positive control (table 6.4 and figure 6.19). Pre2.8 only samples 
were negative. DU 145 had a very faint band at 526bp. Reagent only samples were 
negative. The level of RNA expression for AR was increased with an increased stromal 
cell concentration from 100,000 cells seeded to 400,000 cells. This increase in RNA
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expression was seen in S2.13/Pre2.8 co-cultures and in S2.13 only matrigel cultures. 
Equal RNA concentrations were observed for P-actin (table 6.4 and figure 6.19).
6.4.2 PSA
Similar nuclear and cytoplasmic expression was observed for PSA and AR in co- 
cultures grown at 33°C and 37°C in the absence and presence of mibolerone (table 6.2) 
(figure 6.17). The prostate tissue section, NPro2 showed PSA staining in the luminal 
epithelial cells and no background staining was present in negative controls (figure 
6.17). A distinct PSA negative area was present in the centre of the organoids, where 
PSA secretion might be expected. PSA staining was observed in Pre2.8/S2.13 co­
cultures, but it consisted of cytoplasmic and nuclear staining (table 6.2).
RT-PCR results for PSA were inconclusive (table 6.4 and figure 6.19). The expected 
size band for these PSA primers is 362bp. The LNCaP positive control and DU145 
produced a band at the correct size, 362bp, but all other samples produced a 500bp 
fragment. Reagent only controls were negative.
Supernatants from Matrigel and monolayer cultures set-up with Pre2.8 and S2.13 cells 
grown in PrEGM/DMEM medium with and without mibolerone were tested for PSA. 
Samples from three different time points at 33°C, 37°C and 39°C were tested (table 
6.3). All samples were negative for PSA, while controls (supernatants from the cell line 
LNCaP) were positive. Supernatant taken from Pre2.8/S2.13, S2.13 only and Pre2.8 
only matrigel cultures were negative for PSA expression. If PSA is expressed in these 
cultures, it is not being secreted into the medium.
6.4.3 PAP
PAP was negative for all Pre2.8/S2.13 co-cultures and other cultures grown at 33°C and 
37°C, in the presence or absence of mibolerone. Prostate tissue sections were positive 
for PAP antibody (table 6.2) (figure 6.18).
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6.5 MIBOLERONE
Similar results were obtained in the presence and absence of mibolerone (figures 6.6,
6.13 and 6.14). The effect of mibolerone was studied under the various conditions 
described in the previous three sections (table 6.2) (figures 6.6, 6.13 and 6.14). The 
addition of mibolerone at either 10-8 or 10'9M tended to favour the production of small 
and large organoids (table 6.2, figure 6.6) and possibly encourage co-expression of K14 
and K8 (table 6.2, figures 6.13 and 6.13).
6.6 CELL PROLIFERATION
The presence of cell proliferation was examined by Ki-67 immunofluorescence. Ki-67 
expression was observed in the NPro2 positive control, Pre2.8/S2.13 (4:1 cell ratio), 
Pre2.8/3T3 (1:1 cell ratio), S2.13 only (100,000 cells seeded) and Pre2.8 only (400,000 
cells seeded) matrigel cultures (table 6.2 and figure 6.20). Proliferation appears more 
concentrated in 3T3/Pre2.8 compared to Pre2.8/S2.13 co-cultures.
Table 6.1: Morphology Of 3-D Cultures
Cell Type Medium Temp Mibolerone 3-D Structures
Pre2.8/S2.13 PrEGM only 33°C - Lattice
+ Small organoids
37°C - Lattice
+ Small organoids
Pre2.8/S2.13 PrEGM + DMEM/FCS 33 °C - Small and large 
organoids
+ Small organoids
37°C - Large organoids
+ Small and large 
organoids
Pre2.8 only 52.13 conditioned 
medium (PrEGM).
52.13 supernatant -  
cells grown in PrEGM 
medium.
33°C - Lattice
37°C + Small organoids
33°C - Lattice
37°C + Small organoids
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Table 6.2: Immunohistochemistry Of 3-D Structures At 33°C, 37°C And 39°C
Temp Sample Mib AR PSA PAP K14 K17 K19 K8 K18 SMA Vim Ki67
33°C Pre2.8/S2.13 + +(n+c)
+
(n+c) - + + - + nt nt nt nt
Pre2.8/S2.13 - +(Sn+c)
+
(n+c) - + + - + nt nt nt nt
37°C Pre2.8/S2.13 + +(n+c)
+
(n+c) - + + — + nt nt nt nt
Pre2.8/S2.13 - +(n+c)
+
(n+c) - + + - + - - + +
3T3/Pre2.8 - + - + + - nt - - + +
Pre2.8 only - b/g nt nt + + - nt - - - -
S2.13 only - nt nt - - - - nt - - nt +
3T3 only - + - - - - - nt - - + +
39°C Pre2.8/S2.13 + nt nt nt + nt nt - nt nt nt nt
Pre2.8/S2.13 - nt nt nt + nt nt - nt nt nt nt
Control Background
Benign
prostate
(NPro2)
+ (n) + (c) + (c) + . + + + - + + +
Abbreviations: AR (androgen receptor); PSA (prostate specific androgen); PAP (prostatic acid 
phosphatase); K (keratin antibody); SMA (smooth muscle actin); Vim (vimentin); Ki67 
(proliferation marker); + (positive); - (negative); n+c (nuclear and cytoplasmic cell staining); nt 
(not tested); b/g (background staining)
Table 6.3: PSA Level In Co-Culture Supernatant
Set-up R e s u l t s
Temp Culturetype Sample Mibolerone PSA in culture supernatant
d l l d l 8 d l 9
33oC 3-D Pre2.8/S2.13 + - - -
3-D Pre2.8/S2.13 - - - -
monolayer Pre2.8/S2.13 + - - -
monolayer Pre2.8/S2.13 - - -
37oC 3-D Pre2.8/S2.13 + - - -
3-D Pre2.8/S2.13 - - - -
monolayer Pre2.8/S2.13 + - - -
monolayer Pre2.8/S2.13 - - -
39oC 3-D Pre2.8/S2.13 + - - -
3-D Jpre2.8/S2.13 - - - -
monolayer pre2.87S2.13 + - - -
monolayer Pre2.8/S2.13 - - -
Pos control + + +
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Table 6.4: Summary Of RT-PCR Results
RNA origin
(culture set-up at 37°C)
PSA AR K5 (Basal) K18 (luminal) 3-Actin
Expected fragment size
362bp 526bp 350bp 544bp
Pre2.8/S2.13 (Culture ratio 
of 1:1) pos (500bp) wpos pos neg pos
Pre2.8/S2.13 (Culture ratio 
of 1:4) pos(500bp) pos pos neg pos
S2.13 only (100,000) pos(500bp) wpos neg neg pos
S2.13 only (400,000) pos (500bp) pos neg neg pos
Pre2.8 only (100,000) pos (500bp) neg pos neg pos
LNCaP positive control pos (362bp) pos neg pos pos
DU145 vwpos(362bp) vwpos neg neg pos
Reagent Only control neg neg neg neg neg
Reverse Transcriptase 
control neg
Abbreviations: pos -  positive; wpos -  weak positive; vw pos -  very weak positive; 
neg- negative
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Figure 6.5: Spheroid Development Of 3-D Cultures
33°C
37°C
39°C
Comparison of organoid (spheroid) development for Pre2.8/S2.13 matrigel (in PrEGM and 
DMEM/FCS medium) co-cultures at 33°C, 37°C and 39°C, after 20 days in culture. Three main 
types of 3-D structures were observed; a lattice formation at 33°C, large interconnecting 
organoids at 37°C and small organoids at 39°C. Original magnification x40 (objective lense).
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Figure 6.6: Effects Of Mibolerone On Spheroid Development
33°C
37°C
37°C
33°C
37°C
Comparison of organoid (spheroid) development for Pre2.8/S2.13 or Pre2.8 cells only, in 
matrigel co-cultures at 33°C, 37°C and 39°C, after 20 days in culture. Different culture 
conditions with and without mibolerone at 33°C and 37°C; 1) Pre2.8 and S2.13 cells in PrEGM 
medium only; 2) Pre2.8 and S2.13 cells in equal volumes of PrEGM and DMEM/FCS; 3) 
Pre2.8 cells only in S2.13 conditional PrEGM medium. Original magnification is x40 (objective 
lense).
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Figure 6.7: Vimentin And SMA Expression In 3-D Cultures At 37°C
S2/13/Pre2.8 3T3/Pre2.8
S2.13 Only 3T3 Only
NPro2
Paraffin sections of day 24 matrigel cultures (in PrEGM and DMEM/FCS medium) at 37°C 
with varying cell types, S2.13/Pre2.8, 3T3/Pre2.8, S2.13 only and Pre2.8 only cells. Normal 
prostate tissue (NPro2) sections were used as positive controls: Fluorescence: Vimentin (red); 
Smooth muscle actin (green); Hoechst (blue). Original Magnification is x40 (fluorescent 
microscope -  objective lense).
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Figure 6.8: K14 And K17 Expression In Pre2.8/S2.13 Matrigel Cultures At 37°C
K14g
K17r
K14g
K17r
Paraffin sections of Pre2.8/S2.13 matrigel co-cultures (in PrEGM and DMEM/FCS medium) 
after 3 weeks at 37°C, in the presence of mibolerone, a synthetic DHT. Fluorescence: K14 
(green); K17 (red); Hoechst (blue). Original Magnification is x20 (fluorescent microscope -  
objective lense).
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Figure 6.9: K14 And K17 Expression In 3-D Cultures At 37°C
S2.13/Pre2.8 3T3/Pre2.8
Pre2.8 only N Pro2
Paraffin sections of 24-day old matrigel cultures (in PrEGM and DMEM/FCS medium) at 37°C 
with varying cell types, S2.13/Pre2.8, 3T3/Pre2.8 and Pre2.8 only cells. Normal prostate tissue 
(NPro2) sections were used as positive controls. Fluorescence: K14 (green); K17 (red) and 
Hoechst (blue). Original magnification was x40 (fluorescent microscope -  objective lense).
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Figure 6.10: K19 Expression In Pre2.8/S2.13 Matrigel Cultures At 37°C
Paraffin section of Pre2.8/S2.13 matrigel co-culture (in PrEGM and DMEM/FCS medium) after 
3 weeks at 37°C, in the presence of mibolerone, a synthetic androgen. Immunofluorescence was 
carried out with nuclear Hoechst (blue) and keratin 19 (green). Original magnification was x20 
(fluorescent microscope -  objective lense).
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Figure 6.11: K8 Expression In Pre2.8/S2.13 Matrigel Cultures At 37°C
Paraffin section of Pre2.8/S2.13 matrigel co-culture (in PrEGM and DMEM/FCS medium) after 3 
weeks at 37°C, in the presence of mibolerone, a synthetic androgen. Immunofluorescence was 
carried out with nuclear Hoechst (blue) and keratin 8 (red). Original magnification was x20 
(fluorescent microscope -  objective lense).
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Paraffin sections from 3-D matrigel co-cultures after 3 weeks at 33°C and 37°C, in the presence of mibolerone, a synthetic DHT. Cultures were set up 
either with Pre2.8/S2.13 cells in PrEGM medium only, Pre2.8 cells only in S2.13 supernatant or Pre2.8/S2.13 in equal volumes of PrEGM and 
DMEM/FCS. DAB staining: K8 (brown); hematoxylin (blue). Original Magnification is x40 (objective lense).
Figure 6.13: K14 And K8 Expression In Pre2.8/S2.13 Matrigel Cultures Without
Mibolerone
KI4g/K8r KI4g K8r
33 °C
37°C
39°C
Paraffin sections o f Pre2.8 and S2.13 matrigel co-cultures (in PrEGM and DMEM/FCS 
medium) after 3 weeks at 33°C, 37°C and 39°C, without mibolerone, a synthetic 
androgen. Fluorescence: K14 (green); K8 (red); Hoechst (blue). Original Magnification 
is X40 (fluorescent microscope -  objective lense).
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Figure 6.14: K14 and K8 expression in Pre2.8/S2.13 Matrigel Cultures with
Mibolerone
K 14g/K 8r K I4g K8r
33°C
37°C
39°C
Paraffin sections o f Pre2.8 and S2.13 matrigel co-cultures (in PrEGM and DMEM/FCS 
medium) after 3 weeks at 33°C, 37°C and 39°C, in the presence o f mibolerone, a 
synthetic androgen. Fluorescence: K14 (green); K8 (red); Hoechst (blue). Original 
Magnification x40 (fluorescent microscope -  objective lense).
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Figure 6.15: Keratin 5 And Keratin 18 RNA Expression In 3-D Cultures
K5mRNA 
(350bp)
K18 mRNA
(544bp)
Pre2.8 and S2.13 cells were set up in matrigel cultures together and alone. Reverse transcribed 
cDNA was amplified using K5 primers (A) and K18 primers (B). The expected PCR product for 
K5 is 350bp and for K18 is 544bp.
161
Neg C o n tr o l
k
Neg Control Mibolerone - M ibolerone +
Paraffin sections of day 24, S2.13/Pre2.8 matrigel cultures at 33°C and 37°C. Cultures were set up in the presence and absence mibolerone. Normal 
prostate tissue (NPro2) sections were used as positive controls. Spheroid sections were used as negative controls (i.e. no primary antibody). DAB 
staining: AR (brown); Hoechst (blue). Original Magnification is x40 (objective lense).
NPro2
Mibolerone - Mibolerone +
37°C
33°C
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Neg Control M ibolerone M ibolerone +
NPro2
Neg Control M ibolerone - M ibolerone +
Paraffin sections of day 24, S2.13/Pre2.8 matrigel cultures at 33°C and 37°C. Cultures were set up in the presence and absence mibolerone. Normal 
prostate tissue (NPro2) sections were used as positive controls. Spheroid sections were used as negative controls (i.e. no primary antibody). DAB 
staining: PSA (brown); Hoechst (blue). Original Magnification is x40 (objective lense).
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37°C
Mibolerone - Mibolerone +
NPro2
Neg Control Mibolerone - M ibolerone +
Paraffin sections of day 24, S2.13/Pre2.8 matrigel cultures at 33°C and 37°C. Cultures were set up in the presence and absence mibolerone. Normal 
prostate tissue (NPro2) sections were used as positive controls. Spheroid sections were used as negative controls (i.e. no primary antibody). DAB 
staining: PAP (brown); Hoechst (blue). Original Magnification is x40 (objective lense).
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Figure 6.19: AR And PSA RNA Expression In 3-D Cultures
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Pre2.8 and S2.13 cells were set up in matrigel cultures together and alone. Reverse transcribed 
cDNA was amplified using; A) ARAs and ARDa primers, located on exon 1 and exon 4 of AR, 
respectively and B) PSA. The expected PCR product for AR is 524bp and for PSA is 362bp. C) 
Equal loading and integrity of the RNA was confirmed by amplification of (3-actin mRNA.
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Figure 6.20: Proliferation In 3-D  C ultures
S2.13/Pre2.8 3T3/Pre2.8
S2.13 only Pre2.8 only
NPro2
Paraffin sections of day 24 matrigel cultures (in PrEGM and DMEM/FCS medium) at 37°C 
with varying cell types, S2.13/Pre2.8, 3T3/Pre2.8, S2.13 only and Pre2.8 only cells. Normal 
prostate tissue (NPro2) sections were used as positive controls. Fluorescence: Ki-67 is green and 
Hoechst is blue. Original Magnification is x40 (fluorescent microscope -  objective lense).
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6.7 SUMMARY
In order to develop an in vitro prostate model using normal prostate cell lines, the 
capacity of Pre2.8 and S2.13 cell lines to form 3-dimensional (3-D) structures in vitro 
was investigated. The model was based on matrigel cultures using primary prostate cells 
that produced prostate morphology and differentiation (Hudson et a l, 2000b). Initial 
investigations determined the optimum culture medium for use with both cell lines in 
matrigel cultures. Conditions were optimised to achieve organoid (spheroid) 
development most likely to produce morphology and differentiation. During 
optimisation the role of stroma in matrigel cultures for achieving prostate like 
characteristics were investigated. The morphology and cell differentiation status of 
prostate (Pre2.8 and S2.13 BPH cell lines) matrigel (3-D) cultures were investigated 
using immunofluorescence staining for cytokeratins, immunocytochemistry staining for 
stromal cell markers and prostate-specific differentiation was studied at both protein and 
mRNA levels. The influence of androgen (mibolerone, a synthetic androgen) on the 
development of 3-D structures by Pre2.8 cells was also studied.
3-D structures developed from Pre2.8 cells in Matrigel in equal volumes of PrEGM and 
DMEM/FCS. The addition of 4% serum resulted in the development of larger 
organoids. 3-D cultures set-up with Pre2.8 cells grown in PrEGM alone or with 
conditioned medium developed lattice-like structures. Although larger structures were 
observed with Pre2.8/S2.13 co-cultures in PrEGM, the cells did not appear to be 
organised into basal and luminal layers.
Increasing S2.13 cell concentration was not advantageous because the Matrigel 
contracted and no 3-D structures developed. An alternative cell line, 3T3 mouse 
fibroblasts, did not improve the ability of Pre2.8 cells to grow in Matrigel. In 
conclusion, there is no evidence that either the conditioned medium or the addition of 
the S2.13 stromal cells had a significant influence on the morphology or differentiation 
of the Pre2.8 cells in 3-D culture.
The structures formed by Pre2.8 cells in Matrigel showed a limited degree of 
differentiation. They have the potential to form a basal (K14+ K17*) layer surrounding 
an intermediate or early luminal epithelial layer (K14' K17+ K19' K8*). K14* K17+ and 
K8+ cells also tend to be scattered in a disorganised fashion throughout the Matrigel.
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RT-PCR shows K5 (early basal cell marker) expression but no K18 (late luminal 
marker), showing limited differentiation occuring.
Although there was some multilayering, little differentiation towards a luminal 
phenotype was observed. However, positive staining for AR and PSA was observed in 
the nuclei and cytoplasm. AR is expressed in all cells, from 3-D cultures by 
immunocytochemistry while RNA expression of AR is found in Pre2.8/S2.13 co-culture 
and S2.13 only Matrigel cultures, but not in Pre2.8 only Matrigel cultures. PSA was 
found in the nucleus as well as in the cytoplasm, of 3-D cultures by 
immunocytochemistry. RT-PCR showed that this PSA expression may be non-specific 
because a different size band was amplified for 3-D cultures compared to PSA 
expression in LNCaP positive control, showing that correct primers were used. The 
particular PSA primer oligonucleotide used for this PCR appears to be annealing to a 
larger sequence (not expected) that does not have complete homology to the primer 
sequence (non-specific). AR is expressed in stromal but not epithelial cells in this 3-D 
model. There is clearly no PSAP expression.
The presence of mibolerone in 3-D cultures appears to inhibit lattice formation and 
increase organoid formation (figure 6.6), although no difference was observed for cell 
differentiation or prostate specific characteristics.
In conclusion, a 3-dimensional in vitro model using BPH stromal and epithelial cells 
from the same patient has been investigated. There are limitations to this model and 
further optimisation of culture conditions is required. An alternative model such as a 
collagen sponge may support a greater degree of differentiation.
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CHAPTER 7 
DISCUSSION
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7.1 DISCUSSION
The aim of this project was to establish conditionally immortalised epithelial and 
stromal cell lines from human prostate tissue that could be used to study prostate 
differentiation in vitro and in vivo. This study describes the establishment and 
characterisation of the epithelial cell line Pre2.8 and the stromal cell line S2.13 in 
monolayer culture. In order to study prostate stromal and epithelial cell interactions
52.13 and Pre2.8 cells were developed into a 3-dimensional model.
7.1.1 Derivation and Authentication and Purity
Two temperature sensitive cell lines, Pre2.8 epithelial and S2.13 stromal cells have been 
established from BPH tissue, from the same patient. The authenticity of these cell lines 
was confirmed by showing that the cell lines had the same DNA profile as tissue from 
the patient from whom the sample was obtained. This finding rules out the possibility of 
cross-contamination with other cells (Masters et al., 2001). Mycoplasma contamination 
was ruled out using PCR analysis (Hopert et al., 1993a; Hopert et al., 1993b). Both cell 
lines were grown for more than 200 population doublings, indicating that they are 
immortal. The presence of SV40 large T-antigen was confirmed using 
immunocytochemistry.
Pre2.8 cells were routinely grown in a commercially available serum-free prostate 
epithelial medium, PrEGM. It has previously been determined that this culture medium 
supports the growth of prostate epithelial cells (Fry et al., 2000c). Primary cultures from 
10 patients became vacuolated and did not survive past 3 weeks in WAJC 404 
(McKeehan et al., 1984). Cells from primary cultures of 6 patients grown in mammary 
epithelial growth medium (MEGM, Bio Whittaker UK Ltd) or a combination of MEGM 
with WAJC 404 or its supplements became squamous after 4-6 weeks and began to 
detach from the flask. In contrast, cells from 12 patients grown in PrEGM became 
neither vacuolated nor squamous. Pre2.8 cells grow routinely in PrEGM medium and 
can be passaged following trypsinisation as long as the cells are centrifuged and washed 
to remove the trypsin.
52.13 cells were routinely grown in DMEM (Life Technologies) supplemented with 
10% foetal calf serum (FCS). Stromal cells tend not to grow in the absence of serum 
(Peehl and Stamey, 1986b; Peehl et al., 1988a). Smooth muscle cell (SMC) 
differentiation can be induced by basic fibroblast growth factor (bFGF) and bovine
170
pituitary extract (BPE) (Kassen et al., 1996a). Primary smooth muscle cultures 
gradually lose SMC-specific proteins after 10 passages and develop a myofibroblast 
phenotype (Zhang et al., 1997). It was thought that horse serum suppresses proliferation 
of fibroblasts and myofibroblasts. Therefore Zhang et al developed a SMC growth 
medium, containing horse serum instead of FCS, insulin, dexamethasone and 
conditioned medium from CRL-5813 and LNCaP tumor cells. Prostatic tumor cells 
secrete growth factors that stimulate SMC proliferation (Carney et al., 1985; Kooistra et 
al., 1995b).
The morphologies of both cell lines change when the cells are transferred from 33°C to 
39°C, indicating that these cell lines are temperature sensitive. In monolayer cultures at 
33°C and 37°C, Pre2.8 epithelial cells are slow growing and have a typical cobblestone 
appearance, while S2.13 cells are fast growing and have a slightly elongated 
appearance. Fibroblasts tend to be more obviously elongated in appearance. At 39°C, 
Pre2.8 cells lose their tightly compact appearance and appear to increase in size. S2.13 
cells become more loosely associated and more elongated in appearance at 37°C and 
39°C.
Confirmation of the change in cell size of Pre2.8 cells following transfer from 33°C to 
39°C was carried out initially using a Coulter Counter, showing a change in cell size 
from 13.25pm at 33°C to 16.25pm at 37°C and 16.57pm at 39°C. The similarity in cell 
size found at 37°C and 39°C did not agree with the observations made under the 
inverted microscope where some cells at 39°C appeared to be larger than at 37°C. Cell 
size was repeated with adherent cells. The mean size was 40pm at 33°C, 43pm at 37°C 
and 52pm at 39°C. These findings suggest that the cells become more flattened as the 
temperature is raised. S2.13 cells were much larger than Pre2.8 cells. A shift in cell size 
was also seen in these cells, from 55pm to 64pm and 88pm when transferred from 33°C 
to 37°C and 39°C respectively.
The effect of temperature on the proliferation of Pre2.8 cells was measured to ensure 
that the immortalisation remained conditional. Pre2.8 cells grow exponentially at 33°C 
for 17 days, while at 37°C cell growth plateaus much earlier, by day 12. No exponential 
growth was achieved at 39°C. One important observation is the long lag phase, 2-3 days
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before Pre2.8 cells start to divide exponentially. S2.13 cells show a similar pattern. The 
proliferation rates of these temperature sensitive cell lines are clearly affected when the 
conformation of the SV40 LTAg is changed at 39°C and 37°C. The growth of 
conditionally immortalised cell lines was also compared to the growth of cell lines 
immortalised with wild type HPV. Pre2.8 cells grow faster than the HPV-immortalised 
1542- NPTX cells at 33°C, while 1542-NPTX cells grew better at 39°C. Similarly,
52.13 cells did not grow at 39°C, while HPV immortalised 1542-NPFT cells grew well 
at this temperature.
Colony forming efficiencies provide an indication of stem and transit-amplifying cell 
fractions within a population (Hudson et al., 2000b). This method also tends to be the 
preferred method for analysing differences in cell proliferation (colony size) and 
survival (colony number) within a population. No colonies developed from Pre2.8 cells 
at 39°C, or when less than 5000 cells were plated at 33°C. Pre2.8 cells grow as a tightly 
compact monolayer and do not grow well when isolated. The long lag phase may inhibit 
the survival capacity of these cells under these conditions. Alternatively, these cells may 
produce autocrine growth factors and need a minimum cell density in order to 
proliferate.
7.1.2 Cytogenetic Analysis
The karyotype of Pre2.8 and S2.13 cells was analysed by Dr Rod McLeod (DSMZ, 
Braunschweig, Germany). Using a combination of multicolour fluorescence in situ 
hybridisation and single locus analysis using bacterial artificial chromosome clones, 
chromosome rearrangements were studied. Strikingly, both cell lines show 
amplification of chromosome 20q. In S2.13, chromosome 20 was highly involved in the 
more complex chromosomal changes and showed the most intense signals.
Pre2.8 cells have a near diploid karyotype with loss of chromosome Y and formation of 
an isochromosome i(8q), where redistribution of material covered 4q. The long arm of 
chromosome 20 is inserted into the short arm (pl2) of one chromosome 14 and partial 
duplication of one chromosome 20-homolog.
52.13 cells have a hypertetraploid karyotype, with many numerical and minor structural 
changes. Markers of three homogeneous staining regions (HSR) were derived from 
chromosome 4,19 and 20.
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Although cell lines are prone to genetic instability it is known that many genetic events 
are likely to be involved in prostate tumorigenesis. It is difficult to distinguish between 
chromosomal abnormalities occurring due to immortalisation and genetic abnormalities 
that were present in the primary tissue. Up-regulation of chromosome 20 has been 
associated with immortalisation and the ability of cells to escape senescence (Cuthill, 
1999) (Jarrard and Waldman, 1999).
Some of these findings, particularly alterations of chromosome 20q and the formation of 
an isochromosome in chromosome 8, i(8) have been observed by other research groups. 
Gain of chromosome 20 has been associated with many cancer types including prostate, 
bladder, melanoma, colon, pancreas and breast (Brothman et al., 1990; Richter et al., 
1998; Bastian et al., 1998; Korn et al., 1999; Mahlamaki et al., 1997). More specifically 
amplification of chromosome 20ql3 was observed in breast cancer (Tanner et al., 1994) 
and in other tumor types (Ohyashiki et al., 1992; Mohapatra et al., 1995; Schlegel et al., 
1995; Bockmuh et al., 1997). A novel androgen-induced gene, PMEPA1 that encodes a 
polypeptide with a type lb transmembrane domain was cloned and characterised (Xu et 
al., 2000). Database searches showed sequence homology of this gene to genomic 
clones, RPS-1059C7 and 718J7, which were mapped to chromosome 20 ql3.2- ql3.33. 
Using comparative genomic hybridisation, chromosome alterations were found to be 
possibly associated with clinically defined CaP stage (Wolter et al., 2002). This group 
found losses at chromosome 13 (q21.1-21.3), 8p21.2, 6q and 16q, and gains at 
chromosome 17q, 20 (ql3.2-13.3) and 9q.
Prostate cancer can be sporadic, familial or hereditary. Sporadic cancers are most 
widely studied. In a study comparing androgen-sensitive prostate (AS) cancers with 
androgen-insensitive prostate (Al) cancers, early stage CaP was associated with loss of 
8p. Progression of metastatic Al CaP is associated with loss of chromosomes 2q, 5q, 
lOq, llq , 13q, 16q, 17q, 20q (Cher et al., 1994). A study of differential gene expression 
between cell lines, LNCaP (AS) and LNCaP-r (Al) found 3 genes associated with 
development of Al CaP. An upregulation of the fibronectin (FN) gene, mapped to 2q 
was found while downregulation of the breast basic conserved gene-1 (BBC1), mapped 
to 16q and ubiquitin enzyme variant-1 (UEV-1), mapped to 20q was observed.
A hereditary CaP study was carried out to look for the existence of familial clustering 
and increased hereditary risk (Berry et al., 2000). They carried out a genome wide
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search on 162 North American families and found linkage to chromosome 20ql3, which 
they designated as HPC20. Various confirmation studies were unsuccessful in finding 
confirmation of linkage to these CaP susceptibility loci. No linkage was found for 
HPC1, CAPB and HPCX in a study of 64 South West European families, although 
linkage was associated to the PCAP locus (Cussenot and Valeri, 2001) which was 
originally identified from a study of French and German families. Epidemiology may be 
an important factor in linkage studies of familial and hereditary CaP. A confirmation 
study of 20ql3 was carried out using 172 families affected by CaP, who were 
participating in the University of Michigan Prostate Cancer Genetics Project (PCGP) 
(Bock et al., 2001). No significant evidence for CaP susceptibility for linkage to 20ql3 
was found, with the exception of black families. Differences between family size, age of 
CaP diagnosis and ethnic composition could be factors allowing for the lack of 20ql3 
linkage.
Cytogenetic and array comparative genomic hybridisation and expression analysis was 
carried out on prostate cancer xenograft (WISH-PC14), derived from a locally advanced 
tumor (Bar-Shira et al., 2002). Abnormalities were predominantly found on 
chromosome 8,20 and X and overexpressed genes were located to chromosome 20ql3.
An association of loss of chromosome 8p and gain of chromosome 8q sequences, 
suggests the formation of isochromosomes, i(8q) in advanced prostate tumors (Macoska 
et al., 2000). This group found trisomy for chromosome 20 and rearrangements 
involving chromosomes 3, 4, 8, 9, 10, 16, 17, 18, 19, 21, and 22. They concentrated 
their studies on numerical and structural alterations of chromosome 8 in two normal 
prostate epithelium cell lines and three human prostate tumor cell lines. They found loss 
of 8p in prostate tumor cell lines and two tumor cell lines demonstrated an i(8q) 
chromosome, as well as rearrangement of chromosome 8 material with either 
chromosome 20 or 21 for one of the tumor cell lines. Gain of chromosome 8q from 
ql 1.2 to q24, although not in the form of an i(8q) was found in one of the normal 
epithelial cell lines. These authors have shown evidence to support the theory that 
chromosomal loss of 8p in primary human prostate tumors may not result from simple 
deletion of all or part of the short arm, but involves 8p loss. This may result from 
complex structural rearrangements of chromosome 8, which sometimes results in gain 
of 8q material and this may occur during tumorigenesis.
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These studies indicate that chromosomes 20 and 8 alterations may be associated with 
CaP. The presence of CaP chromosomal alterations, associated with our BPH cell lines, 
Pre2.8 and S2.13 is unexpected since, BPH is not believed to be a pre-cancerous 
condition. One explanation is that these genetic changes enable prostate cells to extend 
their lifespan and have been selected during the immortalisation of the cell lines. Pre2.8 
and S2.13 cells do not form colonies in semi-solid agar cultures. It may be useful to 
repeat this analysis at a later passage level in order to show cell stability and to 
determine if passaging produces further chromosomal alterations and to see if 
chromosome 20 and 8 alterations are consistant with with passaging.
7.1.3 Differentiation
The aim of this project was to establish a prostate epithelial and stromal cell model for 
the study of prostate differentiation in vitro. Most continuous cell lines appear to be 
relatively undifferentiated cells with the capacity to proliferate, but tend not to 
differentiate in vitro. We attempted to overcome this limitation by using a temperature 
sensitive switch for SV40 T-antigen that drives cell proliferation (Jat and Sharp, 1989; 
Stamps et al., 1994). Immortalised temperature sensitive cells are expected to proliferate 
at permissive temperatures (33°C), while at non-permissive temperatures (39°C) 
proliferation should be switched off and cell differentiation is anticipated.
We observed a substantial proliferating population for Pre2.8 cells at 33°C (93% 
proliferating cells), which substantially decreased when cells were transferred to 37°C 
(26% proliferating cells) and 39°C (15% proliferating cells), another indication that the 
temperature sensitive switch was working correctly. It would be interesting to determine 
if this substantial proliferating population was also observed in the original tissue. It 
would also be interesting to obtain S2.13 proliferation data for comparison.
To my knowledge there are no other immortalised temperature sensitive prostate cell 
lines and there is a limited number of immortalised temperature sensitive cell lines 
established from other human tissues. Most temperature sensitive cell lines have been 
produced from mouse and rat tissues. Human mammary epithelial cells were 
immortalised using the temperature sensitive SV40 T-antigen and used to investigate 
the role of the T-antigen gene and its site of integration in human epithelial cell 
immortalisation (Stamps et al., 1994). Immortalisation of freshly isolated normal adult 
human mammary fibroblasts and endothelial cells was unsuccessful using functional
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telomerase (hTERT) alone or by using the temperature sensitive (ts) mutant (U19tsA58) 
of the SV40 LT antigen alone. A combination of hTERT and tsLT-ag generated 
conditionally immortalised human cells in a reproducible manner (O'Hare et al., 2001). 
An early optic-nerve progenitor cell model, tsU19-9 was established from postnatal day 
2 rats using the ts SV40 LT-antigen. At 33°C these nestin (neuronal precursor marker) 
expressing cells had a flat epithelial morphology. These cells underwent morphological 
and antigenic differentiation to cells characteristic of the oligodendrocyte lineage at 
39°C (Cohen et al., 1999). Three temperature sensitive human “ovarian surface” cell 
lines have been established (Leung et al., 2001). This is the area where epithelial 
ovarian carcinomas develop. At 34°C most cells expressing the epithelial keratin 
markers varied between cell lines from 20-97%. Collagen type 3, a mesenchymal 
marker was present in 24-43% of cells. When cell lines were switched to 39°C, 
proliferation was inactivated and keratin expression was increased to 85-100% in all cell 
lines, while collagen type 3 expression increased significantly in 2 cell lines.
One hundred neural stem and progenitor cell lines were immortalised, using ts SV40 
large T-antigen (A58/U19) from primary hippocampal and cerebellar progenitor cells 
from embryonic day (E) 16.5 to 17.5 C57BL/10SnJ murine fetuses. From these cell 
lines a clonal neural stem cell line (MK31) gave rise to 3 of the major CNS cellular 
elements (neurons, astrocytes and oligodendrocytes). At 33°C single neural stem cells 
exhibited self-renewal, clonal expansion and both symmetric and asymmetric modes of 
cell division. When these cells were switched to 39°C they stopped proliferation and 
successfully differentiated into neuronal, oligodendroglial and astroglial cell lineages, 
under the influence of specific sets of cytokines (Gokhan et al., 1998). As part of a 
study on signal transduction pathways leading to neuronal differentiation a hippocampal 
stem cell line, HiB5 was established from the CNS of the rat, E16 hippocampus using 
the ts SV40 LT-antigen gene (Renfranz et a l, 1991). HiB5 cells have stem cell markers 
such as nestin and intermediate filament and differentiate into neuronal cells in vivo 
when implanted into rat brain. They proliferate in response to serum or retinoic acid at 
33°C and differentiate into a non-proliferating, neuronal phenotype in response to 
PDGF (platelet-derived growth factor) at 39°C (Chung et al., 2000; Kwon, 1979).
Masuo Obinata has described a different approach to the establishment of temperature 
sensitive cell lines (Yanai N and Obinata M, 2001). He hopes that someday all distinct 
cell types in the body, of which there are 200 known so far, could be separated from
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each other to produce a cell bank. He suggests that all cell types could be readily 
available for analysis in order to answer fundamental questions about the development 
of different cell types into tissues or organs. A database containing this information 
could then be established. It would first be necessary to immortalise these cells. In order 
to overcome the loss of original cell differentiation function they used the tsSV40 LT- 
antigen, but not directly into each cell type. Instead they produced transgenic mice 
harbouring the tsSV40 LT-antigen gene derived from tsA58 virus. BamHl DNA 
fragment of whole tsSV40 LT-antigen DNA, along with the major histocompatibility 
complex H-2Kb promoter was injected into fertilised eggs of C57BL/6 mice (Yanai et 
al., 1991). These transgenic mice were called H2T-transgenic mice. Various tissue cell 
lines have been established from these H2T-transgenic mice and also from ts transgenic 
rats (Yanai N and Obinata M, 2001). Most of these cell lines grow at 33°C but cell 
proliferation is arrested at 39°C, allowing the differentiation functions of these cell lines 
to be successfully maintained. Some examples of established H2T-transgenic cell lines 
from different organs of H2T mice are hepatocye cells (Yanai et al., 1991), renal cells 
(Hosoyamada et al., 1996), colonic epithelial (Tabuchi et al., 2000), tracheal epithelial 
cells (Sugiyama et al., 1998) and bone marrow stromal cells (Kameoka et al., 1995).
Cell lines have been invaluable as experimental tools for the study of neural and sensory 
function, particularly in inner ear research. In order to push forward and increase the 
value of such cell lines, the tsSV40 LT-antigen was used to create temperature sensitive 
cell lines from different tissues and developmental stages of the inner ear. Sensory cells 
of the inner ear were immortalised using the H2Kbts58 transgenic mouse 
(Immortomouse)(Holley and Lawlor, 1997). Using this Immortomouse, different cell 
lines representing different developmental stages can be more readily compared because 
the immortalising gene is incorporated and expressed in exactly the same way. Alarid et 
al. targeted the T-antigen gene with promoters that were activated at different stages of 
development to c reate committed and uncommitted pituitary cell lines. Most of these 
cell lines have retained their original phenotype (Alarid et al., 1996). These 
conditionally immortal cell lines differentiate in an ordered manner in terms of gene 
expression. This provides the potential to study the different effects of various 
signalling molecules.
Temperature sensitive transgenic mice have been successfully used to establish cell 
lines that maintain their original phenotype and differentiation can easily be switched
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on. This approach may not be beneficial for human prostate research since the mouse 
prostate is very different from the adult human prostate.
BPH is predominantly a stromal disease (McNeal, 1978) (Rohr and Bartsch, 1980). 
There are three types of stromal cells in prostate tissue, fibroblasts (vimentin, fibroblast- 
AS02), myofibroblasts (vimentin, SMA) and smooth muscle cells (vimentin, SMA, 
SM-myosin). S2.13 cells are fibroblast cells, expressing vimentin and fibroblast 
antibody only.
Epithelial cells are responsible for the protective and secretory function of many organs. 
The function of the prostate is not clear, but it is involved in secretion of PSA and 
PSAP. Epithelial cells are good models for differentiation and studying stem cells. Stem 
cells are thought to be located in the basal layer in the adult prostate (Bonkhoff and 
Remberger, 1996; Robinson et al., 1998b). Prostate epithelium is the site of malignancy. 
Cytokeratin antibodies have been widely used to determine epithelial cell phenotype 
and differentiation status. There are two main cell types in prostate epithelium tissue, 
the basal (K5, K14, K17) and luminal (K8, K18) cells. Pre2.8 cells have stronger K8 
and K18 staining at 37°C and 39°C, indicating a more differentiated phenotype at the 
higher temperatures.
Although there is no definitive evidence for the existence of an intermediate epithelial 
cell it is now generally accepted. Co-expression of basal and luminal markers in an 
intermediate phenotype was identified with some cells expressing K14, K5, p63, K17, 
K19, K8, K18 and GSTpi (Bonkhoff et al., 1994; Bonkhoff and Remberger, 1996; 
Hudson et al., 2000a; Xue et al., 1998). Keratin 19 expression frequently occurred in 
basal and in luminal cells of normal, malignant and BPH (Hudson et al., 2001a; Peehl et 
al., 1996). Hudson et al (2001) suggests that K19 expressing cells represents a 
population of basal cells in the process of differentiation into luminal cells. They 
proposed a hypothetical differentiation pathway for human prostate epithelial cells 
based on patterns of keratin staining. Basal stem cells (K5 and K14 only) give rise to an 
intermediate transit amplifying population, expressing K19. These cells differentiate 
into luminal cells with transient co-expression of K19, K8 and K18 before complete 
differentiation into cells expressing K8 and K18 only. K19 is switched on in Pre2.8, at 
low levels at 37°C and 39°C, suggesting the presence of an intermediate transit 
amplifying population.
178
Evidence contradicting the proposal that K19 is an intermediate epithelial marker and 
that basal cells are the site for stem cells was found by another group (Wang et al., 
2001). They studied the urogenital sinus epithelium, the progenitor of the prostate 
epithelium precursor, to look for expression of epithelial subtypes. They used 
cytokeratin markers and other differentiation markers (p63 and GSTpi) and compared 
its differentiation profile with developing and adult prostate. They suggested that the 
embryonic urogenital sinus epithelium should be rich in prostatic stem cells, i.e. contain 
a differentiation marker profile similar to that of prostatic stem cells. Wang et al found a 
cell population in the foetal urogenital sinus epithelium that only contained the full 
marker compliment (K14, K5, p63, K19, K8, K18 and GSTpi). They also found a 
population of cells in the adult prostate with this marker profile. They suggested that the 
small population of basal/luminal expressing cells are prostate stem cells since they are 
also found in urogenital sinus epithelium. Otherwise any other proposed stem cell 
population should be expressed in urogenital sinus epithelium. Their hypothetical cell 
differentiation model suggests that cells co-expressing K14, K5, p63, K19, K8, K18 and 
GSTpi give rise to definitive basal cells (K14, K5, p63, K19 and GSTpi positive only) 
and luminal cells (K8, K18 positive only). On the basis of this theory, Pre2.8 cells may 
contain stem cells since they express a small population of K14, K17, K19, K8 and K18 
positive cells at 37°C and 39°C. This is unlikely otherwise K19 would also be expressed 
at 33°C. Further investigations need to be carried out in order to clarify the various 
hypothesis for prostate epithelial, cell differentiation. Pre2.8 cells are potentially a good 
prostate model for this work and for studying proliferation and differentiation.
7.1.4 Androgen Expression
The prostate is an androgen-dependent organ. Testes are the main source of androgen. 
They synthesise and secrete testosterone into the blood. Testosterone is not the primary 
androgen responsible for maintenance of the prostate. It is converted to 
dihydrotestosterone (DHT) by 5a-reductase (5a-R) enzymes (Bartsch et al., 2000). 
DHT binds with greater affinity than testosterone to the androgen receptor (AR) and this 
complex is transported to the nucleus. AR is activated and causes upregulation of 
androgen-sensitive genes to regulate prostate cell growth, differentiation and secretion 
of various proteins such as PSA and PAP. The androgen receptor remains in the 
cytoplasm until ligand binding occurs and the dissociation of Heat Shock Proteins
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(KSPs) is thought to allow conformational change in the AR and mediate translocation 
to the nucleus (Gnanapragasam et al., 2000).
There are two 5a-R isoenzymes, type 1 and type 2 and possess approximately 50% 
sequence homology between them. Type 1 5a-R enzyme is predominantly found in 
tissues other than the prostate, particularly the skin and liver, while Type 2 is mainly 
associated with the prostate and both forms are found in serum (Steers, 2001). 5a-R was 
identified in stromal and epithelial cells in CaP and BPH. Using polyclonal antibodies 
against 5a-R type 1 and type 2 Bonkhoff et al. showd that 5a-Rl was predominantly 
expressed in nuclei of secretory luminal cells and 5a-R2 was predominantly expressed 
in cytoplasm of basal cells. In general 5a-Rl was more abundant than 5a-R2 in stromal 
and epithelial cells (Bonkhoff and Remberger, 1996; Habib FK et al., 1998).
Mutations in 5a-R2 suggest that this enzyme plays a central role in normal prostate 
development (Andersson et al., 1991). A non-functional 5a-R2 or AR can cause 
Pseudohermaphroditism, a condition in men who have small prostates and do not 
develop BPH. This knowledge led to the production of 5a-R targeting drugs such as 
Finasteride. Finasteride inhibits 5a-R2 (by 80%-90%) but not 5a-Rl, leading to a 
reduction in prostate volume (Steers, 2001).
Pre2.8 epithelial and S2.13 stromal cells have lost their androgen receptor expression in 
monolayer cultures. Both cell lines are negative for 5a-R2, AR, PSA and PAP, and are 
positive for 5a-Rl. A reduction of the enzyme 5a-R2 in stromal and basal cells will 
prevent conversion of testosterone to DHT and hence AR will not be activated to 
produce PSA and PAP. Pre2.8 do not fully differentiate into luminal cells at 37°C or 
39°C, hence secretion of PSA and PAP would not be expected. Using RT-PCR, Habib 
et al showed that primary cultures expressed both isoforms of 5a-R. Expression of 
mRNA persisted for 6 passages of primary BPH fibroblast cells, after which expression 
stopped (Habib FK et al., 1998). It appears that temperature sensitive SV40 LT-antigen 
immortalisation is not sufficient for these BPH cell lines to maintain all of their original 
characteristics. The loss of androgen expression and secretory function is likely to be 
due to monolayer culture conditions or due to the absence of appropriate inductive 
stromal signals. It would therefore be interesting to examine androgen expression in 
cultures where Pre2.8 epithelial cells are combined with S2.13 stromal cells. Expression
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of PSA and PAP proteins is dependent on the correct cell morphology and architectural 
organisation being present (Hayward et al., 1992). Matrigel cultures may assist in 
maintaining the correct architectural organisation.
There are a few immortalised epithelial cell lines and two stromal cell lines that have 
partially maintained normal prostate function. In general these epithelial cell lines are 
fully differentiated luminal cells, unlike Pre2.8 cells which are basal epithelial cells at 
33°C. NP-2s stromal and NP-2e epithelial cell lines express 5a-R enzymes (Lechner et 
al., 1978). NP-2e cell line was further transformed to produce 267B1,272E1 and 272E4 
epithelial cells, which showed weak immunostaining for PSA and PAP. These three cell 
lines were luminal cells (K8+ and K18*) with a mixture of stromal cells (vimentin+ and 
acting. The PNT1 luminal epithelial cells line (K8+, K18+ and K14') were weakly 
positive for PSA and PAP (Cussenot et al., 1991). BPH-1 luminal cells (K8+, K18+, 
K19+ and K14‘) showed faint AR and PAP immunostaining but could not be confirmed 
by RT-PCR or Northern blotting (Hayward et al., 1995). PSA was negative by 
immunostaining. Although Hayward et al suggested 5a-R activity in BPH-1 cells, they 
have no evidence. They based their result on the presence of DHT, which implies the 
presence of 5a-R activity. The supernatant of this cell line contained testosterone. 
RWPE-1 epithelial cells showed AR and PSA expression in response to mibolerone 
(Webber et al., 1996). RWPE-1 expressed cytokeratins K8, K18, K5 and K14, although 
K5 and K14 data was not shown. Therefore it is not conclusive whether these cells are 
fully differentiated or intermediate epithelial cells. BRF-55T luminal epithelial cells 
(K8+ and K18*) express AR and PSA, although these cells may be pre malignant cells 
(Iype et al., 1998).
S2.13 cells are fibroblasts unlike Duk50 (Roberson et al., 1995), a smooth muscle cell 
line and WPMY-1 (Webber et al., 1999), a myofibroblast cell line, both of which 
express AR. Smooth muscle cells make up most of the stromal tissue and contain a high 
proportion of androgen receptors in vivo (Planz et al., 1998). This may account for these 
two cell lines expressing AR and not S2.13 cells.
7.1.5 3-Dimensional Cultures
Stromal-epithelial cell interactions (Timms et al., 1995; Bayne et al., 1998; Liu et al., 
1997) and production of basement (Smola et al., 1998) are the principal processes 
involved in development of normal prostate function and differentiation. In order to
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translate these processes into an in vitro model while overcoming the limitations for 
using primary cells and immortalised monolayer cell cultures, we set up 3-dimensional 
cultures combining Pre2.8 epithelial and S2.13 stromal cells in matrigel Laminin plays 
a major role in extra cellular matrix (ECM) (basement membrane) interactions (Malinda 
and Kleinman, 1996). Laminin makes up 60% of matrigel, which also consists of 
collagen 5, other matrix proteins and several growth factors and proteases. Prostate 
epithelia in matrigel cultures have been shown to form acini capable of secreting 
prostate specific (Webber et al., 1997).
Temperature sensitive Pre2.8 epithelial and S2.13 stromal cells grew fastest in medium 
containing 10% serum. Pre2.8 cells in monolayer cultures changed their morphology 
when grown in RPMI containing 10% serum compared to growth in PrEGM medium. 
This could suggest that serum contains growth factors, in addition to those present in 
PrEGM that may be important in prostate epithelial cell proliferation and differentiation.
Three main types of cell clustering developed, lattice formation at 33°C, large inter 
connecting organoids at 37°C and small organoids at 39°C. The large inter connecting 
structures most resemble spheroids obtained by Hudson et al from primary type 2 
epithelial colonies in matrigel cultures, containing 3T3 conditioned medium (Hudson et 
al., 2000a). We did not observe side branching in these organoids. Pre2.8 epithelial cells 
grown in matrigel with S2.13 conditioned medium produced a lattice, showing no 
resemblance to structures produced by type 2 epithelial colonies. Immortalised 
epithelial cells in comparison to primary cells appear to have lost a key factor in 
epithelial cell morphology. Pre2.8, S2.13 matrigel cultures, in PrEGM medium only, 
produce very small organoids compared to large interconnecting organoids in 
PrEGM/DMEM-FCS. These results confirm the presence of important growth factors in 
serum. The presence of mibolerone tended to reduce organoid development to very 
small structures, with sparse large interconnecting organoids.
Paraffin sections of organoids showed great organisational variation. In general 
organoids grown at 39°C did not grow large enough to develop acinus structures with 
distinct basal, luminal or stromal layers. Organoids at 33°C and particularly at 37°C 
showed greatest potential for prostate like architecture. Early experiments were set up 
with complete growth factor matrigel, while later experiments were set up with growth 
factor reduced matrigel. In general earlier experiments produced organised structures
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containing acini surrounded by layers of intermediate epithelia (K14‘ K17*), which was 
surrounded by basal cells (K14+ K17+) that was surrounded by non-epithelial cells, 
likely to be stromal cells. This organisation appeared to be similar to organised 
structures observed with type 2 epithelial colonies (Hudson et al., 2000a). Experiments 
using reduced GF matrigel produced mostly unorganised structures without acini. 
Unorganised structures expressed both cytokeratins 14 and 17, but K17 was scattered 
without any organisation. Cytokeratin 8 staining had high background therefore was 
difficult to determine its location, although in organised spheroids layers of K8+ 
appeared to be surrounded by a layer of K8' cells, likely to be basal cells. Cytokeratin 
18 was negative by RT-PCR. Growth factors removed from reduced GF matrigel may 
be critical for correct prostate morphology and differentiation. Hudson et al used 
complete growth factor matrigel. Stromal cell markers (vimentin +, SMA*) were only 
tested in organoids from GF reduced matrigel. Fibroblasts were distributed without any 
organisation.
Although limited differentiation occurred in Pre2.8/S2.13 matrigel cultures, they do 
appear to differentiate (K14’ K174) further than in monolayer cultures. In addition, 
matrigel cultures permit AR expression, confirmed by immunocytochemistry and RT- 
PCR analysis. AR staining was found in the cytoplasm and the nucleus. Androgen 
receptor remains in the cytoplasm until ligand binding occurs and the dissociation of 
heat shock proteins (HSPs) is thought to allow conformational change in the AR and 
mediate translocation to the nucleus (Gnanapragasam et al., 2000). Previously, AR 
expression in primary cultures was observed in the cytoplasm and nuclei (Cussenot et 
al., 1994b; Robinson et al., 1998a). Cussenot et al suggested that AR expression in the 
cytoplasm and nuclei is due to partial blockage of this receptor in a non-bound state. 
Robinson et al suggest that nuclear localisation of the androgen receptor is dependent, in 
part, on the occupancy of the receptor. Studies on AR in vivo support a ligand-activated 
transport mechanism, i.e endogenous AR is nuclear in the presence of androgen, and 
unliganded AR is perinuclear in the cytoplasm (Kemppainen et al., 1992; Georget et al., 
1997).
PSA expression observed in the nucleus and cytoplasm was not confirmed by RT-PCR, 
since the incorrect size band was obtained. PSA positive cells were distributed 
throughout organoid sections except for distinct PSA negative clusters, consistently 
situated in the centre of cell clusters. This adds further confusion to these results since it
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is expected that PSA would be expressed in the centre of structures where the lumen is 
expected. This does fit with the unorganised distribution of cytokeratin 8 expressing 
cells. PSAP was negative by immunocytochemistry and RT-PCR. These results were 
consistent with type 2 epithelial colonies in matrigel cultures. Type 2 epithelial colonies 
are thought to contain stem cells.
PNT2-C2, a normal epithelial cell line grown alone in matrigel cultures successfully 
formed spheroids of cells, but do not form'acim, containing a lumen (Lang et al., 2001). 
These cells maintain their monolayer phenotype. In contrast Webber et al grew RWPE- 
1 epithelial cells in matrigel and these cells formed spheroids that contained acini that 
secreted PSA (Webber et al., 1997). Lang et al suggest that formation of acinus-like 
structures in matrigel is dependent on the differentiation state of the epithelial cells.
Temperature sensitive Pre2.8 and S2.13 cells are thought to stop proliferation and start 
differentiation at 37°C and 39°C. S2.13 stromal cells express the Ki-67 proliferation 
marker at 37°C, indicating that the SV40 large T antigen is not being completely 
inactivated. This may be a limiting factor for normal growth and morphology of 
epithelial cells in this model.
Urogenital sinus mesenchyme (UGM) induces epithelial differentiation and 
proliferation and, in turn prostate epithelial cells induce smooth muscle differentiation 
in UGM (Wong YC et al., 1992). Cunha suggests that once the UGM differentiates into 
smooth muscle in adulthood, it is the smooth muscle cell that becomes the crucial 
interactive element in the epithelial microenvironment. S2.13 fibroblast cells do not 
survive well in these matrigel cultures. Smooth muscle cells make up most of stromal 
tissue. SM cells contain a high proportion of androgen receptors. These cells are in close 
proximity to epithelial cells therefore, it is suggested that the stromal, epithelial 
interaction theory is more likely to be a smooth muscle, epithelial interaction (Planz et 
al., 1998). Co-culture of epithelial cells with fibroblast cells in matrigel may not be the 
optimum combination for induction of epithelial cell differentiation and function.
Matrigel is clearly a contributing factor in achieving normal epithelial cell 
differentiation and function, due to induced expression of AR. The expression of AR in 
3-dimensional cultures indicates the presence of 5a-R2 activity. In a study of 
testosterone metabolism jn BPH and CaP (Delos et al., 1998), it was confirmed that 5a-
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R2 was predominantly expressed in prostate tissue and primary prostate cultures 
(Jenkins et al., 1992b). Delos et al observed that 5a-Rl was the isoform preferentially 
expressed in epithelial cell cultures (freshly isolated and long term). 5a-R2 was 
preferentially expressed in epithelial matrigel cultures, indicating that matrigel was 
responsible for changes in enzyme isoform activity. Our results are consistent with 
Delos et al’s findings. In monolayer cultures 5a-Rl, not 5a-R2 was observed in both
S2.13 and Pre2.8 cells, while 5a-R2 is likely to be expressed in Pre2.8, S2.13 matrigel 
cultures. Androgen receptor is expressed in luminal cells, not basal cells and in 50% of 
stromal cells of tissues. Further confirmation of the importance of stromal, epithelial 
and ECM interactions for normal prostate metabolism, is the expression of AR in 
matrigel cultures with S2.13 cells alone, but not with Pre2.8 cells alone. When S2.13 
and Pre2.8 cells are co-cultured in matrigel AR is expressed. As previously mentioned it 
is thought that androgens act on smooth muscle cells to maintain epithelial 
differentiation and in a paracrine manner epithelial cells maintain the differentiated state 
of smooth muscle cells (Cunha et al., 1997).
To date there are three animal models (Timms et al., 1995; Hayward et al., 1999; 
Hayward et al., 1997)and one human model (Lang et al., 2001) co-culturing stromal and 
epithelial prostate cells in matrigel. Lang et al compared epithelial cells alone in 
matrigel containing serum-free medium, then cultures containing serum and finally the 
addition of stromal cells. All culture conditions had similar phenotypes except that the 
addition of stromal cells produced AR expression, which indicates greater 
differentiation. Epithelial and stromal cells in matrigel cultures, in medium containing 
serum, oestrogen and DHT produce compact spheroids that are regular in shape and 
contain a lumen surrounded by one or two epithelial cell layers. The basal layer was not 
intact. We did not find any significant effect with the addition of mibolerone, but we did 
not test the effect of oestrogen. In general Lang et al showed that the outer layer of 
organised spheroids expressed cytokeratin 1,5,10 and 14 and the inner layer expressed 
cytokeratin 18. PSA and PAP was expressed with all culture conditions. Epithelial cell 
types showed no obvious difference in spheroid formation or morphology for CD44+ 
basal cells compared to whole population epithelial cells. A population of CD44" 
epithelial cells did not grow within matrigel, indicating that basal cells are a 
contributing factor in epithelial cell growth. Lang et al showed that stroma co-cultured 
on inserts produced greater spheroid formation compared to stroma mixed with 
epithelial cells in matrigel or stroma laid on top of matrigel. From these results 3-
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dimensional culture set-up may be an important factor. S2.13 stromal cells were directly 
mixed with Pre2.8 epithelial cells in equal volumes of PrEGM and DMEM-FCS and 
placed on top of solid matrigel in 24-well culture plates. Lang et al’s results suggest that 
this is not the optimum culture set-up.
Co-cultures of Pre2.8 epithelial and S2.13 stromal cells in matrigel cultures requires 
further optimisation to achieve terminal epithelial differentiation and production of 
prostate secretions. The matrigel model established by Lang et al, although very useful 
is limited because they are primary cells and have a limited lifespan. A continuous 
supply of primary tissue for these experiments is not achievable. Pre2.8 epithelial and
S2.13 stromal are immortalised cell lines, thus providing a continuous supply of cells. 
Another advantage for the use of Pre2.8 and S2.13 cell lines is that they are temperature 
sensitive. If it is true that non-basal epithelial cells do not grow in matrigel (Lang et al., 
2001), Pre2.8 basal/intermediate epithelial cells are the ideal epithelial population for 
setting up matrigel cultures. In addition to this it is possible that Pre2.8 cells contain a 
stem cell population makes them a useful cell line for studying prostate stem cell 
differentiation. As mentioned above it is likely that S2.13 fibroblasts are not the ideal 
cells for establishing a prostate model. Replacing S2.13 cells with a smooth muscle cell 
line would be preferable.
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